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Summary 
Sox2 and Oct4 partner to regulate the transcription of many genes in the pluripotent 
lineage through binding composite Sox-Oct cis-regulatory elements (SO-CREs). While sequence 
variation within this SO-CRE is evident across multiple target genes, strong conservation within 
a specific SO-CRE across species argues for functional constraints within the specific SO-CRE 
sequences. Given the dynamically changing expression levels of Sox2 in pre-implantation 
development and its role in cell fate decisions I sought to identify the quantitative differences in 
Oct4-Sox2-DNA interaction on target genes important for blastocyst biology. I used a 
combination of electrophoretic mobility shift assay (EMSA) and fluorescence correlation 
spectroscopy (FCS) on full-length fluorescently tagged Sox2 and Oct4 to generate quantitative 
binding data for Sox2-Oct4 complex formation on different SO-CREs. On key target genes, I 
found differences in dissociation constants that correspond with pre-implantation Sox2 protein 
levels and target gene transcriptional output. Specifically, the expression of Fgf4, a growth factor 
that is itself essential for pre-implantation development, parallels expression of Sox2. Fgf4 
expression, though mediated through a cooperative interaction between Oct4 and Sox2, is more 
sensitive to Sox2 levels than other target genes. I also used my developed quantitative assay to 
analyze the complexity in dimer formation of Oct4, highly expressed in embryonic stem (ES) 
cells and Oct6, abundantly expressed in neuronal stem (NS) cells in the presence of Sox2. I 
showed that preferential transcriptional complex formation of POU factors in the presence of 
Sox2 accounts for the difference. Oct6 tends to form a homodimer on palindromic or more 
palindromic Oct regulatory elements (PORE/MORE) rather than forming a heterodimer with 
Sox2 on SO-CRE. This pattern of complexation supports the enrichment for PORE/MORE 
motifs at Oct6 binding loci in NS cells. Conversely, Oct4 prefers to form a heterodimer with 
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Sox2 on SO-CRE rather than a homodimer on a PORE element providing an explanation for the 
observed enrichment of the SO-CRE motif at Oct4 and Sox2 bound loci in ES cells. This helps to 
understand the reason behind the differential cis motif enrichment between these two Pou/Sox 
expressing cell types. Such quantitative analyses will be essential to achieve a systems level of 
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Chapter 1−Introduction  
1.1. Mouse pre-implantation development 
For a long period of time, mouse pre-implantation development has been an 
attractive model to explore gene regulatory networks which control cell fate decisions. 
The cell fate decisions have been morphologically well described for the last two 
decades. The developmental period starts at fertilization and advances from the 1-cell 
zygote to the blastocyst which ends approximately by embryonic day 4.5 (E4.5) (Rossant 
and Tam, 2009) prior to implantation on the uterine wall. At around E3.2-3.5 the embryo, 
commonly referred to as the early blastocyst, comprises two specific cell populations, the 
inner cell mass (ICM) and the trophectoderm (TE). Afterwards at approximately E4.2, the 
ICM segregates into two specific cell lineages, the primitive endoderm (PE), and the 
epiblast (EPI) (Figure 1.1). After the embryo’s implantation on the uterine wall, these 
three cell lineages undergo further differentiation. The TE is a functional epithelium 
which is responsible for mediating attachment with, and helping successful implantation 
on the uterine wall. Subsequently, the TE develops to be the placenta (Hardy and Spanos, 
2002). On the other hand, the PE is an extra-embryonic cell type. The descendants of 
both the TE and PE supply patterning cues and nutrient to the developing embryo 
(Rossant and Tam, 2002). The embryo proper is created from the pluripotent EPI which 
gives rise to all cell types of the embryo and is also the source of embryonic stem (ES) 
cells in in vitro cell culture system. In the present thesis, I am particularly interested to 
seek the experimental validation for the current hypothesis that exists behind the 
segregation of ICM into PE and EPI. 
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Figure 1.1 | Mouse pre-implantation development from embryonic day 0 (E0) to day 4.5 
(E4.5) is shown here (http://stemcells.nih.gov/info/scireport/appendixa.asp). It is 
interesting to note that the embryo takes a journey approximately E4.5 to complete its 
pre-implantation development. 
 
1.2. Current understanding on the hypothesis favouring segregation of the ICM into 
PE and EPI 
The segregation of the ICM into the PE and EPI is the second differentiation 
event in pre-implantation development. This differentiation event is known for more than 
two decades. However, the mechanism of ICM differentiation is still unclear. Previously 
it was thought that the PE segregation is driven by the positional signals coming from the 
interface between ICM and blastocoel (Yamanaka et al., 2006). However, this was later 
challenged by different observations. Rossant et al. showed that different lineage specific 
markers such as Nanog for EPI and Gata6 for PE, are mutually restricted to two groups 
of cells (probably reflecting upcoming lineage commitment) but their positions are not 
aligned as expected from the previously defined positional signals (Rossant et al., 2003).  
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Rather, those cells are randomly distributed in ICM, requiring cell sorting cues to be 
aligned for the preferred segregation. On the other hand, some other studies supported the 
model that ICM cell fate is largely determined prior to the borderline alignment with the 
interface between ICM and blastocoel (Chazaud et al., 2006; Gerbe et al., 2008; Plusa et 
al., 2008) and further supported by a single cell microarray approach showing the most 
comprehensive gene expression analysis yet in ICM (Kurimoto et al., 2006). 
Recently, some key findings by Guo et al. shed light on the PE-EPI segregation. 
Taken together with the notion of temporal difference in the formation of inner cells 
(Fleming, 1987; Pedersen, 1986), two key findings from Guo et al., inner cell specific up-
regulation of Sox2 and the inverse correlation in the expression of Fgf4 (ligand) and 
Fgfr2 (receptor) in early the ICM (Guo et al., 2010), could well  explain  this segregation 
event. This part will be discussed in chapter 2. So far, the most plausible hypothesis is 
focused on Fgf signalling, which seems to be mainly controlled by the inner cell specific 
up-regulation of Sox2. In addition, Fgf4 and Fgfr2 have been shown to be essential for 
this segregation (Arman et al., 1998; Chazaud et al., 2006; Feldman et al., 1995). 
Furthermore, a chromatin immunoprecipitation sequencing (ChIP-seq) study showed that 
Fgf4 and Fgfr2 are the target genes of Sox2 (Chen et al., 2008). Two studies also showed 
that Sox2 can work as repressor for Fgfr2 (Masui et al., 2007) and activator for Fgf4 
(Yuan et al., 1995). All these findings point to the most plausible hypothesis working 
behind the segregation, which is, the sensitivity of Fgf4 and Fgfr2 expression to Sox2 
levels determines the cell fate of ICM. However, this needs further experimental 
validation based on true molecular binding interaction on the protein level of Sox2 with 
those gene’s cis regulatory elements. 
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1.3. The scope of this study 
To date, there has been no description of the quantitative interaction between full-
length Sox2 and Oct4 with different SO-CREs. While some qualitative studies were 
attempted on Sox2-Oct4-DNA assembly (Kuroda et al., 2005; Rodda et al., 2005) the 
results were inconclusive to understand the details of sequence specificity and their 
mutual synergism in stable complex formation. Therefore, I conducted a quantitative 
binding study to gain an in-depth understanding on Sox2-Oct4-DNA assembly. This 
study could infer the level of dependency between Sox2 and Oct4 for forming the stable 
transcriptional complex assembly with different SO-CREs. Moreover, the findings of the 
required level of Sox2 protein concentration for stable complex formation on the cis 
elements of Fgf4 and Fgfr2 correlates well with these genes’ expression levels. As this 
Fgf signalling is directly responsible for the segregation of ICM into PE and EPI, I 
experimentally validate the current hypothesis favouring the cell fate decision of ICM. In 
addition, I establish the notion of sequence specificity over stable complex formation by 
experimental validation. This quantitative binding interaction assay will further help us to 
understand the synergism (cooperativity) between transcription factors interacting on 
closely associated CREs involved in the gene regulatory network directing the 
segregation of ICM into PE and EPI. 
Therefore, strategies to validate the hypothesis are: 
• Validate dynamic levels of Sox2 protein in pre-implantation embryos. 
• Confirm direct binding of Sox2 to the regulatory elements of Fgf4 and Fgfr2. 
• Determine the level of Sox2 concentration for stable complex formation on the 
SO-CRE of Fgf4  
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• Compare in vitro binding interaction data with in vivo findings to bridge my data 
with the segregation of ICM into PE and EPI. 
1.4. Research Aim: 
The main purpose of my dissertation was to investigate the molecular binding 
interaction among transcription factors with their respective DNA binding site that 
enhances our understanding into the cell fate decision of ICM in the pre-implantation 
development in more quantitative detail. Specifically, my aims were: 
1) To develop a robust quantitative binding assay based on a single-molecule sensitive 
technique, fluorescence correlation spectroscopy (FCS) and a biochemical assay, 
electrophoretic mobility gel shift assay (EMSA) and determine the quantitative binding 
interaction on the assembly of protein-protein, protein-DNA, and protein-DNA-protein 
complexes. 
2) To establish a correlation of these quantitative data in the context of the mouse pre-
implantation development and provide experimental validation of our hypothesis on the 
cell fate decision within the ICM.  
3) To apply my quantitative assays to investigate differences in the behaviour of Sox2 
and POU factors between ES cells and NS cells. This section of ES and NS cell 
comparison is well discussed in Chapert 4.3 due to avoinding any confusion with the 
main study which is the segregation of ICM into PE and EPI. 
The thesis contains five chapters structured as follows: 
Chapter 1 provides the introduction. 
Chapter 2 contains a literature review focused on a detailed discussion of the background 
research and techniques used for different assays. 
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Chapter 3 contains the material and methods used during the research. 
Chapter 4 contains results and discussion within three subsections focusing on; (a) 
establishment of a novel and robust quantitative assay, (b) testing the hypothesis that the 
sensitivity of Fgf4 and Fgfr2 expression to Sox2 levels determines cell fate, and (c) 
characterizing the different nature of Sox and POU motif enrichment between ES cells 
and NS cells. 
Finally, chapter 5 gives the general discussion of my overall study and concludes with 
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Chapter 2−Literature Review 
2.1. Early cleavages and developmental bias 
Pre-implantation development in the mouse starts with successful fertilization 
where after fertilization an oocyte becomes a single cell zygote at embryonic day one 
(E1.0). After passing through the oviduct the zygote subsequently travels to the uterus, a 
journey that takes roughly 4 days through successive cell divisions. The first cleavage 
makes two indistinguishable cells, which is followed by another cell division producing 
4-cells embryo. If these cells detach from one another, the potential outcome is 
genetically identical embryos which is the basis of identical twins. However, in normal in 
vivo conditions the cells typically remain together and go through further cell division 
producing 8-cell embryos at approximately E2.0 (Gilbert and Sarkar, 2000). In the 8-cell 
stage embryo, all the cells, called blastomeres now, are tutipotent (Johnson and 
McConnell, 2004). Each of the blastomeres after being isolated from 4- to 8-cell stages 
can grow and form a blastocyst-like structure when cultured in vitro (Rossant, 1976). 
Additionally, it is important to note that fetal development is not affected by the ablation 
of a blastomere (Ciemerych et al., 2000; Tarkowski, 1959; Tsunoda and McLaren, 1983; 
Zernicka-Goetz, 1998). Thereby, different blastomeres of early cleavage sustain the 
potential to generate all cell lineages (Yamanaka et al., 2006). Although each blastomere 
is equally potential in further development, these are not identical.  It is already 
established that they could end up with completely different cell fate decision after being 
exposed to small difference in the external environment or the internal programs. While 
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totipotency does exist until the 8-cell stage, there may be developmental bias between 
individual blastomeres at these stages (Zernicka-Goetz, 2005).  
Morula formation through compaction − During these early cell divisions, studies 
have shown there is no total size increase in the resulting embryo; there is no growth, 
growth only begins at the blastocyst stage. Each successive division splits the blastomeres 
into smaller cells, keeping the total embryo volume relatively constant (Pelton et al., 
1998). Once the embryo reaches the 8-cell stage, it undergoes a process called 
“compaction” resulting in a ball of tightly packed cells derived from a formerly “loose” 
array of blastomeres. Blastomeres are now more adhesive and polarized (Johnson et al., 
1986; Yamanaka et al., 2006). This compacted 8-cell embryo is now referred to as a 
morula and undergoes another round of cell division resulting in the 16-cell stage morula. 
In this stage, a group of cells arise in the middle of the embryo to create a cluster of inner 
cells while the rest of the cells remain surrounding the inner cells and are termed as outer 
cells. The morula further goes through another cell division prior to the cavitation stage 
(near at E3.0) resulting in the 32-cell stage. In this cell division (16-cell to 32-cell stage) a 
second wave of inner cells are derived from outer cells of the 16-cell morula. Hence there 
are two waves of inner cells formation; one from 8-cell to 16-cell stage (1st wave) and 
another from 16-cell to 32-cell stage (2nd wave). Therefore, it is important to notice that 
there is a temporal difference in the inner cells formation. Up to 32-cell stage, all the cells 
in inner cell cluster remain pluripotent whereas the outer cells are multipotent and differ 
from the inner cells at the molecular level (Guo et al., 2010).  
Cavitation to blastocyst − By E3.0, the embryo begins to cavitate creating a fluid-
filled cavity called the blastocoel resulting from the fluid pumping action of the newly 
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formed trophectoderm (TE) on the outside of the embryo (Fong et al., 1998). As a 
consequence of blastocoel formation, a physical separation happens between outer cells 
and inner cells in morula which further results in early blastocyst from morula stage. 
Because of growing blastocoel, the compacted inner cells are forced to move to one side, 
known as the embryonic or polar end, and create is termed the inner cell mass (ICM). At 
this stage, the embryo, now no longer a morula but a blastocyst contains two discrete cell 
populations: the TE and ICM (Beddington et al., 1999). Furthermore, in successive cell 
division, ICM which is pluripotent in nature, differentiates in two definitive cell lineages,  
  
Figure 2.1 | Important developmental stages of the pre-implantation embryo are shown. 
(a) Pre-implantation development starts with the single-celled zygote. The first definitive 
cell lineages appear at the early blastocyst, subsequently the ICM undergoes a second cell 
fate decision. Here “E” represents the embryonic day of developmental growth. (b) The 
appearance of specific cell lineages is shown in different stages during pre-implantation 
development. The colour-coding identified the potency of differentiation. Red and steel 
colours represent pluripotent cells and green and blue colour represent multipotent cell. 
[Modified from(Yamanaka et al., 2006)]. 
 
namely primitive endoderm (PE) and epiblast (EPI) (Rossant and Tam, 2009; Yamanaka 
et al., 2006). By E4.0 the embryo is a mature blastocyst having three distinct cell lineages 
a b 
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prior to hatching from zona pellucida, a protective layer enveloping the oocyte (Figure 
2.1).           
Hatching to implantation − By the end of E4.0 the embryo arrives at the uterus. 
After reaching the uterus, the embryo goes through a specific stage called “hatching”. 
During hatching the blastocyst will come out from the zona pellucida, the glycoprotein 
membrane that prevents the embryo from implanting into the uterine wall (Gilbert, 2001). 
At around E4.5 the mouse embryo implants on the wall of uterus completing its journey 
of pre-implantation development. Further development of the TE results in the formation 
of a functional epithelium responsible for mediating attachment of the embryo with the 
uterine wall. On the other hand, the descendants of PE protect the embryo proper 
resulting from EPI, by supplying nutrient and patterning cues (Guo et al., 2010).  
We have seen here that there are three distinct cell lineages appearing because of 
controlled differentiation process prior to implantation. The first cell lineage choice may 
be understood in terms of cell positioning (the inner versus outer cells of the morula) 
followed by different environmental signalling cues. However, the cell fate decisions 
leading to the PE and EPI from within the ICM are not apparently a result of positioning 
as the precursors to these cell types are intermingled within the ICM. The following is 
what is known on how the PE and EPI form from the ICM.  
2.2. PE and EPI cell fate decision within the ICM 
The early development of many invertebrates and non-mammalian vertebrates are 
facilitated due to the preferred localization of maternal determinants; and polarity could 
be another factor which could be established as early as the single cell zygote (Howley 
and Ho, 2000; Nüsslein-Volhard, 1991). However, the scenario greatly differs in 
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eutherian mammals. It is seen that the contributions from maternal determinants are 
insignificant in pre-implantation development (Johnson et al., 1986). Historically, the 
mouse pre-implantation embryo has provoked a lot of debate on the existence of polarity 
during early cleavage events (Hiiragi et al., 2006). 
A monolayer of cells which are directly facing blastocoel form PE which protects EPI 
from facing blastocoel and thereby EPI is localized in the middle of polar TE and PE 
lineage. For a long time, there was an open question “what is controlling the segregation 
of ICM into PE and EPI?”  
Extensive research has been performed to investigate this event in the last two 
decades leading to a better understanding; the most relevant findings are documented 
here in four different inter-connected sections.  
2.2.1. Temporal differences in inner cell formation 
The heterogeneity in the population of inner cells arising due to a temporal 
difference in inner cell formation is believed to be one of the most important reasons for 
the segregation of ICM into PE and EPI (Fleming, 1987; Pedersen, 1986). Firstly, it is 
important to understand where from this temporal heterogeneity originates. Due to 
asymmetric cell division, some cells will localize in the middle of the morula and those 
cells are called as early inner cells (sometime also call as primary inner cells) while the 
remainder of cells are known as outer cells (Rossant and Tam, 2009). When the early 
morula undergoes another round of successive asymmetric cell division  from outer cells, 
while giving rise to more outer cells, also give rise to some new inner cells, known as late 
inner cells (sometimes called secondary inner cells) (Figure 2.2). As a result, a temporal 
difference is observed in the formation of inner cells, which is possibly creating the gene 
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expression heterogeneity within ICM. Arguably, these two waves of inner cell formation 
create the differences in gene regulatory network between individual cells within the ICM 
that lead to cell lineage specification. Besides, Morris et al. showed that the first wave 
predominantly contributes to EPI and the second wave predominantly contributes to PE 
(Morris et al., 2010). 
 
Figure 2.2 | Two waves of inner cell formation: the source of heterogeneity in the ICM 
(originally drawn by Dr. Paul Robson). 
 
2.2.2. Molecular heterogeneity within the ICM 
Taken together with the temporal difference in the formation of inner cells, a 
complex gene regulatory network is tightly involved for the segregation of ICM into PE 
and EPI. In the second cell-fate decision, specific expressions of TFs for each lineage 
have been identified. Prior to implantation at E4.5, EPI is characterized by pluripotent 
markers such as Nanog, Sox2 and Esrrb (Kurimoto et al., 2006) while PE expresses 
Gata4, Gata6, and Pdgfra (Koutsourakis et al., 1999; Morrisey et al., 1996; Morrisey et 
al., 1998; Plusa et al., 2008). However, the mechanistic basis behind this differential 
regulation of TFs is yet unknown. Prior to EPI and PE establishment at E4.5, the ICM 
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shows a mosaic pattern of cells expressing Nanog and Gata6 (Chazaud et al., 2006). The 
mosaic expression of the markers does not indicate specification; however, as cells 
expressing the PE marker (Gata6/4) can be coaxed into forming the PE lineage and cells 
expressing the EPI marker (Nanog) turn to be the EPI lineage. It is not until E4.5, that the 
cells become restricted to their own lineages. However, it should be noted that individual 
cells of the 8-cell uncompacted embryo lack this heterogeneity. This eventually 
concludes that the molecular heterogeneity must be created between the 8-cell and early 
blastocyst stage (Guo et al., 2010). 
A highly recognized study based on transcriptional microarray analysis of single 
cells from ICM has shown two distinct clusters of cells based on the EPI and PE specific 
markers where one cluster is richer in EPI markers and another enriched with PE specific 
markers (Kurimoto et al., 2006). Sampling gene expression at the single cell level as cells 
dynamically change from the 8-cell uncompacted embryo through to the 64-cell 
blastocyst has revealed the path to molecular heterogeneity within the ICM (Guo et al., 
2010). This work from the Robson group provides the foundation for my PhD thesis 
hypothesis. 
2.2.3. Fgf signalling is essential for the PE formation 
Recent studies have indicated that the Fgf4/Fgfr2 signalling pathway lies 
upstream of this differential expression (Guo et al., 2010; Nichols et al., 2009; Nichols et 
al., 1998). Fgf4 is expressed in the EPI lineage, while Fgfr2 is expressed in PE 
(Niswander and Martin, 1992; Orr-Urtreger et al., 1991). Treatments with an Fgf 
signalling inhibitor transform the mosaic ICM cells into the EPI lineage (Yamanaka et al., 
2010). 
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 Earlier mouse gene knockout studies have revealed that components of the Fgf 
signalling pathway are essential for the establishment of the extra-embryonic endoderm. 
Specifically, Fgf4, Fgfr2, and Grb2, a downstream effector of FGF signalling, null 
embryos all die shortly after implantation due to defective extra-embryonic endoderm 
(Feldman, Poueymirou et al. 1995; Arman, Haffner-Krausz et al. 1998; Cheng, Saxton et 
al. 1998; Chazaud, Yamanaka et al. 2006). In Addition, Chazaud et al. showed that the 
loss of Grb2, a downstream effector of Fgf signalling, leads to the loss of Gata6-positive 
cells (i.e. PE) within the ICM (Chazaud et al., 2006). Moreover, recent findings argue 
that this signalling has an important role in promoting the transition from a naïve (i.e. 
ICM) to a primed states (i.e. PE and EPI) and stopping the reversal event resulting in the 
stabilization of the primed cell state (Greber et al., 2010; Hanna et al., 2009; Hanna et al., 
2010). 
Subsequently, three recent studies showed that there was complete loss of PE 
markers in embryos treated with a pharmacological inhibitor of the Fgf receptor during 
the transition from the 8-cell embryo through to the blastocyst (Guo et al., 2010; Nichols 
et al., 2009; Yamanaka et al., 2010). On the contrary, the reverse nature of cell fate was 
observed when exogenous Fgf4 was added in the cell culture which potentially pointed 
out the essence of Fgf signalling.  This notion is well supported by the study of 
Yamanaka et al. using the PdgfraH2B-GFP reporter mice (Yamanaka et al. 2010). Two other 
studies also observed similar results. Guo et al. have reported that there was elimination 
of PE markers (Gata4, Sox17) and simultaneous activation of EPI markers (Nanog, 
Esrrb) when they treated embryos with Fgfr inhibitor SU5402 (Guo et al., 2010). Nichols 
et al. also showed that embryos lost PE lineage after the treatment with Fgf inhibitor from 
15 | P a g e  
 
E2.5-4.5 (Nichols et al., 2009). Importantly, Guo et al. identified that the Fgf signalling 
axis within the early ICM was established by an inverse correlation of expression of Fgf4 
and Fgfr2, with the former in the presumptive EPI and the later in the presumptive PE 
(Guo et al., 2010). Hence, Fgf signalling taken together with the heterogeneity could be 
pivotal for the cell fate decision in ICM. 
2.2.4. Current working model of PE versus EPI lineage segregation 
With the temporal differences in inner cell formation, the essential requirement 
for Fgf signalling in the establishment of the PE, and the identification that the Fgf 
signalling axis is established through inverse correlation in expression of the ligand-
receptor pair led to the following hypothesis first proposed in Guo et al. (2010). A central 
component of this was the finding by Guo et al. that there is an inner cell-specific 
upregulation of Sox2. Sox2 is a transcription factor well-known to heterodimerize with 
Oct4 and drive pluripotent-specific gene expression (Ambrosetti et al., 1997; Kuroda et 
al., 2005; Nishimoto et al., 1999; Rodda et al., 2005). The expression of Oct4, as well as 
many other pluripotent TFs, while abundant remain unchanged in the pluripotent lineage 
in the 8-cell to blastocyst transition, Sox2 is the only known TF to dynamically change 
through this stage (Guo et al., 2010). In this same data set there was an excellent 
correlation in the expression of Fgf4 and Sox2 fitting with the notion that Sox2 is a 
regulator for Fgf4. In addition, this novel single cell approach showed an inverse 
correlation in Fgf4/Fgfr2 expression upon establishment of the early ICM. Based on this 
expression data set, a model of the developmental genetic regulatory network was 
proposed for the segregation of ICM into PE and EPI lineages (Figure 2.3). The basis of 
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this model again depends on molecular differences resulting from temporal difference in 
the inner cell formation.  
 
 
Figure 2.3 | A proposed developmental genetic regulatory network for the establish- 
ment of cell fate decision in the early ICM [modified from (Guo et al., 2010)]. 
 
In this model the primary molecular difference between inner and outer cells is 
the zygotic activation of Sox2 specifically in inner cells. As inner cells do not form at the 
same time, this will lead to temporal difference in Sox2 upregulation thus cells of the 
ICM will have initiated Sox2 target gene regulation at different times. The model 
proposes that elevated levels of Sox2 in the early inner cells (deep purple cells in Figure 
2.3) results in the transcriptional downregulation of Fgfr2 (Masui et al., 2007) and 
upregulation of Fgf4 (Yuan et al., 1995). Conversely, late inner cells derived from Fgfr2-
positive outer cells come directly in contact with the nascent Fgf4 signal. This exposure 
to Fgf signalling immediately results in the down regulation of a group of pluripotent 
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markers (genes) such as Nanog, Esrrb, and Klf2 and the upregulation of PE markers like 
Gata4 which effectively leads to the PE lineage fate. In contrast, in addition to down-
regulation of Fgfr2, early inner cells would be replenishing the dropping levels of 
maternal Sox2 by the initiation of zygotic expression and this eventually sustaining the 
expression of key pluripotent makers like Nanog that are also known to be Sox2 target 
genes (Rodda et al., 2005).  
While convincing, this hypothesis still lacks experimental validation. This 
experimental validation forms the basis of my thesis work. Key experimental evidence 
still required is firstly, to show Sox2 protein levels correlate well with the dynamically 
changing levels of Sox2 mRNA through pre-implantation development. Second, confirm 
Sox2 directly binds to the sox cis elements of Fgf4 and Fgfr2 and ultimately, to make 
precise measurements on the apparent Kds of Sox2 and its partner, Oct4, on these cis 
regulatory elements to attempt to explain why these genes are most sensitive to 
fluctuating levels of Sox2. Once measured, this information will shed light on the validity 
of this model and thus the mechanisms of cell fate decisions within the ICM. 
2.3. Sox2 function in early embryonic development & pluripotent cells 
SRY (sex determining region Y)-box 2, also known as Sox2, is a member of the 
HMG-box protein superfamily and one of the key factors essential to sustain pluripotency 
and self-renewal of undifferentiated ES cells. Full-length Sox2 contains 319 amino acids 
residue and possesses a single high mobility group (HMG) domain that functions to bind 
DNA with the motif CTTTG(A/T)(A/T) (Harley et al., 1994; Wilson and Koopman, 
2002). While the HMG domain is conserved, regions outside of the domain vary between 
subgroups of the family (Bowles et al., 2000). It also forms complexes with a wide 
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number of transcription factors which together could act as activators or repressors 
(Kamachi et al., 2000). Its active partnering puts it as a regulator of several biological 
processes, such as early mouse development, lens and retina development, and neural 
progenitor specification (Kondoh and Kamachi, 2010). 
Mouse Sox2 expression is observed in pluripotent cells, in the extraembryonic 
ectoderm, and in germ cells. In the pre-implantation development, its zygotic expression 
starts at 8-cell stage and shows increasing level of inner cell specific expression resulting 
in abundant expression in the EPI (Guo et al., 2010). In post-implantation developmental, 
Sox2 gets its expression restricted to the developing neural tube. The neuroepithelium 
and adult neural stem cells experience high expression of Sox2 (Episkopou, 2005; Wood 
and Episkopou, 1999; Zappone et al., 2000). It is experimentally shown that Sox2 null 
embryos are peri-implantation lethal as the maintenance of EPI gets disturbed (Avilion et 
al., 2003). Even, Avilion et al. could not rescue the ICM with the help of exogenous Fgf4 
(Avilion et al., 2003). This could be explained by the reestablishment of the nascent Fgf 
signal due to having abundant expression of Fgfr2 in the Sox2 null embryo. However, the 
presence of maternal Sox2 protein could mask its earlier role within the ICM and 
therefore, it is difficult to track the earliest moment of its requirement in the pre-
implantation development. The maintenance of pluripotent ES cells requires a critical 
level of its expression as its loss in ES cell leads to trophoblast differentiation (Niwa et 
al., 2005).  
A recent work by Chen at al. revealed that Sox2 recognises a highly repeated 
DNA binding motif in partnering with Oct4 through a global ChIP-seq study in ES cells 
(Chen et al., 2008). When similar experiment was done with Oct4, a similar enriched 
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motif came out containing the binding site for both Oct4 and Sox2. This DNA motif is 
known as SO-CRE. This hints for their cooperative nature of interaction resulting in SO-
CRE target gene expression. However, a recent study showed that Sox2 is dispensable for 
a number of SO-CRE target genes. On the other hand, Oct4, another transcription factor 
is capable of rescuing Sox2 deficient embryos suggesting a pivotal role of Sox2 for the 
proper maintenance of Oct4 expression (Masui et al., 2007). Although, we cannot 
arguably neglect the key role of Sox2 in the regulation of SO-CRE target genes as other 
Sox factors such as Sox4 or Sox11 could perform the process in the absence of Sox2. If 
the binding affinity of Sox2 is higher than those Sox factors, Sox2 preferably regulates 
those target genes even in the presence of other Sox factors. 
Because of the presence of a SO-CRE in the Fgf4 enhancer region, it is interesting 
to see the role of Sox2 in the early mouse development. This can be tested by analysing 
its physical interactions using biophysical and biochemical tools. Furthermore, it is 
observed that the small fluctuation in Sox2 protein level results in the differentiation of 
ES cells into a wide range of differentiated cell types (Chew et al., 2005; Kopp et al., 
2008). Consequently, the dynamic level of Sox2 protein is believed to act as a molecular 
rheostat guiding SO-CRE target genes’ expression (Boer et al., 2007). A recent work by 
Matt Thomson et al. uncovered that the increasing protein level of Sox2 differentiates 
pluripotent ES cell to its progenitor neural ectoderm. Conversely, the upregulation of 
Oct4 protein level directs towards the mesendodermal lineage (Niwa et al., 2000). 
Consequently, the dynamic level of Sox2 protein has an immense role in the segregation 
of ICM into PE and EPI in early developing mouse embryo (Guo et al., 2010). 
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2.4. Oct4 function in early embryonic development & pluripotent cells 
Octamer binding transcription factor-4 (Oct4), encoded by gene Pou5f1, is a 
member of POU transcription factor family that are all characterized by a conserved 
bipartite POU domain containing the POU-specific domain (POU-S) and the POU 
homeodomain (POU-HD). Together, these subdomains recognize the canonical octamer 
motif 5’-ATGCAAAT-3’ (Verrijzer et al., 1992). 
Oct4 is known to be a component of a core circuitry regulating pluripotency in 
mouse embryonic stem cells, along with Sox2 and Nanog (Boyer et al., 2005). In the 
developing mouse embryo, its expression can be detected in the one-cell stage, becomes 
restricted in the inner cell mass, and later on expressed only in primordial germ cells 
(Pesce and Schöler, 2001). Even, maternal Oct4 is observed in oocyte which infers its 
importance in the pre-implantation development. It shows very low level of expression in 
the TE lineage whereas it maintains at high expression in the ICM during the first cell 
lineage fate. Furthermore, the expression level remains unaltered in the EPI lineage and is 
strictly restricted in primordial germ cells (Rosner et al., 1990; Schöler et al., 1989; 
Schöler et al., 1990).  
It is experimentally shown that Oct4 null embryos still undergo a blastocyst stage, 
but the ICM cells lose their usual capacity to differentiate into multiple lineages. These 
severely affected embryos only produce the extraembryonic trophoblast cells in vitro 
culture (Nichols et al., 1998). Of note, the sustainability of ES cell is maintained with a 
critical level of Oct4 expression. It is experimentally shown that a less than two fold 
repression of Oct4 provokes differentiation to the TE. In contrast, a less than two fold 
overexpression of Oct4 leads to dedifferentiation into the PE and mesoderm lineage. 
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Therefore, a precise level of its expression is required to be maintained to sustain the 
pluripotency of ES cell (Niwa et al., 2000).  
2.5. The Sox2-Oct4-DNA ternary complex and target genes 
Taken together with the important role of Oct4 (Nichols et al., 1998; Niwa et al., 
2000), the recent findings on Sox2 (Avilion et al., 2003; Guo et al., 2010) suggest that a 
simple combinatorial model which involves Sox2, Oct4 and SO-CRE, can explain the 
establishment of cell lineages arising in pre-implantation embryo development.  Sox2 has 
been known to form a complex with Oct4 in regulating early mouse development. Their 
cooperation is achieved in part through the adjacent location of Sox2 recognition 
sequence and the octamer motif recognized by Oct4 in the enhancer regions of genes 
containing the SO-CRE, which so far includes Nanog (Kuroda et al., 2005; Rodda et al., 
2005), Zfp206 (Wang et al., 2007), Fgf4 (Ambrosetti et al., 1997), Utf1 (Nishimoto et al., 
1999), Fbx15 (Tokuzawa et al., 2003), as well as Sox2 and Pou5f1 (Oct4) (Chew et al., 
2005) themselves. The SO-CRE is reported as 5’-CATTGTTATGCAAAT-3’ in literature 
(Chen et al., 2008), where ‘ATGCAAAT’ represents the Oct4 binding site while 
‘CTTTGTT’ represents the Sox2 binding site (Loh et al., 2006; Verrijzer et al., 1992). 
The proximity of these two motifs exposes the two proteins to specific interaction 
residues. Interestingly, not all enhancer regions of these genes share the same 
organization. The Oct4 and Sox2 binding sites in SO-CRE of Fgf4 are separated by three 
DNA base pairs, introducing both proteins to different interaction residues (Reményi et 
al., 2003).  Although under control of Oct4, Sox2, and SO-CRE, these genes have 
different functions and expression patterns in mouse embryo development (Guo et al., 
2010). 
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2.6. Diversity in transcriptional complex formation by POU factors in embryonic 
development 
POU (Pit-Oct-Unc)-domain transcription factors which are originally 
characterized based on a common region of roughly 150-160 amino acids, represent a 
highly conserved family of proteins including general, developmental and tissue-specific 
regulators of many miscellaneous cell types (Verrijzer et al., 1992; Wegner et al., 1993). 
A broad range of biological processes starting from housekeeping gene functions, viral 
gene expression and DNA replication are controlled by the members of these family 
proteins. Some of them are also known for directing the expression of neuronal gene 
promoters (Pit1, encoded by Pou1f1, and Brn1, encoded by Pou3f3) (Jacobson et al., 
1997), establishing the immune system and antibody production (Oct2, encoded by 
Pou2f2) (Scheidereit et al., 1987) to the programming of ES cells and NS cells (Oct4, 
encoded by Pou5f1 and Oct6, encoded by Pou3f1) (Schöler et al., 1989; Zwart et al., 
1996). This POU domain consists of an N-terminal POU-specific (POUs) subdomain of 
75 amino acids and a C-terminal POU-homeodomain (POUhd) of 60 amino acids which 
is connected by a flexible linker of varying length ranging from 15 to 56 amino acid 
residues or greater (Herr and Cleary, 1995). The bipartite nature of this DNA binding 
domain implies that these two sub-domains could work separately in DNA recognition, 
transcriptional activity or functional interaction with other cofactors involved in gene 
regulation (Botfield et al., 1992). 
One of the well studied roles of these POU transcription factors is controlling the 
gene expression by dimerizing on target promoter-enhancer sequence either in a 
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combinatorial fashion with other cofactors or with itself. It is described in an earlier 
section that Oct4 forms a heterodimer with Sox2 on SO-CREs of different target genes 
including Nanog, Fgf4, Utf1 and themselves (Ambrosetti et al., 1997; Chew et al., 2005; 
Nishimoto et al., 1999; Rodda et al., 2005). However, it is also reported that Oct4 can 
form a homodimer complex on palindromic Oct regulatory element (PORE) sequence, 
(5’-ATTTGAAATGCAAAT-3’) controlling the gene expression of Spp1 (also known as 
OPN) during pre-implantation of the mouse embryo (Botquin et al., 1998). Interestingly, 
there is a genuine question hidden behind this dimerization process of these POU 
proteins. How do they decide when they have to form a heterodimer or homodimer 
complex? In the context of pre-implantation development, the possible answer could be 
the level of Sox2 concentration. In epiblast, Oct4 favors to form heterodimer while 
homodimer in the absence of Sox2 in primitive endoderm (Botquin et al., 1998). 
Furthermore, I could anticipate a similar trend of dimer formation by POU factors in both 
the ES cells and the NS cells as it is known that Sox2 is abundantly expressed in both cell 
lines (Catena et al., 2004; Kim et al., 2008).  Therefore, I was also interested to test this 
hypothesis on the trend of dimer formation between these two cell lines. I considered 
Oct4 for ES cells and Oct6 for NS cells because of their abundant expression in the 
respective cell lines.  
Oct6 is known as a POU family Octamer binding protein-6 transcription factor 
(Ruvkun and Finney, 1991). It is reported to express in the embryonic stem cells during 
the development of neural cells and assists myelinated cell for its differentiation into the 
peripheral and central nervous system (Bermingham et al., 1996; Suzuki et al., 1990). 
Any shortcomings in the expression of Oct6 level may result in neurological disorders 
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like Schizophrenia (Ilia et al., 2002). A bipartite DNA binding domain of Oct6 facilitates 
its binding with a variety of DNA motif including palindromic Oct-factor recognition 
element (PORE), more of PORE (MORE) resulting in the homodimer complex (Jauch et 
al., 2010). 
2.7. Quantitative insight in cooperativity of binding interactions  
The interaction of regulatory proteins with DNA sequences that favor gene 
expression is pivotal for gene regulation in eukaryotes. Such DNA sequences often 
encode multiple binding sites for one or more transcription factors. Synergism among 
those transcription factors is crucial to gene regulation in eukaryotes and it is inherently 
combinatorial in nature (Carey, 1998; Levine and Tjian, 2003). The level of cooperative 
DNA binding seen in vitro binding assays among transcription factors and DNA elements 
can account for the level of synergistic transactivation observed in vivo.  
Cooperativity is considered to be one of the most important functional activities in 
the biological system and is occasionally referred to as the “second secret of life” (Forsen 
and Linse, 1995). In the context of protein-DNA interaction, it is defined to be the ability 
of a protein binding at one site on a cis regulatory element (commonly known as 
enhancer) to influence other protein binding at a juxtaposed site on the same DNA 
element. It is also interesting to look through the reasons behind this most desired 
phenomenon for DNA-transcription factor binding interaction. 
There are possibly two non-mutually dominating models that could explain the 
synergistic transcriptional enhancement. Firstly, it could be achieved by direct protein-
protein interaction when they come closer facilitated by DNA binding. Such a type of 
assistance mediated by DNA could trigger the strong binding interaction from very weak 
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Figure 2.4 | Concept of synergism in transcription factor-DNA binding interaction is 
depicted here. Here Kds represents Kd of Sox2 with DNA binding whereas Kdo stands for 
Kd of Oct4 and DNA binding. Kdso represents the Kd of Sox2 and DNA in presence of 
saturated Oct4. In this project, this Kdso will be considered as Kda , an apparent dissociation 
constant as the titration of Sox2 with DNA will be performed in unsaturated 
concentration of Oct4 targeting the concentration dependency in ternary complex 
formation. 
 
or no interaction in the absence of DNA assistance. On the other hand, pre-structural 
assistance (also called pre-organized binding site) due to binding of one factor earlier to 
another juxtaposed binding site could facilitate the binding of second factor to the 
modified binding site. Thereby, it will be easier to understand protein-DNA binding 
interaction models involved with Oct4, Sox2 and SO-CRE (Figure 2.4). In this model, I 
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would like to make a quantitative determination for justifying the synergism involved in 
the assembly of Sox2-Oct4-DNA complex.  
2.8. Summary of literature review 
Since the key pluripotent markers, under control of SO-CREs, have different 
expression patterns and roles in different cell-stages during early mouse development, it 
has been hypothesized that these differences could be due to differences in the levels of 
Oct4 and Sox2 which has an immense effect on their cooperativity binding on SO-CRE 
(Reményi et al., 2003). However, the dynamic level of Sox2 is the determinant compared 
to Oct4 which remains in almost static level during pre-implantation development (Guo 
et al., 2010).  While sequence variation within this SO-CRE is evident across multiple 
target genes, strong conservation within a specific SO-CRE across species argues for 
functional constraints within the specific SO-CRE sequences (Rodda et al., 2005). The 
importance of this heterodimer complex behind the gene regulatory system has drawn a 
lot of attention in pluripotent stem cell research and pre-implantation development. 
Although it is established that Sox2 and Oct4 form a heterodimer complex in presence of 
SO-CRE, their interactive pathway of the heterodimer formation is still unclear. In 
addition, the importance of the concentration level of interacting proteins and the 
involved cooperativity behind complex formation has not yet been quantitatively 
addressed. Given the dynamically changing expression levels of Sox2 in pre-implantation 
development and its role in cell fate decisions I am seeking to identify quantitative 
differences in Oct4-Sox2-DNA interactions on target genes important to blastocyst 
biology. In addition, I investigate the quantitative difference in transcriptional 
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complexation by Oct4 and Oct6 in the presence and the absence of Sox2 which could 
answer the difference in gene regulatory networks of ES cells and NS cells.  
2.9. Important techniques- theory and principle 
2.9.1. Electrophoretic mobility gel shift assay (EMSA) 
Introduction- EMSA is the core technology underlying a wide range of qualitative 
and quantitative analyses for the binding assay of protein–DNA or protein–RNA 
interactions. It is also sometimes referred to as a gel shift assay, gel mobility shift assay, 
band shift assay, or gel retardation assay and works based on affinity electrophoresis. 
However, although this technique is known for a long time, the most useful binding assay 
was created based on the protocol proposed by Garner and Revzin (Garner and Revzin, 
1981) as well as Fried and Crothers (Fried and Crothers, 1981). 
Working principle − There are several steps for a successful EMSA experiment 
which will be discussed below. Firstly, the technique requires a non-denaturing TBE-
polyacrylamide gel to separate protein DNA complexes from free DNA. Traditionally, 
large format gels were used to resolve those binding reaction for the full-length construct 
for better separation. Depending on the size of the target DNA and the size, number and 
charge of the protein(s) involved in the complex formation, one should determine the gel 
percentage. The typical gel percentages range in between 4% to 8%. One should take 
immense care for loading the reaction sample and make sure that samples are not trapped 
at the bottom of the loading well. Depending on the assay type (whether it is based on 
purified proteins or cell lysate), a competitor DNA is used at optimised amount due to 
avoiding non-specific binding if the assay is based on unpurified nuclear cell lysate. In 
case of purified protein, competitor DNA is not required.  
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  It is necessary to cast and pre-run the gel at least more than one hour prior to 
starting the protein-DNA binding assay for incubation (Figure 2.5). This pre-run should 
be considered with high importance as it removes all traces of ammonium persulfate 
(catalyst of polymerization) and distributes/equilibrates all materials (ions) of the 
electrophoresis buffer any special stabilizing factors or ions that were added to the 
electrophoresis buffer. This pre-run will also establish a constant temperature throughout 
the gel. 
 
Figure 2.5 | Working principle of EMSA is depicted here. (a) A binding assay was shown 
where Oct4 and Sox2 are involved in the binding interaction with DNA element (SO-
CRE). (b) Polyacrylamide gel based separation assay, the central of this technique, is 
shown here. Mobility depends on the shape, molecular weight, and hydrodynamic radius 
of the complex formed. 
 
Once the pre-run is completed, the pre-incubated sample is loaded very gently, 
carefully and quickly. After that, the voltage is reapplied to continue gel run for the 
purpose of separating different complexes and free DNA present in each binding reaction. 
It takes around 80-120 min for sufficient band separation depending on the nature of 
binding reaction. Once the gel run is completed, the gel is taken out of the buffer system 
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and is used for visualization purposes. The visualization process is another important step 
where one has to properly decide the laser and filter step with respect to labeled dye 
tagged to the nucleic acid fragment. However, previously it was generally tagged with a 
radioactive element which should be replaced due to its harmful effect. After successful 
laser scanning, an image will be obtained with bands corresponding with the respective 
complexes and free DNA present in binding reaction as it is seen in Figure 2.5. The 
fluorescence intensity of those bands represents corresponding complex’s amount formed 
in the binding reaction system. 
Improvement − For purified protein-DNA binding assay, standard EMSA where 
DNA detection is enough to confirm the complexation events, is a good choice. However, 
the problem will arise for unpurified full-length proteins which are difficult to purify. In 
this case, a super shift assay, based on specific antibody targeting protein participating in 
the binding interaction, can be applied in EMSA. In this assay, the molecular weight of 
the protein-DNA complex will be higher due to binding of antibody and will provide a 
band shift compared to the binding reaction where no antibody is present (Figure 2.6). 
However, although super shift is a promising way to go, it has to be followed by 
complicated data analysis to detect the band corresponding to the actual complex in the 
midst of other bands. Furthermore, for this process, a highly specific antibody is required 
and its binding strength has to be comparable with that of the protein-DNA binding 
interaction.  
Recently, I have improved this technique using the power of protein detection 
together with DNA detection. I have created fluorescently tagged protein, i.e. a fusion 
protein for the EMSA assay. In this case, it is not necessary to have a super shift band for 
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the complex. By simply merging the band pictures from both protein and DNA detection; 
we can detect the source of band formation with high confidence (Figure 2.6). I termed 
this improved version of EMSA as fluorescent protein based-EMSA (FP-EMSA). Any 
fluorescent protein could be used in this improved assay if the proper laser scanning 
system is available for accessing the band picture.  
 
Figure 2.6 | Comparison between existing super shift-EMSA and improved FP-EMSA 
(Modified from http://www.piercenet.com). 
 
Application − Many cellular processes including transcription, DNA replication, 
recombination and repair are monitored through a very complex system where the 
interaction of proteins with DNA is considered to be central. Especially studying gene 
regulation, those interactions are the most desired events to determine. In this context, 
EMSA which is very simple to understand and easy to perform, could play a key role for 
determining the binding events. Its advantage can be rationalized in the ability to separate 
complexes of different stoichiometry or conformation by an electrophoretic assay (Fried, 
1989; Hendrickson and Schleif, 1985; Revzin, 1989). Another key advantage comes from 
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the source of protein sample which could be unpurified crude nuclear or whole cell 
lysate, column purified protein or in vitro translated protein product. It should be noted 
those proteins remain in its native folding form. Generally, EMSA is performed 
qualitatively in the determination of binding interaction between CREs (DNA oligos) and 
protein (mainly transcription factors in crude lysate). This technique helps to identify 
important binding sequences with a desired fragment of genes containing the regulatory 
region (enhancer). Furthermore, quantitative parameters of binding interaction can also 
be determined by this technique if the concentration of both protein and DNA are known 
(Fried, 1989; Fried and Crothers, 1984; Garner and Revzin, 1981; Hellman and Fried, 
2007). 
 However, there are some disadvantages connected with this technique. Firstly this 
technique is an in vitro assay and therefore, does not necessarily represent the in vivo 
binding scenario. Moreover, EMSA has a detection limit. In that case, an advanced 
technique such as fluorescence correlation spectroscopy (FCS) should be considered 
instead of EMSA. Arguably, there is no problem in performing EMSA for TF-DNA 
binding assay as this kind of binding is in general very strong. Another concern in 
performing EMSA might come from the dissociation of complex formed which might 
occur during electrophoresis. However, this problem could be defended by the "caging" 
effect (Laniel and Béliveau, 2001). This effect generally prevents the diffusion of 
dissociated components and thereby favours the complexation again.  
2.9.2. Fluorescence correlation spectroscopy (FCS) 
First reported in 1972 by Magde, Elson and Webb (Magde et al., 1972), FCS is 
currently and commonly employed to resolve diffusion characteristics and concentrations 
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of very low amount (~ nM to µM range) of biomolecules in vivo and in vitro. Rotational 
diffusion, photodynamic processes, flow properties and chemical reactions are also 
accessible by FCS (Hess et al., 2002; Thompson et al., 2002). 
FCS deals with the fluctuation of the fluorescence signal emitted from the 
fluorophore of interest after being excited with proper laser excitation. These signals are 
transformed by a mathematical procedure known as autocorrelation to extract patterns 
from fluorescence signals. The fluctuation of the fluorescence intensity is defined as, 
                   δF (t) = F (t) − < F(t) >                       (1) 
Where, is the fluorescence intensity at time and  is average of the 
fluorescence intensity over time. This fluorescence signal is autocorrelated with itself at 
different lag times (τ) and used to generate a temporal autocorrelation curve (ACF). The 
normalized autocorrelation function is then defined as: 
G(τ) = (< 𝐹(𝑡).𝐹(𝑡 + 𝜏) >< 𝐹(t) >2                                                       (2) 
Where < > denotes time average. The normalized autocorrelation function takes a 
characteristic form depending on the molecular processes which causes the fluorescence 
fluctuations. For example, the theoretical ACF for the free diffusion of one or two species 
of fluorophores through a 3D-Gaussian observation volume due to Brownian motion with 
triplet state contribution are given by (Aragon and Pecora, 1976; Thompson, 1991; 
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Where N is the effective average number of molecules in the observation volume; ω0 and 
ωz are the radial and axial distances where the excitation intensity reaches 1/e
2 of its 
value at the centre of the observation volume; Dτ and 2Dτ are the diffusion times of the 
first and second fluorophore species through the observation volume (assumed to have 
similar brightness); K is the ratio of ωz to  ω0; ttrip is the triplet state relaxation time; Ftrip 
is the fraction of the particles that have entered the triplet state; F2 is the fraction that 
contributes to the fluorescence fluctuation by the 2nd type of particle; G∞ is the 
convergence value of the ACF for long times with the expected value of 1. 
From Eq. 1, if both particles are equally bright, the amplitude of the autocorrelation curve 
G(0) can be expressed as: 
                                                                                                                    (5) 
Hence, higher concentration of a fluorophore will lead to lower amplitude as shown in 
(Figure 2.7a). On the other hand, the diffusion time τD is a factor of the diffusion 
coefficient of the molecule  (Elson and Magde, 1974; Magde et al., 1974):  
                                                   
                                                                  (6) 
The diffusion coefficient (D) is inversely proportional to the cubic root of the mass (M) 
(Wohland et al., 1999):        





D D 4 
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0 ω τ = 
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Therefore, from equation (6) and (7), the diffusion time is proportional to the cubic root 
of the mass of the fluorophore:  
                                                           𝜏𝐷  ~ √𝑀3                                                                 (8) 
This illustrates that with increased fluorophore molecular weight, the characteristic 
diffusion time will be slower in a particular solvent of certain viscosity (Figure 2.7b). 
However, the particle’s mobility also depends on the viscosity of the medium and it 
moves slower if the viscosity of the medium increases (from Stokes-Einstein equation).  
For Kd value determination, the equation used (Wohland et al., 1999) as, 
                                                             Kd = CDCPCDP                                                         (9) 
 
Figure 2.7 | The working principle of the single colour FCS. The labelled particles diffuse 
through the detection volume, producing a fluctuating fluorescence signal. (A) The 
inverse of the amplitude of ACF [G (0)] is proportional to the particle concentration (N). 
(B) The characteristic decay time of G (t) shows the mobility of the particles. So the 
diffusion time (τD) becomes slower with the higher molecular weight (M).  
 
and bound fraction (y) as: 
                                                              y = CDP(CD)t                                                        (10) 
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where “C” is the sign for concentration of dye labeled DNA (D), untagged protein (P) 
and the complex formed (DP). Therefore, after a certain incubation time t, the bound 
fraction (y) is given by [from  equatin (9) and (10)] (Wohland et al., 1999): 
                        y = (Kd+ (CD)t+(CP)t)
2(CD)t −((Kd+ (CD)t+(CP)t)24(CD)t2  – (CP)t(CD)t)1/2                (11) 
2.9.3. Single wavelength fluorescence cross correlation spectroscopy (SW-FCCS) 
In FCCS, two spectrally different fluorophore are used to determine the 
interactions of the tagged molecules. This resolves FCS’s limitation on the amount of 
molecular weight change. The fluctuation of fluorescence signals are detected in two 
different detection channels and these signals are cross-correlated. If the labelled 
molecules bind to each other, their signals will be correlated in time as they move 
together through the observation volume. Figure 2.8 represents a typical FCCS set up. In 
1997, Schwille, Meyer-Almes and Rigler first used this concept when they performed 
experiments on renaturation of complementary DNA oligonucleotides labelled with 
spectrally different dyes (Schwille et al., 1997). The two fluorophores can be excited by 2 
lasers (dual-color FCCS) (Bacia et al., 2002; Rigler et al., 1998; Schwille et al., 1997) 
two-photon laser (Berland et al., 1995; Heinze et al., 2000) or a single wavelength laser 
(SW-FCCS) (Foo et al., 2012; Hwang and Wohland, 2004, 2005) which is the one 
developed in our laboratory. SW-FCCS has been used successfully to quantify the 
dimerization of an epidermal growth factor receptor in cells (Foo et al., 2012; Liu et al., 
2007; Shi et al., 2009). 
For FCCS, the cross-correlation function is defined as (Schwille and Haustein, 2002): 
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                                                                                         (12)   
where the subscripts 1 and 2 denote the signals from the two detection channels which 
record the signals from the green channel (for GFP detection) and the red channel (for 
mCherry detection).  
 
Figure 2.8 | This is a set up of typical FCS and SW-FCCS system. The cross-correlation 
curve is generated by cross correlating the signal from both channels. The ratio of the 
amplitude of the cross-correlation curve to the two autocorrelation curves indicates the 
amount of binding complex. The higher the amount of complex, the higher the cross-
correlation amplitude relative to the autocorrelation curves. APD: Avalanche photodiode. 
(This picture is originally drawn by Dr. Foo Yong Hwee and taken by permission). 
 
The fluorescence intensity, F in each channel is contributed by the free molecules, 
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can be expressed as a function of the count rate per particle per second (cps), also known 
as brightness, and the concentrations of the particles involved (Hwang and Wohland, 
2004, 2005). 
In SW-FCCS, the different concentrations of two unbound and the complex molecules 
are calculated following the equations as published earlier (Hwang and Wohland, 2004; 
Liu et al., 2007). As seen on Figure 2.9, the cross correlation curve increases along with 
an increasing degree of binding. After knowing the concentrations we can calculate their 
amount of complex formation (complex percentage) which is defined as:          
                                      Cgr
Cg+Cgr
 × 100   OR  Cgr
Cr+Cgr
 × 100                                             (13) 
 
Figure 2.9 | The working principle of SW-FCCS. In SW-FCCS, two spectrally two 
distinct fluorophore (such as GFP & mCherry) are used, which produce fluctuating 
fluorescence signals in their respective colour channels. Each time, the trace is 
autocorrelated (green and red solid curves). In addition, the cross correlation function 
(CCF) between the green and red traces is computed (blue curves). The relative 
amplitude of the cross-correlation curve is a measure of degree of binding or 
colocalization.     
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Where “C” represents concentration and ‘gr’, ‘g’ and ‘r’ represents complex, green, and 
red molecules respectively. One can also quantify the apparent dissociation constant (Kd), 
another important kinetic parameter using the following equation: 
                                                     Kd = Cg×CrCgr                                                                   (14) 
When Cg × Cr is plotted against Cgr, a linear fit to the scatter plot gives a line with a slope 
of KD (KD × Cgr = Cg × Cr). Beside in vitro systems, SW-FCCS can also be employed in 
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Chapter 3−Materials and Methods  
3.1. Design and cloning of TF-fluorescent fusion constructs 
 Oct4, Sox2, and Oct6 fluorescent fusion expression constructs were built to 
enable subsequent FP-EMSA, FCS, and FCCS measurements. N- and C-terminal fusion 
constructs were built for all three TFs. The best construct (N- or C-terminal) in terms of 
expression level, protein stability, and function was utilized for the subsequent 
measurements. Fluorescent proteins used were eGFP and mCherry. The flow chart 
(Figure 3.1) outlines the overall steps involved in the plasmid construction. Basically, 
PCR was used to generate the initial copy of cDNA from the appropriate cDNA source 
for the respective transcription factor and fluorescent protein. Subsequently, fusion PCR 
was performed with the two initial PCR templates and the fusion template was gel 
purified and sub-cloned into the TOPO2.1 vector. The resulting constructs were sequence 
verified to assure a correct fusion template. This fusion product was subsequently 
subcloned into an expression vector containing the CAG promoter known to generate 
robust expression in ES cells.  
 
Figure 3.1 | The flow chart represents the complete steps for creating fusion constructs for 
expressing full-length  fusion protein of necessary transcription factors.  
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 The PCR steps in generating the fusion constructs were performed with the 
expand High Fidelity PCR System (Roche cat. #11732650001). The first round of PCR 
used plasmid vectors with the appropriate cDNA (either TF or fluorescent protein) as 
template. Primers were designed to include restriction enzymes for subsequent 
subcloning, sequence encoding a linker peptide of 4 amino acids (GGSG), and overlap 
sequence to assist in cross-hybridization in the fusion PCR reaction. The sequences of all 
primers are listed in Appendix A1 and initial PCR reaction mixture is shown in 
Appendix A2. Once initial PCRs were completed, equal volumes of the two initial 
products were mixed to generate the template for fusion PCR. The fusion PCR was 
performed following fusion PCR reaction mixture and thermal cycling parameters 
(shown in Appendix A3 & A4 respectively) to fuse previously amplified templates of 
desired genes. The resulting fusion PCR products were subsequently treated with GoTaq 
DNA Polymerase (Promega cat. #M3001) for 15 min to add a 3’-OH “A” overhang to 
enable sub-cloning into TOPO 2.1. 
 The fusion PCR products were separated by agarose gel electrophoresis and 
bands of the desired size were excised and purified by the QIAquick Gel Extraction 
procedure (QIAGEN cat. #28706). These were subsequently cloned into the TOPO 2.1 
vector following the TOPO TA Cloning method using the TOP10 kit (Invitrogen cat. 
#K450001). Drug resistant colonies were selected on LB agar plates containing 100 
μg/ml ampicyline and single colonies picked and grown in LB + amp suspension culture 
overnight. Minipreps were prepared from these using the QIAprep miniprep kit 
(QIAGEN cat. #27106) a fraction of the isolated plasmid DNA was cut with restriction 
enzymes SacI or NotI (NEB cat. #R0156 and #R0189), depending on the restriction sites 
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engineered into the fusion construct. Digested DNA was separated, along with a DNA 
size ladder, on 1% agarose gel, stained with ethidium bromide (EtBr) to visualize DNA 
on a UV visualize system (uvitec). Aliquots of plasmids with appropriately sized inserts 
were sent for sequencing (1st Base, Singapore) to confirm desired construct design. 
Vector NTI software (Life Technologies) was used to analyze the sequencing results and 
only those plasmids with 100% sequence identity with the initial designed template were 
subsequently used. 
 The sequence-verified fusion constructs were subsequently cloned into an 
expression vector containing a promoter (CAG) known to give ubiquitous expression and 
specifically characterized as active in ES cells. The pCAG vector was cut with SacI and 
NotI restriction enzymes followed by shrimp alkaline phosphatase treatment (SAP, 
Promega cat. #M8201) to prevent self-ligation. Gel purified digestions products were 
ligated with SacI or NotI-digested fusion construct insert DNA from the TOPO 2.1 vector 
using T4 DNA ligase (NEB cat. #M0202). XL-1 blue supercompetent bacteria 
(Stratagene cat. #200249) was used for transformation and plasmid-containing bacteria 
selected for with 15 μg/ml kanamycin. Plasmid DNA minipreps and sequence verification 
were as described above. 
 Once the fusion constructs cloned in to the pCAG expression vector were 
sequence-verified, a large-scale plasmid prep was required to generate a large amount of 
endotoxin-free plasmid for subsequent experiments. Plasmids were isolated from 500mL 
of inoculated LB solution cultured with Xl-1 blue supercompetent bacteria using the 
maxi-prep kit (QIAGEN cat. #12262) following the supplier’s standard protocol. 
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3.2. Biological samples preparation for different fluorescence assays 
3.2.1.   Annealing reaction for dsDNA 
All protein-DNA studies used double-stranded (ds) DNA. This dsDNA was generated 
from single stranded (ss) oligonucleotides (Sigma-Aldrich). 50 µL of 10 µM Cy5 labeled 
double-stranded DNA probe was made by mixing 5 ul of each complementary strands of 
100 µM Cy5 labeled ssDNA oligonucleotides, 5 µl of 10 X annealation buffer (50 mM 
MgCl2, 50 mM KCl, 20mM Tris pH 8.0) and 40 µL of TE buffer (standard). This reaction 
was incubated in a PCR machine (DNA Engine Tetrad®, Bio-Rad) at 95 0C for 5 minutes, 
followed by ramping down to 72oC at 0.10C/s, and subsequently held at 720C for 3 
minutes, before further ramping down to 370C at 1.0 0C/s. The formation of dsDNA was 
confirmed by running an aliquot of each on a pre-run polycrylamide gel using the ssDNA 
as a reference. The annealed products were stored at -20 0C until use.  
3.2.2.   Cell culture (ES and CHO cells) 
 E14 mouse ES cells, were grown in Dulbecco’s modified Eagle’s medium 
(DMEM, GIBCO-19600), 20 % ES standard fetal bovine serum (FBS), 1x non essential 
amino acids, 2 mM L-glutamine, 1X penicillin/streptomycin 0.1 mM 2-mercaptoethanol, 
and an aliquot of  recombinant LIF conditioned medium. On the other hand, CHO-K1 
cells (ATCC # CRL-61) were grown in Dulbecco’s modified Eagle’s medium (DMEM, 
GIBCO-19600), 10 % fetal bovine serum (GIBCO), 1x non essential amino acids, 2 mM 
L-glutamine, 1X penicillin/streptomycin. The incubator conditions were set to 37 ºC, 5 % 
CO2 and 95 % humidity.  
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3.2.3.   Transfection with plasmids (with ES and CHO cell) 
 Transfection of plasmid was carried out by using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. Briefly, 25 µg of plasmid was transfected 
into cells (irrespective of ES or CHO) on 59 cm2 plates by incubating with 50 µl of 
Lipofectamine in total 3 ml of DMEM media for 30 minutes. Before this, two separate 
solutions, one with 25 µg of plasmid in 1.5 ml of DMEM (after 5 min incubation) and 
another with 50 µl of Lipofectamine in 1.5 ml of DMEM (after 5 min incubation), were 
mixed and allowed to incubate for 20 minutes before adding to the cells, prewashed with 
PBS buffer. After 30 minutes incubation with the cells, the plate was topped up with 
another 9 ml of cell-specific culture media. If a different sized culture plate was used, the 
plasmid amount was calculated based on the surface area of the plate with reference to 59 
cm2 plate. The post-transfected cells were collected after 24 hrs to prepare nuclear cell 
lysate following the standard cell culture procedure.  
3.2.4.   Nuclear cell lysis 
 The nuclear lysate preparation of transfected CHO or ES cells was performed 
using the modified protocols of Andrews et al. (Andrews and Faller, 1991). Briefly, 
transfected CHO cells, grown on 59 mm plates, were harvested with 1 ml phosphate-
buffered saline (PBS) followed by trypsin-EDTA treatment. The cell pellet was 
resuspended in 400 µl cold buffer A (10 mM HEPES-KOH pH 7.9, 15 mM MgCl2, 10 
mM KCl, 0.5 mM DTT, 0.2 mM PMSF), incubated on ice for 10 minutes, vortexed for 
10 seconds, and centrifuged. The cell pellet was resuspended in 0.6 pellet volume of cold 
nuclear cell lysate buffer C (20 mM HEPES-KOH pH 7.9, 1.5 mM MgCl2, 420 mM 
NaCl, 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM PMSF) and incubated on ice for 22 
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minutes, and centrifuged at 40C. The supernatant was then preserved at -80oC until use in 
assays.  
3.3. Instrumentation and setup for different assays 
3.3.1. Electrophoretic mobility shift assay (EMSA) 
 Standard EMSA was carried out using 37 bp double-stranded Cy5-labelled 
oligonucleotides (Sigma) containing SO-CRE or PORE/MORE sequence (for oligo 
details see appendix C). Each binding reaction consisted of 3 µl of master mix 
containing 0.5 µl of 2 µM Cy5 tagged DNA element, 1.5 µl poly (deoxyguanylic-
deoxycytidylic) acid sodium salt (2µg/µl dGdC) (Sigma), and 1 µl of 80% glycerol 
included in EMSA buffer C (60% of 20 mM HEPES pH 7.9, 10 mM KCl, 1.66 mM DTT, 
1% protease inhibitor mix (Sigma), 0.83 mM EDTA), and was mixed with 9 µl of fusion 
protein extract for a final volume of 12 µl. In titration experiments, the nuclear cell lysate 
was added in varying; here the volume was adjusted with EMSA buffer C to make the 
total volume of 12 µl. In all titration experiments, the DNA concentration was maintained 
at 5nM in final reaction volume by adjusting the DNA concentration in the master mix. 
Binding reactions were incubated on ice for 20 minutes before run through a pre-run 6% 
polyacrylamide gel at 300 V for 2 hours in 0.5X Tris-borate-EDTA. A Typhoon 910 
PhosphorImager (Amersham Biosciences) was used to visualize the gels in the glass plate 
and respective lasers and filters set up were used to scan DNA bands in the gel. 
  Besides the standard EMSA which detects only DNA, a novel fluorescent protein 
(FP)-EMSA approach was developed to utilize the fluorescence of the fusion proteins. 
This provided additional data that allowed the visualization of the location of the 
proteins, either bound to DNA or not, and obviated the need for super-shifts with 
45 | P a g e  
 
antibodies. The lasers and filters were as follows for different fluorophores: Cy5 (λex -
633nm; λem-670nm), laser- 633nm, filter-670nm (BP); eGFP (λex -488nm; λem -510nm), 
laser- 488nm, filter-510(BP); mCherry (λex -587nm; λem -610nm), laser-532nm, filter-
610(BP). The lack of a proper excitation laser (ideally 561nm) on the Typhoon made the 
mCherry scan difficult to identify the respective protein in the EMSA. 
3.3.2. Luciferase reporter assay 
 For a 24-well plate, 0.5 µg of pCAG-eGFP-Oct4, 0.5 µg of pCAG-mCherry-Sox2 
and 0.3 µg of pGL3-Nanog-sox-oct-luciferase (firefly) plasmids were cotransfected into 
each well using Lipofectamine 2000 (Invitrogen) following the supplied protocol. 0.05 
µg of Renilla luciferase plasmid (pRL-TK from Promega) was cotransfected as an 
internal control. Firefly and Renilla luciferase activities were measured 24 hours post 
transfection using the Dual Luciferase Kit (Promega) and a Centro LB960 96-well 
luminometer (Berthold Technologies).  
3.3.3. Western blot 
 Nuclear cell lysates from E14 mES and CHO cell lines were separated on SDS-
PAGE (Tris 1.5 M pH 8.8, 10% SDS, 30% acrylamide/bis of 37.5:1, 10% APS, TEMED 
of 1:2000). The separation was performed at 80 volts for 100 minutes. Proteins were 
transferred to nitrocellulose membrane using transfer apparatus (BioRad) in transfer 
buffer (1x TGS buffer, 20% methanol). The transfer was run at 250 mA for 90 minutes. 
Blotting filters, blotting membrane, and the stacking gel were submerged in the blotting 
transfer buffer for 10 minutes before starting the run. After completion of the rung, the 
membrane was incubated in 5% blocker solution (1x TBS-T buffer with 5% skim milk) at 
room temperature for 1 hour. The western wash was performed thrice as 2x 5minutes and 
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1x 15 minutes with 1x TBS-T on a shaker table. Epitopes for Oct4 and Sox2 were 
detected with primary antibodies Oct4-N19 (1/20,000 dilution, goat, Santa Cruz 
Biotechnology Inc) and Sox2-Y17 (1/5,000 dilution, goat, Santa Cruz Biotechnology 
Inc), respectively.  HPR conjugated rabbit anti-goat antibody (Santa Cruz Biotechnology) 
was used as a secondary antibody in both cases at 1/10,000 dilution. Colour development 
was done incubating in the super signal® west pico chemo luminescent substrate mixture 
[stable peroxide solution and luminal enhancer solution] (Pierce cat.34077) for 5 minutes. 
The final image was obtained using a VersaDoc instrument (BioRad).  
3.3.4. Real time quantitative polymerase chain reaction (RT-qPCR)* 
 The BRC IACUC (Biopolis) approved all mouse work. Embryos were derived 
from intercrosses of Sox2-EGFP heterozygotic females (Ellis et al., 2004) and males and 
collected at 3.5dpc in M2 medium. Total RNA was extracted and purified from the whole 
embryos using a PicoPure RNA isolation kit (Arcturus Bioscience) and cDNA was 
synthesized with a high capacity cDNA archive kit (Applied Biosystems; ABI). To do the 
high throughput Real-time PCR, cDNA was first pre-amplified with a pool of 48 
inventoried Taqman assays (20X, Applied Biosystem) by denaturing at 95°C for 15 s, 
and annealing and amplification at 60°C for 4 min for 14 cycles. The pre-amplified 
products were diluted 5-fold and the expressions of the 48 assays were analyzed with 
48.48 Dynamic Arrays on a Biomark System (Fluidigm). Ct values were calculated from 
the system’s software (Biomark Real-time PCR Analysis, Fluidigm). 
*This experiment was performed by Dr. Choayang Wang as a part of my thesis work. 
Analysis of data and figure preparation were done by me.  
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 3.3.5. Förster resonance energy transfer (FRET)  
 The in vitro FRET measurements were focused on measuring the emission 
intensity of the donor (eGFP) and acceptor (mCherry) using a Spectra Max M5 
spectrometer. Data analysis was performed with Soft Max Pro. The donor (eGFP) was 
excited with a 488 nm laser and emission intensity was collected from 500 nm to 670 nm. 
 3.3.6. Fluorescence correlation spectroscopy (FCS)  
 The FCS setup is based on a commercial Laser Scanning Confocal Microscope 
(FV300, Olympus) with a water immersion objective (60×, NA1.2, Olympus) coupled to 
a custom built FCS module (Pan et al., 2007). A dichroic mirror (560DRLP) and an 
emission filter (670AF60) (Omega Optical, Brattleboro, VT) were used to separate the 
excitation light from the fluorescence emission. The Cy5 labelled DNA were excited with 
the 633 nm line from a helium-neon laser line (Melles Griot) at 50 µW laser power. 
Autocorrelations were computed in real-time by a hardware correlator (Flex02-01D, 
Correlator.com). Curve fitting was done by a custom written program (developed in the 
Wohland lab) in Igor Pro 6.0 (Wave Metrics, Lake Oswego, OR).  
3.3.7. Single wavelength fluorescence cross-correlation spectroscopy (SW-FCCS)  
The SW-FCCS instrumentation is mainly an extension of FCS system described 
above (Hwang and Wohland, 2004). Here, both the fluorescent proteins GFP and 
mCherry were excited using an argon ion 514 nm laser line at 20µw (for in vivo 
experiment) and 50µw (for in vitro experiment) laser power. A 560DCLP dichroic mirror 
(Omega Optical, Brattleboro, VT) splits the fluorescence light into the green and red 
detection channels. Band-pass filters, 545AF35 and 615DF45 (Omega Optical) were used 
in the green and red channels respectively in front of the two avalanche photodiode 
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detectors (SPCM-AQR-14-FC, Pacer, Berkshire, UK). Autocorrelations and cross-
correlations were computed in real-time by a hardware correlator (Flex02-01D; 
Correlator.com). Curve fitting was performed by a custom written program (developed in 
the Wohland lab) in Igor Pro 6.0 (Wave Metrics, Lake Oswego, OR). The concentration 
of different unbound and bound particles was calculated by a custom written program 
(developed in the Wohland lab) in Mathematica 5.2 (Wolfram Research). 
3.3.8. Immunocytochemical staining and image j based semi-quantification*  
 Embryos were fixed in 2.5% PFA for 15 min at 37oC, washed through Triton 
(0.1% in PBS; 5 min), Triton (0.5% in PBS; 20min), Triton (0.1% in PBS; 5 min), and 
BSA/Tween (0.1%BSA and 0.01% Tween in PBS; 30 min). After incubation with 1o 
antibody (Sox2-Y17) in BSA/Tween (60 min), embryos were washed through 
BSA/Tween (3x15min), and then incubated with 2o antibody (Goat anti-Rabbit IgG ) 
conjugated with Alexa Fluor 488 (Molecular Probes, Carlsbad, CA) for an additional 
hour. Following BSA/Tween washes (3x15min), embryos were passed through increasing 
concentrations of mounting solution containing To-Pro prior to final mounting. Images 
were captured with a confocal microscope (LSM 510 META; Zeiss, Thornwood, NJ). 
 In the second phase for quantifying the level of Sox2 protein, all the Z-stack 
images from an embryo were grouped into one stack picture based on average 
fluorescence intensity employing image J software (NIH). Nuclear staining dye To-Pro 
was used as a control for normalizing the fluorescence intensity of Alexa Fluor 488 
tagged with Sox2 targeted antibody. It is known that intensity varies with respect to the 
absolute concentration and hence the ratio of fluorescence intensity of Sox2 to that of To-
Pro will be the equal to the ratio of concentration of Sox2 to that of To-Pro. This 
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normalized Sox2 concentration ratio which is a unitless parameter, was calculated from 
different stages of the pre-implantation mouse embryo.  
* Experimental part (immunochemical staining) was performed by Ms. Lili Sun, research 
officer in Dr. Robson’s lab. 
3.4. Titration reactions for cooperativity studies 
 Titration reactions were performed in two steps to determine the synergistic 
pattern in the complex formation between Oct4 and Sox2 in the presence of DNA. 
Firstly, titration of an individual protein was continued with a constant concentration of 
DNA element for obtaining individual Kd as shown in table 2.4.1. For obtaining the 
overall Kd, the respective protein extract was titrated up to its saturation with a constant 
amount of other protein extract while the DNA concentration remained constant as shown 
in table 2.4.2. Mr. Wei Ping, an undergraduate student, helped me in performing these 
titrations in my active presence and involvement when he was learning the assays for his 
own project under my supervision. 
3.4.1. Binding reaction for individual protein titration 
BINDING REACTION FOR TITRATION USED IN FCS AND EMSA 
In absence of 
co-factor 
Volume / µl 
Protein (EO or ES) 0.0 0.5 1.0 1.5 2.0 3.0 5.0 7.0 9.0 
BBC(make up to 9ul) 9.0 8.5 8.0 7.5 7.0 6.0 4.0 2.0 0.0 
BBC 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
NOS DNA element 
(150nM) 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
BB(75% glycerol) 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
dGdC(2ug/ul) 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
Total 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 
 
 





3.4.2. Binding reaction for protein titration in the presence of its cofactor 
 
In presence of  
co-factor 
Volume / µl 
Protein (EO or ES) 0.0 0.5 1.0 1.5 2.0 3.0 5.0 7.0 8.0 
BBC (make up to 9ul) 7.0 6.5 6.0 5.5 5.0 4.0 2.0 1.0 0.0 
Cofactor (MS or EO) 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
NOS DNA element 
(150nM) 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
BB(75% glycerol) 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
dGdC(2ug/ul) 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
Total 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 
  EO-eGFP-Oct4, MS-mCherry-Sox2, BBC-Binding Buffer-C, BB- Binding Buffer. 
3.5. Data Treatment  
3.5.1. Concentration measurement 
 I applied a standard calibration approach to determine the absolute concentration 
of the fusion proteins (Buschmann et al., 2009). Dyes with known diffusion coefficients 
were used in order to obtain an accurate determination of the confocal volume. For the 
eGFP-Oct4, the system calibration was performed with 5 nM of fluorescein being excited 
with 488 nm laser line at 30 µW using a 510AF23 emission filter.  For the mCherry-
Sox2, 5 nM of Atto 565 was excited for calibration with 543 nm laser line at 30 µW 
using a 593AF40 emission filter. The autocorrelation curves generated were fitted with a 
3D-1particle-1triplet model using Igor Pro 6.0 as shown in equation (3) (see chapter 2, 
page 32). The number of fluorescently labeled proteins within the confocal volume (N) 
was obtained from equation (5) (see chapter 2, page 32). The value of N was divided by 
confocal volume and NA (Avogadro number) to obtain the protein concentration. 
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3.5.2. Calculating bound fraction from EMSA and FCS 
 The fusion protein’s nuclear extract of known concentration (determined by FCS) 
was used in the titration with Cy5 tagged DNA oligo. After incubation for 22 minutes at 
room temperature, the reaction samples of different titration points were loaded into 
separate lanes of an EMSA gel. After the completion of the gel run, the individual band 
intensities were quantified using IQ-quant software by taking into account the 
background contribution followed by a Cy5 scan. The band intensity was treated as 
equivalent to the concentration of the reaction species. From the computed band 
intensities of complex and free DNA, bound fractions of different titration points were 
calculated as shown in appendix D. For FCS, eight repeated measurements of 20 seconds 
each for each reaction were performed. Using Igor Pro 6.0, the generated autocorrelation 
curves were first tested with a 3D-1particle-1triplet model (Equation 3, see chapter 2, 
page 32) to observe whether there is actual binding happening throughout the entire range 
of titration. The molecular species were assumed to be in a 3D free translational motion. 
The autocorrelation curves were further fitted with a 3D-2particles-1triplet model 
(Equation 4, see chapter 2, page 32) due to determining a parameter, F2 which represents 
the bound fraction, was extracted from each reaction mixture. The complex mentioned 
above includes all the monomer and dimer complexes.  
Bound fraction is expressed as 
Bound fraction =  CDPCD + CDP 
where CD, CP, and CDP represent the concentration of unbound protein, unbound nucleic 
acid and nucleic acid-protein complex respectively. 
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3.5.3. Derivation of bound fraction plots to obtain apparent dissociation constant, Kd   
The calculated bound fractions were plotted against their respective protein 
concentration and further fitted with my chosen model curves. An empirical sigmoid plot 
was used to fit the curves where dimer formation was involved and quadratic equation for 
one protein involved in the titration. The fitting with sigmoid curve provides the 
requirement of protein concentration at 50% bound fraction of the complex. By physical 
meaning the dissociation constant, Kd, is defined to be the concentration of protein 
required for 50% binding as determined by the sigmoid fitting. Furthermore, I defined 
this apparent Kd in synergistic scenario as Kda . It is noted that both Kd and Kda  here are the 
apparent dissociation constant which are good for comparative study. The established 
quadratic equation, which was used for fitting bound fraction plot in the case of single 
protein titration with DNA element, directly gives Kd as a fitting outcome (Wohland et 
al., 1999).  
3.5.4. Calculation of complex percentage in protein–protein interaction SW-FCCS 
study 
In SW-FCCS, the different concentrations of the two unbound individual fusion 
proteins and when both are in complex are calculated by a  custom written program 
(developed in the Wohland lab) in Mathematica 5.2 (Wolfram Research) following the 
equations as stated in Appendix B. After knowing the concentrations one can calculate 
their amount of complex formation (complex percentage) which is defined as:         
𝐂𝐠𝐫
𝐂𝐠 + 𝐂𝐠𝐫  × 100   OR 𝐂𝐠𝐫𝐂𝐫 + 𝐂𝐠𝐫  × 100 
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where “C”, ‘gr’, ‘g’ and ‘r’ represents concentration, green-red heterodimer complex, 
green, and red molecules respectively.  
3.5.5. ChIP-seq data analysis.  
Using “CisFinder” (Sharov and Ko, 2009), a de novo motif identification tool, I 
identified over-represented TF binding motifs in the available ES (Chen et al., 2008) and 
NS cell (wet lab experiment is performed by Dr. Lea Thean, unpublished) ChIP-seq data. 
The over-represented transcription factor binding motifs were clustered based on 
similarity (correlations of PWMs), and motif clusters (primary and secondary) were 
selected based on total frequency and number of motifs involved making the cluster 
(Figure 6.1, see page 91). These selected motif clusters which represent binding motifs 
more accurately were used to scan the ChIP-seq peak sequence for their occurrences. 
Peaks with motif occurrences in a 40bp window with peak as the centre were mapped to 
















Chapter 4 − Result and Discussion  
4.1. Quantitative assay design 
All previous work studying the Oct4 and Sox2 protein complex on DNA have 
used only the DNA binding domain (DBD) of these transcription factors. While 
simplifying the construction and purification of these factors, one should not rule out the 
possibility that the DBD may not properly represent the role of the full-length protein. 
For Oct4 the DBD represents only 43.2% of the full-length protein and for Sox2 24.8%. 
It is entirely possible that the additional 200 and 240 amino acids in full-length Oct4 and 
Sox2, respectively, may affect the nature of protein folding and subsequently influence 
the accessibility of the DBD for DNA or protein-protein interactions. Hence, in my 
dissertation work, a robust quantitative assay was developed for studying the binding 
interaction of full-length transcription factors with their target DNA binding site. The 
strategy taken was as follows; 
A) Firstly, it was the consideration of full-length protein. If it were possible, wild-type 
transcription factors would be the best choice. However, the concentration measurement 
of these would be impossible without purifying them through conventional biochemical 
assays which itself is challenging. Therefore, an alternative approach was taken where the 
full-length TFs were genetically tagged with the fluorescent proteins eGFP and mCherry 
for detection in biophysical assays and concentration measurement in nuclear cell lysates.  
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B) Secondly, the functional characterization of these TF-fluorescence fusion proteins was 
performed to verify their capability to recapitulate the function of the wild-type TFs and 
thus be appropriate for my planned quantitative assay. 
C) Thirdly, the testing and verification of an appropriate cell line for generating fusion 
protein extracts was performed to identify a line that had an absence of the endogenous 
proteins of interest (Sox2, Oct4, and Oct6) so that this would not interfere in my 
measurements. In addition, the chosen cell line for generating the protein sample was 
further evaluated for the absence of non specific protein-DNA complex. 
D) Lastly, I determined whether protein-protein interactions occur between Sox2 and 
Oct4 in solution in the absence of DNA. The outcomes of this would have informed the 
design and interpretation of my later quantification of protein-DNA binding interactions. 
A flow chart of the quantitative assay design further elaborated on in the text: 
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4.1.1. Making the fusion protein constructs 
I used fusion PCR to build the TF-fluorescent fusion constructs. This technique 
enable me to combine two coding sequences (CDS) from two different genes into a single 
transcript with one long polypeptide consisting of the two CDSs separated by a 4 amino 
acid polypeptide linker (Figure 4.1). For each fusion product there are four primers, two 
outer and two inner primers. Each CDS was amplified using one outer and one inner 
primer. The outer primers anneal to the 5’ end of the CDS at the 5’ side of the linker and 
the 3’ end of the gene at the 3’ side of the linker. These primers, aside from consisting of 
a complementary sequence to the CDSs, contain an overhang with the restriction sites for 
restriction enzymes for cloning (SacI and NotI). The inner primers contain sequence 
matching the CDS, a long overhang consisting of the linker sequence (ggcggcagcggc; 
codons for the peptide sequence Gly-Gly-Ser-Gly), and a sequence complementary to the 
other CDS for fusion. Thus, for each fusion CDS one inner primer is a reverse 
complement of the other CDS's inner primer. The linker sequence was carefully chosen to 
create a short, structureless, hydrophilic sequence so only minimum disruption to the two 
fused protein is expected. This consisted of three glycines, the smallest amino acid, and a 
single serine with its small size and polar side chain and so it was expected that the 
folding of the two fused protein remains similar to when they are not fused.  
The eGFP protein contains a mutation (at base pair 206 of eGFP’s CDS, alanine 
to lysine) to reduce its tendency to form a weak homodimer by self-association (Shaner et 
al., 2008; Zacharias et al., 2002a). This homodimer formation is not desired because this 
will give an artefact in the brightness calculation for eGFP in FCCS experiments. 
57 | P a g e  
 
Electrophoresis results of the initial PCR, fusion PCR, and fusion product (after gel 
extraction) can be seen in Figure 4.2. 
 
Figure 4.1 | Fusion PCR Scheme. Various plasmids containing the sequence for each 
protein were used as templates for the first round of PCR. The subsequent PCR rounds 
used the amplicons of eGFP and Oct4 or mCherry and Sox2 as the template and their 
respective outer primers to generate the final fusion constructs.  
For detailed fusion protein design, see appendix A. In summary, I successfully generated 
expression constructs designed to produce full-length mouse Oct4 and Sox2 fused, via a 
four amino acid linker (GGSG), with eGFP and mCherry, respectively. 
4.1.2. Functional characterization of fusion proteins 
Initially I tested functionality of both N-terminal and C-terminal fusion constructs from 
both Oct4 and Sox2 to determine which gave the best functional read out. Transient 
transfections into mouse ES cells and CHO cells indicated these synthetic constructs were 
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expressed and the resulting fusion proteins were capable of nuclear localization (Figure 
4.3a). Western blots, using antibodies against the respective transcription factors, on 
 
.  
Figure 4.2 | Gel electrophoresis of samples at various fusion product preparations. Lanes: 
1: marker (Fermentas cat. #SM323), 2: mCherry after initial PCR, 3: Sox2 after initial 
PCR, 4: mCherry-Sox2 after fusion PCR, 5: fusion product of mCherry-Sox2 after gel 
purification. 
 
lysates from ES cells transfected with these constructs confirmed the expression 
and stability of the fusion proteins (Figure 4.3b). Higher levels of eGFP-Oct4 (N-
terminal) were observed as compared to its C-terminal tagged counterpart while there 
were fewer differences in expression levels between the two Sox2 fusions. Importantly, 
there were only two types of bands detected, namely for the fusion protein (upper bands) 
and the endogenous protein (lower bands), suggesting that the fusion proteins were not 
sensitive to protease cleavage. 
I further sought to determine if these modified TFs retained the ability to bind 
DNA similar to their endogenous counterparts. This was performed using EMSA with ES 
cell lysates and Cy5-labeled DNA, containing the Nanog SO-CRE (NOS). Both 
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endogenous proteins and their fusion counterparts are capable of binding this DNA 
element as monomers and as heterodimers (Figure 4.3c). Differentially shifted bands 
indicate that the fusion proteins can heterodimerize with both their respective endogenous 
and fusion protein partners. The fusion-containing complexes are readily detectable 
despite these proteins being expressed at lower levels (Figure 4.3b) and expected 
competition with their endogenous counterparts in this assay. These results indicate that 
these fusion proteins are as competent as their wild type proteins to bind with DNA 
containing the SO-CRE. As binding does not necessarily indicate functional activation of 
gene expression, I next tested my fusion constructs in their ability to activate transcription 
in a luciferase promoter assay. CHO cells were used in these experiments as they lack 
endogenous Oct4 and Sox2. In transient transfection assays, co-transfection of the Oct4 
and Sox2 fusion constructs with the wildtype Nanog promoter resulted in significant 
luciferase activity above that of the control promoter and the mutated NOS (Figure 4.3d), 
indicating that the fusion constructs had the ability to drive transcription from the Nanog 
promoter. 
4.1.3. Cell line characterization 
For the present study, a cell line was required as the source of fusion protein 
generation. ES cells cannot be used for protein sample preparation as there will be 
complications/competition from endogenous Oct4 and Sox2 proteins in our quantitative 
binding study.  I tested several cell lines and determined the CHO cell line was the most 
suitable for my study. First of all, it is the most commonly used mammalian host for large 
scale recombinant protein generation as the expression level driven from the pCAG 
plasmid is quite high (Figure A.4, see Appendix G) (Alexopoulou et al., 2008). 
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Figure 4.3 | Functional determination of synthetic fusion protein constructs. (a) 
Fluorescent channels overlain with bright field confocal images of mouse ES cells and 
CHO cells transfected with fusion expression constructs. (b) Expression of endogenous 
and exogenous proteins detected by western blot on nuclear extracts of mouse ES cells 
transfected with the indicated expression constructs. Polyclonal antibodies against the 
endogenous proteins were used for detection. (c) Electrophoretic mobility shift assays 
(EMSA) of mouse ES cell nuclear extracts transfected with a fusion construct expression 
vector. Cy5-labeled 37 bp DNA containing the SO-CRE found within the Nanog 
promoter (NOS) was included in all lanes. A – heterodimer complex (fusion Oct4/fusion 
Sox2/NOS element); B – heterodimer complex (fusion Oct4/wild type Sox2/NOS 
element); C – monomer complex (fusion Sox2/NOS element); D – monomer complex 
(fusion Oct4/NOS element).(d) Dual luciferase assays comparing transcriptional activity 
from the wild type Nanog’s SO-CRE (wt), a mutated SO-CRE (O/S), and the pGL-Basic 
luciferase vector (control).  
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Secondly, it grows as monolayer which favors efficient transfection of a high 
percentage of cells due to having comparatively large surface area accessible to the 
transfection reagent. Thirdly, this cell line is free from the endogenous expression of Oct4 
and Sox2 as indicated by Western blot (Figure 4.4a). Not only that, this cell line appears 
to be free from proteins causing non-specific binding with my DNA of interest.  
 
Figure 4.4 | CHO cell line is ideal for fusion protein generation. (a) Western blot results 
with Oct4 (left) and Sox2 (right) probe. All samples contained nuclear extracts prepared 
using small-scale nuclear lysate preparation of CHO cell. (b) FP-EMSA result using CHO 
cell system with Nanog SO-CRE element. A= heterodimer complex, B= monomer 
complex, C= free fusion Oct4, and D= free DNA. 
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Experimentally, I showed that there is no non-specific bands as well as 
endogenous Oct4 and Sox2 (further validation of Western blot result) using my newly 
developed FP-EMSA (Figure 4.4b). 
4.1.4. Do Oct4 and Sox2 interact in the absence of DNA? 
 Having proved that the Oct4 and Sox2 fusion proteins behave functionally similar 
to their endogenous counterparts, I next sought to utilize these fusion proteins to measure 
the behaviour of these transcription factors in solution. Although both N and C terminals 
fusion proteins were functional, N-terminal fusion proteins were chosen as higher band 
intensities were obtained from EMSA and western blot illustrating their more abundance 
in the transfection.  
Using in-vitro FRET experiment I qualitatively investigated complex formation in 
solution. Sox2-Oct4 interaction was examined in the presence and absence of DNA 
containing the SO-CRE using nuclear extracts from transfected CHO cell to test the effect 
of the presence of DNA for Sox2-Oct4 interactions. Similar to the negative control, there 
was no positive FRET signal when eGFP-Oct4 was tested with mCherry-Sox2 in the 
absence of DNA containing the SO-CRE (Figure 4.5a). However, when DNA was 
included in the mixture with these fluorescently-tagged transcription factors, a distinct 
FRET signal was evident (Figure 4.5b), with a decrease in eGFP intensity and 
concomitant increase in mCherry intensity. This observation indicates that the DNA 
brings the tagged Oct4 and Sox2 into close proximity, presumably through binding to the 
SO-CRE, thus promoting the transfer of energy from the donor eGFP fluorophore to the 
acceptor mCherry fluorophore.  
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To further validate DNA-mediated Oct4-Sox2 interactions, I used FP-EMSA 
where I used the fluorescence of eGFP on the eGFP-Oct4 fusion protein. Again, there 
was neither any evidence for interaction between Oct4 and Sox2 without DNA nor 
multimers of Oct4 (Figure 4.5c). Comparing the results from the mixture containing 
 
Figure 4.5 | FRET and EMSA confirm DNA-mediated complex formation. In FRET 
analysis (a-b) samples (nuclear extracts isolated from transfected CHO cells) were 
excited with a 488 nm laser and emission intensity collected above the 500 nm 
wavelength. In this scenario eGFP (emission max 510 nm) acts as a donor whereas 
mCherry (emission max 610 nm) acts as an acceptor. (a)  FRET analysis in the absence 
of DNA. (b) FRET analysis in the presence of DNA containing SO-CRE. Arrows point to 
the significant difference in the cross correlation curve. (c) An EMSA with detection 
based on emission from the eGFP fused to Oct4. Note complexes detected in the presence 
of DNA only. 
 
the two transcription factors in absence and presence of the NOS element (Figure 4.5c), 
protein-DNA heterodimer complexes were only possible in the presence of NOS element. 
In addition, mixing of the two different transcription factors only produced bands 
indicating monomers. This shows that in absence of DNA, there is no direct Oct4 and 
Sox2 interaction. 
I also tested this protein-protein interaction using the power of SW-FCCS to 
measure complex formation in solution. Sox2-Oct4 interaction was similarly tested in the 
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presence and absence of DNA containing the SO-CRE. This quantitative assay is capable 
of measuring the complex percentage formed between eGFP-Oct4 and mCherry-Sox2.  
 
Figure 4.6 | SW-FCCS indicates DNA mediated complex formation. (a) Unlinked eGFP 
and mCherry (the negative control; (b) an eGFP-mCherry fusion protein (the positive 
control; (c) eGFP-Oct4 and mCherry-Sox2 in the absence of SO-CRE (DNA motif) (d) 
eGFP-Oct4 and mCherry-Sox2 in the presence of SO-CRE (DNA motif). Note the 
increased cross-correlation in d versus c. The intensity values below the correlation 
curves indicate the average photon counts over data acquisition time (30s). ACF – auto-
correlation function; CCF - cross-correlation function; G(τ) – Amplitude of correlation; 
t(s) – lag time. 
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The complex percentage measured in the negative control (unlinked eGFP and 
mCherry) was 3.5 ± 2.2 % and for the positive control (an eGFP-mCherry fusion protein) 
was 56.7 ± 5.4 % (Figure 4.6a & b).The complex percentage determined from the 
correlation function of the tagged TFs in the absence of DNA was 2.9 ± 1.7 % (very close 
to the negative control) suggesting little or no interaction between Oct4 and Sox2 without 
DNA present. In the presence of DNA the correlation function of the tagged TFs jumped 
to 32 ± 4 % (Figure 4.6c & d) clearly indicating DNA-mediated Sox2-Oct4 interaction. 
Thus this SW-FCCS data argues that in the absence of a SO-CRE Sox2 and Oct4 do not 
interact but readily form a DNA mediated ternary complex. 
Previously, the DNA binding domains of Oct4 and Sox2 have been shown to form 
a complex in absence of DNA (Ambrosetti et al., 1997). Conversely, another recent study 
provides strong evidence behind the DNA dependency for the binding interaction of Sox2 
and Oct4 (Lam et al., 2012). These contradictory studies raise the question whether 
heterodimerization occurred through protein-protein interaction followed by DNA 
binding or whether the proteins interact only via DNA mediated contact. Therefore, 
further studies were also essential to this point. In the present study, I showed that full-
length proteins only heterodimerize in the presence of DNA through FRET, FP-EMSA, 
and SW-FCCS.  
4.1.5. Quantitative insight for the stability of protein-DNA complex formed 
In previous sections, it is proved that the fusion proteins are capable to bind with 
DNA and their binding interaction on the SO-CRE is the key to its target gene 
expression. Therefore, it will be important to look into the quantitative details on the 
assembly of Sox2-Oct4-DNA in terms of how much of Sox2 and Oct4 protein were 
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required to make a stable complex. By studying the Kd of a protein-DNA complex one 
can find the concentration required to form a stable complex, this indirectly infers the 
preferred requirement of one protein over another in situations where binding sites of two 
proteins are juxtaposed. First of all, if there is a situation where one incubates Oct4, Sox2, 
and the DNA element and allows them to interact in a physiological condition, two 
monomer complexes and one heterodimer complex as well as free DNA will be found 
(with DNA in excess) (Figure 4.7). Hence finding the Kd of the single protein complexes 
with DNA will provide significant insight into the level of protein concentration. On the 
other hand, performing one protein titration in the presence of a constant concentration of 
additional binding partner, one can anticipate the major significance of one protein over 
another. For my single protein titration experiments with DNA, the measured apparent 
Kd. Alternatively, titration of one protein in the presence of another protein provides 
another apparent Kd, represented as Kda . This separate notation is helpful to understand the 
different titration condition. However, although both Kd and Kda  are apparent dissociation 
constants, those are the good estimate on the requirement of a protein at 50% bound 
faction for the complex formation in a comparative study.  
4.1.6. Confirmation on the reliability of titration results 
Before obtaining the results that answered my hypothesis, I first compared my 
titration results obtained from FCS with that of FP-EMSA. This comparison is essential 
to check the reliability of my experimental results. Moreover, if the independent 
experimental systems give similar results, the data will be more reliable.  
The titration strategy is shown in Figure 4.8a. Direct evidence of complex 
formation by Fgf4 SO-CRE in different titration condition was shown by both techniques 
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in a comparative manner (Figure 4.8b). The  Kda  values obtained by FCS from the bound 
fraction plots for titration using the Fgf4 SO-CRE were found to be similar to that of 
 
Figure 4.7 | Quantitative insight and titration scheme to access quantitative parameters. 
This cartoon shows how Oct4 and Sox2 protein behave with the SO-CRE in terms of 
monomer and heterodimer complex formation. This also illustrates how to find the 
different apparent Kds with respect to monomer and heterodimer. A titration approach is 
shown to find Kds. In the present study, the measured apparent Kd in the presence of a 
cofactor is defined as Kda . 
 
EMSA, at  Kda  of 25.2 ± 4.1 nM compared to  Kda  of 25.3 ± 2.2 nM for EMSA in a 
titration with eGFP-Oct4 in presence of mCherry-Sox2 at 72 nM (Figure 4.8c). On the 
other hand, a titration of mChery-Sox2 in presence of eGFP-Oct4 at 40 nM produced  Kda  
as 23.2 ± 1.2 nM from FCS compared to  Kda  of 24.0 ± 3.0 nM (Figure 4.8d). This 
confirms the reliability of the experimental results. In a second series, a titration of 
mChery-Sox2 in the presence of eGFP-Oct4 at 40 nM produced  Kda  of 23.2 ± 1.2 nM 
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from FCS compared to  Kda  of 24.0 ± 3.0 nM from the EMSA measurements (Figure 
4.8d). This again confirms the reliability of the experimental results.  
 
Figure 4.8 | FCS and EMSA Kd measurement comparisons. (a) Conceptual scheme 
showing the titration of eGFP-Oct4 in the absence and presence of mCherry-Sox2 and 
vice versa. (b) EMSA scans and FCS autocorrelation curves for Fgf4 element titration 
with (I) eGFP-Oct4; (II) mCherry-Sox2; (III) eGFP-Oct4 with fixed amount mCherry-
Sox2 and (IV) mCherry-Sox2 with fixed amount of eGFP-Oct4. a: Fgf4 monomer 
complex with eGFP-Oct4; b: Fgf4 monomer complex with mCherry-Sox2; c: Fgf4 
heterodimer complex with both eGFP-Oct4 and mCherry-Sox2; d: Unbound Cy5-Fgf4 
element. (c) The bound fraction plots obtained from both FCS and EMSA for titration of 
eGFP-Oct4 in the presence of mCherry-Sox2. (d) The bound fraction plots generated 










4.1.7. Quantitative assay design summary 
In a summary of my quantitative assay design I have schematically represented 
the approach in Figure 4.9. Briefly, I first confirmed the CHO cell was the best cell line 
for fusion protein expression. Cells transfected with my fusion constructs showed nuclear 
localization of the fusion proteins, abundant expression, and appropriately sized products 
with no sign of degradation based on Western blot analysis. Subsequent FP-EMSA both 
with CHO lysates as well as similarly transfected ES cells indicated the Sox2 and Oct4 
fluorescence fusion proteins appropriately bound SO-CRE elements and could compete 
with their endogenous counterparts. FCS was used for measuring the concentration of 
fusion proteins in the crude nuclear CHO cell lysate. Once the protein concentration was 
known, titration experiments were performed using both EMSA and FCS techniques in 
equilibrium to determine apparent Kd (single protein-DNA) and  Kda  (Sox2-Oct4-DNA 
complex formation). I also found through FRET and FCCS analysis that the Oct4 and 
Sox2 interaction is DNA dependent. Thus in summary, these fluorescent fusion 
constructs are functionally similar to their endogenous counterparts and are appropriate 
and essential tools to my subsequent experiments.  
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Figure 4.9 | Pictorial representation of the complete strategy for designing the quantitative 
assay. 
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4.2. Dynamic changes in Sox2 levels direct temporal-
spatial expression of Fgf4 and Fgfr2 
4.2.1. Outline 
In this section, I would like to present those experimental validations required for 
the hypothesis, the sensitivity of Fgf4 and Fgfr2 expression to Sox2 levels determines the 
cell fate of ICM. Here, I would like to remind the reader of the steps for validating the 
hypothesis once again. 
Steps to validate the hypothesis are; 
• Validate dynamic levels of Sox2 protein in pre-implantation embryo. 
• Confirm direct binding of Sox2 to the regulatory elements of Fgf4 and Fgfr2. 
• Illustrate the importance of variable base pairs in the motif sequence with binding 
interaction. 
• Determine the level of Sox2 concentration for stable complex formation on Fgf4 
element 
• Compare in vitro binding interaction data with in vivo findings to bridge my data 
with the segregation of ICM into PE and EPI.  
•  Model the hypothesis based on three key findings obtained from overall research 
till today; a)  all inner cells donot form at the same time resulting in a temporal 
difference in Sox2 protein level among the inner cells, b) inner cell specific 
increment of Sox2 protein favours upregulation of Fgf4 and downregulation of 
Fgfr2 in the early inner cells, and finally c) Sox2 protein directly binds to the 
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regulatory elements of Fgf4 (ligand) and Fgfr2 (receptor) resulting in a inverse 
correlation in ligand/receptor  expression levels in early inner cells. 
4.2.2. Relative concentration level of Sox2 in different cell stages of early mouse 
embryo  
Previously, it has been shown that the Sox2 mRNA level is dynamic and bimodal 
compared to Oct4 which remains almost static during pre-implantation development 
(Guo et al., 2010). In order to test whether Sox2 fluctuation is also present at the protein 
level, I measured its protein level across progressive cell stages during pre-implantation 
development. My data showed that Sox2 protein concentrations remain high up to the 4-
cell stages and then steadily decreases until the 16-cell stages (Figure 5.1a & b). After 
the 16 cell stage, Sox2 is upregulated in ICM and downregulated in TE. It was also 
observed that Sox2 concentration reaches a maximum in ICM and minimum in TE at the 
64-cell stage. This finding suggested that the dynamic level of Sox2 concentration might 
play an important role in SO-CRE targeted gene expression compared to that of Oct4 
which remains almost static at both transcript and protein levels (Dietrich and Hiiragi, 
2007; Palmieri et al., 1994). 
4.2.3. Characterization of the SO-CRE 
The quantitative measurements of the assembly of Sox2-Oct4-DNA ternary 
complexes for SO-CREs targeted genes such as Nanog and Fgf4 were the focus of the 
current chapter. However, a thorough understanding of SO-CRE's sequence and base pair 
patterns was essential before proceeding to quantitative measurements.  
From the Oct4 and Sox2 ChIP-seq data in ES cell, highly conserved nucleotide 
positions were observed in Oct4 and Sox2 binding sites. The sequence logo, a graphical 
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Figure 5.1 | Relative Sox2 protein concentration measurements during mouse pre-
implantation development is shown. (a). Confocal Z-stack images of representative Sox2 
and ToPro nuclear stained embryos. (b). Relative quantification of Sox2 expression levels 
based on immunostaining data. Concentration ratio with different cell lineage of early 
developing mouse embryo was plotted. 
 
representation of the sequence, of SO-CREs were created from the published ChIP-seq 
data of Oct4 and Sox2 (Chen et al., 2008) to illustrate these conserved nucleotide 
positions using the de novo motif identification algorithm “CisFinder” (Figure 5.2a). 
Web logos suggest that some positions in the SO-CRE are conserved such as 3rd position 
whereas some positions are non-conserved such as 7th position in the motif sequence. 
This further raises the question whether these variable positions in the motif sequence are 
important or not. To answer this question, I specifically looked at the SO-CRE sequence 
for Nanog and Fgf4 across different mammalian species. Sequence alignments of SO-
CREs from Nanog and Fgf4 genes across different mammalian species were shown to 
illustrate this (Figure 5.2b). Notably, it was observed that the heptamer sequence of the 
Sox2 binding site and the octamer sequence of the Oct4 binding site of the SO-CREs 
irrespective of the nature of the binding site (Nanog or Fgf4) are highly conserved among 
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the different species. The evolutionary trend of this SO-CRE being well conserved is 
illustrated in Figure 5.2b using a cumulative evolutionary phylogenetic tree. This tree 
further demonstrates the importance of the variable positions in SO-CRE within the 
mammalian genome being unaltered for more than 100 million years. This clearly 
suggests the importance of their sequence specificity and their close involvement in gene 
regulation.  
Furthermore, I also examined the conservation pattern of different SO-CREs from 
the known genes, Nanog, Utf1, Oct4, Sox2, and Fgf4. The position of those cis elements 
with respect to target genes are shown in appendix E. A sequence alignment is shown to 
illustrate the difference in different SO-CREs (Figure 5.2c). I found that 2nd and 7th 
positions in Sox2 binding site and 5th-8th positions in Oct4 binding site are variable 
positions among those SO-CREs. I sought for experimental validation of the variable 
positions in transcriptional activity employing luciferase assay. Using Nanog element as 
the reference, it was found that mutations in the non-conserved regions of the Sox2 motif 
affected the transcriptional output in a luciferase assay (Figure 5.2d & e).  
For better experimental confirmation, mouse mSox, mOct, and mOctSox mutated 
sequences used by Rodda et al. were included as reference motifs besides our desired 
mutation NOS2, NOS6, NOS7 and NOS11 (Rodda et al., 2005). Out of these four 
mutations, NOS2 and NOS7 were applied in variable positions in the Sox2 binding site 
whereas NOS6 and NOS11 were applied in conserved position of the SO-CRE sequence. 
It was observed that there was the similar trend of transcriptional output from mSox, 
mOct, and mOctSox as seen earlier (Rodda et al., 2005). In addition, I also noticed a 
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drastic drop in luciferase activity for NOS11 as expected. However, NOS6 did not show 
any significant decrease in transcriptional output as NOS11. This suggests that the 11th 
 
Figure 5.2 | Characterization of SO-CRE is shown. (a) The binding motifs of Oct4 and 
Sox2 transcription factors identified from Oct4 and Sox2 ChIP-seq peaks (Chen.et.al, 
2008) using the de novo motif identification algorithm CisFinder.  (b). Eutherian Nanog 
and Fgf4 SO-CRE for  different species were aligned disclosing the importance of non 
conserved base pair in the consensus shown here. A phylogenetic tree is shown for those 
animals used in alignment illustrating the importance of variable positions of SO-CRE in 
cumulative evolution. It is seen that all the positions are conserved in higher mammalian 
species excluding the spacer of Fgf4. (c). An alignment of different SO-CREs from 
known Sox2-Oct4 mouse target genes Nanog, Utf1, Oct4, Sox2, and Fgf4 is shown. (d). 
Mutations generated in the SO-CRE of the mouse Nanog 400 bp proximal promoter that 
were subsequently tested in E. (e)*. Promoter activity of constructs in (d) measured by 
luciferase activity in transfected F9 embryonal carcinoma cells. (*) This luciferase assay 
was performed by Mr. Leng Hiong Lim. 
 
position is more important than the 6th position in terms of transcriptional activity though 
both the positions are conserved in the SO-CRE sequence. Alternatively, a significant 
decrease was observed in luciferase activity for NOS2 compared to NOS7 although both 
positions are non-conserved positions in the SO-CRE sequence. This further illustrates 
that the 2nd position is more favoured in transcriptional activity than that of 7th position. 
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Therefore, this experimental validation proved that variable positions in SO-CRE have 
played an important role in gene regulation besides the conserved positions of the motif. 
4.2.4. Confirmation of the direct binding of Sox2 protein to the cis regulatory 
elements of Fgf4 and Fgfr2 
Although it has been previously hypothesized that Fgfr2 gene is a direct target for 
Sox2 at the sox cis element illustrated in Figure 5.3a, in this study, I looked for 
quantitative evidence for the direct complex formation of Sox2 protein at the sox cis 
element of Fgfr2.  As described earlier, the anti-correlation of Fgf4 and Fgfr2 (Guo et al., 
2010) controlled by Sox2 was also studied by quantitatively comparing them in terms of 
Sox2 binding and complex formation with their sox binding site. Furthermore, Mausi et 
al. have experimentally shown that Fgfr2 is upregulated in the absence of Sox2 which 
plays a role of repressor for the gene (Masui et al., 2007). An enriched sox cis motif was 
found in Fgfr2 gene through a motif analysis in available Sox2 ChIP-seq (Chen et al., 
2008) and the corresponding peak and motif are shown in Figure 5.3a.  
However, sequence alignment for the sox cis element across different mammalian 
animals revealed that the motif sequence might be important only for rodents as for 
primates, it is not conserved which might results in different activity of Fgfr2 in these 
two mammalian species. Recently, Roode et al. showed that Fgf signal is active for the 
segregation of ICM into PE and EPI in mouse where human’s pre-implantation 
development does not show any importance of Fgf signalling in this cell fate decision 
(Roode et al., 2012). This could be the result of the above stated conservation mismatch. 
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Figure 5.3 | Direct binding of Sox2 protein to cis elements of Fgf4 and Fgfr2. (a) The sox 
cis regulatory element of Fgfr2 analysis from the Sox2 ChIP-seq data, and its 
conservation in different mammalian species is illustrated using the UCSC genome 
browser. (b) EMSA represents the binding interaction between binding motifs of Fgfr2 
(lane 1) and Fgf4 (lane 2) with fusion Sox2 protein where “yellow star” and “white star” 
stand for Sox2-DNA complex and free unbound DNA respectively. (c) & (d) Normalized 
autocorrelation curves demonstrate complex formation by showing diffusion time shift at 
higher Sox2 protein concentration for Fgfr2 (c) and Fgf4 (d) motifs. 
 
For the first time, I showed direct evidence for the support of direct binding 
interaction of Sox2 with Fgfr2 sox-cis motif through EMSA (Figure 5.3b), followed by 
FCS (Figure 5.3c). The quantitative result further showed that both Fgfr2 (Kd values is 
81.2 ± 15.1 nM) and Fgf4 (Kd values is 70.2 ± 19.1 nM) require high concentrations of 
Sox2 protein for stable Sox2-DNA monomer complex formation, leading to 
downregulation of Fgfr2 and upregulation of Fgf4 (Figure 5.3c). However, the presence 
of the oct binding motif in Fgf4 SO-CRE favors stable dimer complex formation even at 
low Sox2 concentration compared to sox-cis motif of Fgfr2. This might be the reason for 
having a good correlation between Fgf4 and Sox2 in expression level. Fgfr2 expression is 
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not solely dependent on Sox2 except in EPI where Sox2 concentration is high and 
thereby, Fgfr2 expression is repressed by Sox2.    
4.2.5. Influence of sequence variation in different SO-CREs on the protein-DNA 
binding affinity 
  Earlier, it was noticed that changes in the conserved and non-conserved regions 
of the Sox2 motif had an impact on the luciferase activity. Such activity could be linked 
to the degree of Oct4 and Sox2 binding affinities to the elements to form a stable 
heterodimer. 
 Changes in the Sox2 binding site have an impact on the binding affinity of Sox2 
on SO-CRE of these genes. The change in the sequences of the Sox2 binding site 
“CATTGTA” in Nanog to “CATTGTT” in Utf1 revealed a slight decrease in the Sox2 
binding affinity as the Kd increased from 31.7 ± 4.6 nM to 44.0 ± 9.8 nM (Figure 5.4a). 
The change in the 7th position in the sequences “CATTGTA” in Nanog to “CATTGTG” 
in Sox2 revealed a slight decrease in the Sox2 binding affinity as the Kd increased from 
44.0 ± 9.8 nM to 66.1 ± 18.2 nM. Additionally, it also was noticed that there was a slight 
decrease in the Sox2 binding affinity when both the 2nd and the 7th positions were 
changed to “CTTTGTT” in Fgf4 from “CATTGTA” in Nanog causing an increase of ∼ 
39 nM in Kd value. This illustrates that the variable positions in heptamer sequence play 
an important role in binding interaction of Sox2 with SO-CRE while the conserved 
positions are the key for strong interaction. Variable positions create diversity in the 
sequence of SO-CRE motif across different SO-CRE targeted genes.  
 When I sought for correlation among binding affinities of Oct4 with oct binding 
site of those different SO-CREs, the first four base pairs ATGC in the octamer motif were 
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seen to be conserved among those SO-CREs. As we observed earlier in luciferase assay, 
this quantitative binding assay again showed that this conserved region (ATGC) has an 
important role in Oct4 binding at the oct binding site. In addition, the assay also showed 
that the non-conserved region (5th to 8th position in octamer motif) also has an important 
role in the degree of binding affinity. Comparing between SO-CRE of Oct4 and that of 
Sox2, I found that the 7th position plays a role in increasing the Kd values from 7.7 ± 1.1 
nM to 15.9 ± 1.6 nM (Figure 5.4b). On the other hand, the comparison between Utf1 and 
Fgf4 motifs showed that the 7th position plays an important role increasing the Kd value 
from 32.0 ± 5.5 nM to 42.5 ± 5.5 nM. The 5th-6th position had a drastic change when 
“AT” was replaced by “TA”; the value increased ~ 25nM when the comparison was 
performed between Sox2 and Fgf4 motifs. Therefore, my comparative Kd measurement 
demonstrates the essential role of variable positions in the sequence of different SO-
CREs, which results in influencing the binding activity. 
 
Figure 5.4 | Table showing the correlation of variable positions in SO-CRE sequences 
with Kd values. (a) Kd’s obtained from single protein (Sox2) titration on Sox2 binding 
site are tabulated here. (b) Kd’s obtained from single protein (Oct4) titration on Oct4 
binding site are tabulated here. 
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4.2.6. Determination of Sox2 level required for stable complex formation with Oct4 
on the cis element of Fgf4 compared to that of Nanog  
With the role of SO-CRE in Sox2-Oct4 heterodimer formation established, I next 
investigated their cooperativity. To address this I measured the in vitro Kd for Sox2 and 
Oct4 independently and in the presence of each other using FCS.  
My objective was to evaluate whether Fgf4 SO-CRE shows any significant 
correlation with Sox2 concentration in the presence of Oct4. Titration results revealed 
apparent cooperativity which displayed synergism between Sox2 and Oct4. In the 
presence of Sox2, the binding affinity of Oct4 to SO-CREs increased. Similarly, the 
presence of Oct4 aided the binding of Sox2 to these regulatory elements (Figure 5.5). 
However, Kd data revealed a significant difference in synergism among Fgf4, Nanog and 
Utf1 from the perspective of Sox2 concentration.  
 
Figure 5.5 | Table representing significant alteration in synergistic effect with the level of 
Sox2 concentration compared to that of Oct4 at Nanog, Fgf4, and Utf1 elements revealed 
synergistic activity between these two factors in the formation of stable heterodimer. 
However, Fgf4 shows more dependency on Sox2 concentration for a stable heterodimer 
complex formation. 
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 The enhanced binding of Oct4 to SO-CRE of Nanog, Fgf4 and Utf1 depends on 
the concentration of Sox2 as validated by the increase of the apparent cooperativity factor 
at high Sox2 concentration. The Fgf4 element individual titration with Sox2 gave a Kd of 
70.2 ± 19.1 nM (Figure 5.5). Because of the lower binding affinity of Sox2 to Fgf4 as 
compared to Nanog and Utf1 element, the influence of Sox2 on Oct4 binding is smaller, 
giving an apparent cooperativity factor close to 1 at a Sox2 concentration of 37nM.  At a 
higher Sox2 concentration of 72nM, a greater apparent cooperativity factor of 1.7 ± 0.4 
nM was obtained (Figure 5.5). In contrast, Nanog and Utf1 elements showed a similar 
kind of synergistic effect at a low Sox2 concentration of 37 nM which established that 
higher Sox2 concentration is essential for Fgf4 SO-CRE. The strength of Sox2 binding at 
the Fgf4 element correlates with the dynamic level of Sox2 protein (Figure 5.1) seen in 
the developing mouse embryo, suggesting that the expression of Fgf4 might be driven by 
Sox2.  
4.2.7. Validation of the role of Sox2 for its targeted genes in Sox2-null embryos  
Quantitative expression data from Sox2 null mouse embryos confirmed that Fgf4 
and Fgfr2 are the direct target genes of Sox2. However, the mode of targeting differs 
between Fgf4 and Fgfr2. Sox2 was observed to be an activator of Fgf4 while it acts as 
repressor for Fgfr2 (Figure 5.6). I noticed that the expression of Nanog is not influenced 
by the absence of Sox2 which further supports in-vitro data where Nanog element formed 
stable ternary complexes at lower Sox2 concentrations than for the Fgf4 element. It 
should be noted that there is still maternal Sox2 protein present which might be sufficient 
for Nanog but not for Fgf4 and Fgfr2 as they need high Sox2 concentration to be 
replenished by zygotic Sox2 expression (Avilion et al., 2003).  
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Figure 5.6 | Validation of Sox2’s role for it targeted genes. Experimental validation of 




In the present study, I examined the binding kinetics of full-length Oct4 and Sox2 
using fusion constructs to assess how their bindings are related to early mammalian 
embryonic development. Fusion Oct4 and fusion Sox2 proteins were specifically used for 
a quantitative binding study with five different SO-CREs from five genes previously 
known to have the SO-CRE: Nanog, Fgf4, Utf1, Oct4 and Sox2. These SO-CREs are 
distinctly observed as the top regulatory elements maintaining the regulation of these 
genes, which are considered essential factors to sustain the pluripotency of ES cells and 
the ICM.  
83 | P a g e  
 
 
The quantitative measurements for Fgf4 element showed mutual cooperativity 
between Oct4 and Sox2, though the expression of Fgf4 depends more on the level of 
Sox2 concentration. I observed in mutual titration that there was no synergistic effect at 
lower concentration but a significant cooperativity was noticed at higher concentration 
level of Sox2. On the contrary, high cooperativity was observed from Oct4 at lower 
concentration, which clearly demonstrated that a stable Sox2-Oct4-DNA ternary complex 
was formed at a lower level of Oct4 but requires a higher level of Sox2 concentration. 
This suggests that Sox2 plays a major role facilitating binding of Oct4 with DNA. Hence, 
Sox2 provides more specificity to the DNA conformation by aiding Oct4 to bind tightly 
with DNA. Sox2 might bend the DNA upon binding to form a favourable site for Oct4 
(Rudnick and Bruinsma, 1999). Besides, a recent study reported that the expression level 
of Fgf4 correlates with the expression level of Sox2 (Guo et al., 2010). I also found 
resemblance of the expression level of Sox2 with its protein expression level in the semi-
quantitative immunostaining-based protein expression analysis. In contrast, Nanog 
showed higher cooperativity even at lower concentration level for both Oct4 and Sox2 in 
mutual titration. This strongly suggests that their expression does appear before the 
expression of Fgf4 in the early development of mouse embryo, as seen in the literature 
(Guo et al., 2010). 
I finally would like to propose a model establishing a strong correlation of the 
observed cooperativity in SO-CRE targeted gene expression with the level of Sox2 in 
different cell stages (Figure 5.7). My results suggested that when Oct4 binds to SO-CRE 
in absence or very low concentration of Sox2, no stable ternary complex will be formed. 
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Here, I would like to correlate two genes Fgf4 and Nanog with the level of Sox2 
concentration. I observed at a Sox2 concentration of 37 nM, the Kda  value for Nanog is 
13.8 ± 3.0 nM with an apparent cooperativity factor of 2.0 ± 0.6. At the same Sox2 
concentration, Fgf4 has a Kda   of 42.5 ± 5.5 nM with an apparent cooperativity factor of 
0.9 ± 0.1. This suggests that at this low concentration, Nanog will be expressed but Fgf4 
will hardly be expressed. This is in agreement with gene expression on the transcript level 
(Figure 5.7a & b). It was observed that around the 8-cell to the 16-cell stage, where the 
Sox2 concentration is sufficiently low, Nanog is highly expressed whereas Fgf4 is not 
expressed. But at a Sox2 concentration of 72 nM, the Kda   value for Nanog element 
remained close to the previous value (2.0 ± 0.6) with an apparent cooperativity factor of 
2.4 ± 0.7 implying that Nanog expression remains at the same level. Conversely, Fgf4 
expression increases and tends to a maximum at high concentration of Sox2 as it shows a Kda  value of 25.2 ± 4.1 nM with an apparent cooperativity factor of 1.7 ± 0.4. Thereby, I 
predict that this low Sox2 concentration (37nM) represents the level of Sox2 in the 
morula cell stage and the high Sox2 concentration (72 nM) represents the level of Sox2 in 
the ICM. 
Therefore, the present study showed that there is ICM specific increment of 
zygotic expression of Sox2 protein in the pre-implantation development and the 
sensitivity level of Fgf4 and Fgfr2 expression is highly correlated with the level of Sox2. 
Taking together the present data and the existing hypothesis behind the cell fate decision 
for the segregation of the ICM into the PE and the EPI (Guo et al., 2010), I propose the 
most plausible interacting gene regulatory model using online available Bio-tapestry 
software (Figure 5.8).  I started my model gene network at the 16 cell morula stage 
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consisting of a group of cells named inner cells and another group called outer cells. In 
the inner cells, for a yet to be discovered inner cell signal, the zygotic expression of Sox2  
 
Figure 5.7 | Bridging between in vitro data with in vivo context is shown. (a)Hypothetical 
diagram showing relation of Kd to gene expression with respect to Sox2 concentration is 
depicted. This predicts the level of Sox2 concentration in morula and ICM. (b) the 
diagram represents the importance of cooperation from Sox2 in the expression of its 
target genes. 
 
starts but initial concentration is not enough to drive upregulation of Fgf4 and repression 
of Fgfr2. The thickness of the blue line refers to the level of increasing concentration 
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(Figure 5.8). Alternatively, due to lacking the inner cell signal, zygotic expression of 
Sox2 is missing as well as maternal Sox2 protein level is depleted in the outer cells 
resulting in no upregulation of Fgf4 and Fgfr2 is not repressed by Sox2. The scenario 
becomes more critical for outer cells at the end of another round of cell division where 
Sox2 levels decrease further resulting in no upregulation of Fgf4 and Nanog, and no 
Fgfr2 repression.  
 At the end of the 32-cell stage, outer cells behave like presumptive trophectoderm 
(TE) cell lines. However, at the end of this stage prior to the cavitation process, 
heterogeneity remains among inner cells because of a 2nd wave of inner cells formation 
after cell division. Moreover, early inner cells will already express Fgf4 and 
downregulate Fgfr2 due to increasing level of Sox2 whereas late inner cells are missing 
Fgf4 expression and express high Fgfr2 level. This scenario contributes to the temporo-
spatial molecular level heterogeneity in ICM after the cavitation process. 
After the cavitation process, the late morula goes to the early blastocyst stage 
where those outer cells are already turned to be TE. On the other hand, the early and late 
inner cells represent the presumptive EPI and presumptive PE, respectively. At this 
embryonic stage, early inner cells possess a high level of Fgf4 expression with a complete 
downregulation of Fgfr2. On the contrary, late inner cells still possess high level of Fgfr2 
expression, which directly comes under the nascent intercellular Fgf4 signal resulting in 
the downregulation of a number of pluripotency marker genes like Nanog, Klf2, and 
Esrrb etc. This further results in downregulation of zygotic Sox2 expression and 
upregulation of PE specific marker genes like Gata6 inducing those cells to form the PE 
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Figure 5.8 | Gene regulation modelling of Fgf4, Nanog and Fgfr2 during the segregation 
of ICM into PE and EPI. In the model, we followed the standard rule of Bio Tapestry 
software (Longabaugh, 2012). Additionally, the thickness of the line corresponds to the 
level of expression for Sox2. The black ball represents Oct4 protein which is also 
involved in the regulation of Nanog and Fgf4 with Sox2. Inter cellular signalling is 
highlighted by bright green color network and the repression of Nanog by the output of 
the FGF signalling pathway is shown by the orange colour network. 
 
lineage. On the other side, early inner cells contribute to the upregulation of pluripotent 
maker genes and increasing Sox2 level compensates the depleting level of maternal Sox2 
protein. Consequently, these cells commit to the EPI lineage. Thereby, at the end of the 
64-cell stage, the blastocyst possesses three distinct cell lineages prior to the implantation 
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4.3. POU factors show a diverse nature of transcriptional 
complexation in the presence of Sox2 resulting in the difference 
in gene regulation between ES cell and NS cell. 
4.3.1. Interlink with the Sox2-Fgf signalling project  
This project is indirectly connected with the Sox2-Fgf signalling project. For the 
Sox2-Fgf signalling project, I was involved to find highly enriched CREs for Sox2 and 
Oct4 in their corresponding ChIP-seq data performed in ES cell (available online) (Chen 
et al., 2008). Using “CisFinder” software, an online module with high searching 
efficiency finding the CREs, it was noticed that both Sox2 and Oct4 show a similar type 
of a highly enriched motif known as SO-CRE where a heptamer sox motif is juxtaposed 
to an octamer Oct4 binding site. The combinatorial code of the SO-CRE suggests their 
cooperation involved in the regulation of its target genes. This finding raised the question 
whether there is any similar pattern in motif enrichment in neuronal stem cells (NS cells) 
where Sox2 is abundantly expressed with POU3 factors. Recently, Dr. Lee Thean, a 
postdoc in the Robson laboratory, performed ChIP-seq experiment on Sox2 and Oct6, a 
member of POU3 family, in NS cells. I searched through the NS cell ChIP-seq data using 
similar approach which was used for ES cell data analysis with help of Mr. Devasia Arun 
George, a bioinformatics expert. He refined raw ChIP-Seq libraries (Oct4_ES, Sox2_ES, 
Oct6_NS, and Sox2_NS) and created test and created creation of test and control datasets 
for each ChIP-seq library to help in my “Cis-Finder” analysis. Surprisingly, a different 
nature of a highly enriched motif was found in case of Sox2 ChIP-seq data compared to 
that of Oct6 ChIP-seq data in NS cells (Figure 6.1). On the contrary, I anticipated that the 
combinatorial nature of motif from my previous project experience would be similar in 
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the case of Oct6. This contradiction in the motif’s nature motivated me to look into the 
details of the molecular level binding interactions between Sox2 and Oct6 in comparison 
with Sox2 and Oct4.  
4.3.2. Aim 
Motif analysis of available ChIP-seq data of Oct4 and Sox2 in ES cells shows that 
there is an enrichment of SO-CRE. Alternatively, a similar approach with Oct6 and Sox2 
in NS cells demonstrates the preferable enrichment for palindromic or more palindromic 
Oct binding regularity element (PORE/MORE). A thorough investigation was essential to 
understand this fundamental difference in the enrichment for cis regulatory element 
between those two cell lines.  
4.3.3. Gap and Purpose 
The purpose of this project is to find whether there is any difference in stability of 
the known homodimer complex of Oct4 and Oct6 (Tomilin et al., 2000) and the role of 
Sox2 in the complex formation process by POU factors. The insight of complexation 
through quantitative determination could answer the question of the different nature of 
motif enrichment in those two cell lines. From the motif analysis of Oct4 ChIP-seq data 
in ES cells, the SO-CRE was found to be the most enriched regulatory element. However, 
instead of SO-CRE, PORE/MORE motifs appeared to be the most enriched regulatory 
elements in NS cells from a similar approach of motif analysis into Oct6 ChIP-seq data in 
NS cells. Based on those findings, I hypothesized that Oct4 prefers association with Sox2 
while Oct6 prefers self-association to facilitate the expression of those enhancers’ target 
genes. Here, in this study, I focused to find the Kds in different cases to validate our 
hypothesis based on qualitative and quantitative binding interaction. The insight of those 
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experimental results could be pivotal to understand the intrinsic driving force that 
controls the differentiation of ES cells to NS cells. 
4.3.4. Result 
The enrichment of over-representated motif analysis between ES and NS cell lines 
shows a drastic difference − I have looked through the available ChIP-seq data of Oct6 
and Oct4 in NS cell and ES cell line respectively. It is known that Sox2 is expressed in 
both cell lines at similar levels (Kim et al., 2008). However, looking through over-
represented Sox2 motifs in Sox2-ChIP-seq data analyzed by cis-finder a close similarity 
was observed between the primary Sox2 motif and the primary Oct4 motif in ES cells 
where Sox2 binding site, a heptamer motif is juxtaposed with Oct4 binding site, an 
octamer motif (Figure 6.1). On the contrary, there is no similarity between over-
represented primary Sox2 binding motif and that of Oct6 in NS cell line. Therefore, the 
well-known synergism between Sox2 and Oct4 in ES cell line may not be true for the 
Oct6 and Sox2 pair in NS cells. Several studies supported that Sox2 and Oct4 make 
heterodimer complex on these over-represented SO-CRE for pluripotent specific gene 
regulation in ES cells and early development of mammalian embryo (Ambrosetti et al., 
1997; Rodda et al., 2005). However, there is no study which showed that Oct6 is 
preferably involved in forming a heterodimer complex with Sox2 on SO-CRE. However, 
it is known that Oct6 is involved in gene regulation by homodimer formation (Jauch et 
al., 2010). This suggests that there might be a difference in the binding strength and the 
stability of the complex formed. It was important to understand whether the heterodimer 
complex formation on SO-CRE with Sox2 is preferable or the homodimer formation on 
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PORE/MORE element for both the POU factors (Oct6 and Oct4). This could account for 
the difference in over-represented motifs in different cell lines. 
 
Figure 6.1 | Over-represented motif sequences from enriched TF binding sites. Using 
available ChIP-seq data of Oct4 and Sox2 from ES cells and that of Oct6 and Sox2 from 
NS cells, top 500 over-represented motifs were analyzed and followed by creating a 
cluster of motifs using Cis-Finder. Based on N-members and frequency, primary and 
secondary enriched motifs providing a sense of complexation on DNA for those TFs were 
classified. Web logo represents the position frequency matrix for those over-enriched 
motif sequence. 
 
Oct4 can homodimerize on PORE element besides its preferable heterodimer 
formation with Sox2 − Homodimer formation of full-length Oct4 on PORE elements was 
shown here using the NOS element. Oct4 was observed to form homodimer in vitro on 
PORE element (Figure 6.2a). However, one can argue that this homodimer formation 
could be an artefact of the fluorescence tag. To eliminate this possibility, we created a 
fusion Oct4 construct with mCherry and tested in EMSA. I showed that Oct4 can form a 
homodimer on PORE element irrespective of whether it is labeled with eGFP or mCherry 
(Figure 6.2b). Interestingly, when the complex formation of Oct4 was monitored in 
presence of Sox2 on each of the NOS and PORE elements, Oct4  
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Figure 6.2 | Confirmation of homodimer formation of Oct4 and its qualitative comparison  
with heterodimer formation. (a) The ability of Oct4 to make homodimer with PORE 
element was tested. Lane 1 and Lane 2 were used as control to assess the sequence 
specificity. Homodimer formation was clearly shown in lane 3 with PORE-wt element 
and further specificity of homodimer formation was tested in lane 4 using mutated 
version of PORE element (PORE-mt) where we clearly observed that homodimer 
formation is hampered. (b) Homodimer formation is independent from tagged 
fluorescence protein. mCherry-Oct4 was tested instead of eGFP-Oct4 with PORE-wt and 
PORE-mt and clear homodimer formation was appeared in lane 1 and off in lane 2 as we 
expected from the nature of motifs. (c) Ability of Oct4 for forming homodimer and 
heterodimer formation in presence of Sox2 with PORE (lane 2) and SO-CREs (lane 3) 
was tested respectively. Qualitatively, heterodimer formation was much preferred than 
homodimer formation. In all cases, yellow, red, white, and green stars represent dimer 
complex, monomer complex, free protein, and free DNA respectively. 
 
preferentially binds with Sox2 on NOS element forming a heterodimer compared to a 
homodimer on PORE element (Figure 6.2c). This result suggests that different types of 
dimer formation depend on the specific DNA element. However, irrespective of the DNA 
element, Oct4 prefers complex formation in presence of Sox2.  
Stability of homodimer complex depends on the specificity of base pairs in the 
PORE motif − Furthermore I examined whether this homodimer complex formation is 
specific to the binding motif or not. Therefore, it would be interesting to see whether this 
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stability is dependent on the specific base pair in the motif sequence. For the purpose, 
Oct4 as POU factor was considered with PORE element using different types of designed 
mutations in the sequence. Making the experimental design more economical, I chose to  
 
Figure 6.3 | The specificity of base pair in motif sequence plays a crucial role in the 
stability of homodimer formation. (a) Homodimer formation was tested with unlabelled 
DNA with reference of labeled DNA. In lane 2 and lane 4, I observed homodimer 
formation comparable with labeled DNA (in lane 1 and lane 3). This verification helped 
us economically to reduce the cost of experiment for motif characterization applying 
several mutations in the sequence. (b)  Several mutations were tested inside as well as 
outside of PORE motif. The chosen mutations showed different capability in homodimer 
formation (lane 1 to lane 7) compared to PORE-wt in lane 8. (c) The non palindromic 
residue in the PORE-motif (AAATG) was tested in different variable combination. I 
found that the sequence “AAATG” showed its importance on homodimer formation. Its 
deletion from the motif reduced capability of homodimer formation compared to wild 
type sequence. However, the mutation in 3rd-5th base pair of “AAATG” showed lower 
efficiency than 1st-3rd base pair mutation in homodimer formation. In all cases, yellow 
star represents dimer complex, red star represents a monomer complex, white star 
represents free protein and green represents free DNA. 
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use FP- EMSA detecting protein instead of DNA. The approach was first verified with 
conventional EMSA where tagged-DNA was used for detection. DNA detection was 
compared with protein detection (Figure 6.3a).  
This proves that mutation variations can be tested using non-conventional 
approach. Several point mutations and artificial spacers between two POU domains’ 
binding sites in the PORE motif were considered. The purpose was to verify the 
importance of those base pairs over the stable homodimer formation. It was clearly 
distinguished that applied mutations outside of the motif have no effect on homodimer 
formation whereas those mutations within the motif play a crucial role in regulating the 
ability of homodimer formation (Figure 6.3b). This reflects the specificity of the base 
pair sequence in the motif. The importance of the spacer between the POU domain 
binding site was studied as described by Botquin et al. (Botquin et al., 1998). I noticed 
that the spacers are actually taking part in complex formation, confirming it as an integral 
part of the motif rather than the spacer (Figure 6.3c). 
Oct4 prefers heterodimer formation on SO-CRE over homodimer formation on 
PORE element − The capability of Oct4 to form both homodimer and heterodimer was 
proved on PORE and NOS element, respectively, in our qualitative experiment. However, 
it would be interesting to show its preferential binding in a quantitative approach. Kd 
measurements were performed by FP-EMSA for those dimer complexes formed by Oct4 
alone and Oct4 with Sox2 on the specific regulatory elements. I noticed that heterodimer 
formation of Oct4 on SO-CRE is much more favourable giving a Kd of 8.0 ± 4.0 nM 
compared to its homodimer formation on PORE motif resulting in a Kd of 64.0 ± 2.0 nM 
(Figure 6.4). These results suggest that Sox2 assists Oct4 via cooperative binding as the 
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Kd of monomer formation on SO-CRE is 26.9 ± 4.8 nM. However, two Oct4 proteins do 
not support each other for a favourable homodimer formation as the monomer shows a Kd 
of 36.1 ± 2.6 nM. Overall, Oct4 shows preferable binding with SO-CRE as monomer or 
dimer. 
 
Figure 6.4 | Oct4 preferentially binds with Sox2 forming heterodimer over homodimer. (a 
& b) Titrations of fusion Oct4 with PORE-mt and PORE-wt were shown respectively. 
Respective bound fraction vs. concentration plots were shown in b. Quantitative 
determination of Kd showed that dimer formation is not favourable with PORE motif. (c 
& d) Titrations of fusion Oct4 with NOS element were shown in absence and presence of 
Sox2 respectively. Respective bound fraction vs. concentration plots were shown in d. 
Results justified that heterodimer formation is preferred which showed synergism 
between Oct4 and Sox2. The motif sequences were shown in Figure 6.2. In all cases, 
yellow star represents dimer complex, red star represents a monomer complex, and green 
star represents free DNA. 
 
Oct6 prefers homodimer formation on PORE/MORE element compared to Oct4 − 
The findings in ChIP-seq data analysis for Oct6 in NS cells directed me to check its 
capability in homodimer formation with palindromic elements. I tested the ability of 
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Figure 6.5 | Oct6 prefers homodimer formation compared to Oct4. (a) Qualitative 
representation of preferential homodimer formation of Oct6 was shown in comparison 
with that of Oct4 with four different motifs. Sequences of those motifs were shown with 
the location of motifs highlighted with underline and mutation with lower case alphabets. 
Positions of tagged dye were shown by red colour. In all cases, Oct6 showed better 
homodimer formation capability than Oct4 (qualitatively). (b) I further determined 
respective Kd  (nM) values of Oct6 and Oct4 which are shown here as tabulated form.   
 
homodimer formation for full-length Oct6 on different palindromic motifs in comparison 
with Oct4. My result, based on qualitative (comparing bands intensity) and quantitative 
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(finding Kd) findings showed that Oct6 always has stronger binding affinity compared to 
Oct4 on PORE and MORE elements (Figure 6.5a & b).  
These findings strongly suggest that Oct6 showed better efficiency of homodimer 
formation compared to Oct4 which besides supports the notion of the difference in motif 
enrichment between NS and ES cells. In addition, another significant finding from this 
data is that MORE elements showed better efficiency in homodimer formation than 
PORE elements. 
Sox2 shows little influence on Oct6 whereas it has a high synergism with Oct4 − 
It is now proven that Oct6 binds more strongly with palindromic elements than Oct4. 
However, we still need to understand how Oct6 behaves in presence of Sox2 in complex 
formation on SO-CRE. To investigate this question, a binding interaction through non-
conventional EMSA was performed in a qualitative EMSA approach. The difference in 
the complex formation between Oct6 and Oct4 in presence and absence of Sox2 was 
monitored on NOS element. I observed that Oct4 and Oct6 show similar capability in 
monomer formation on NOS element in absence of Sox2 (Figure 6.6, lower panel). 
However, Oct6 shows a drastic difference with Oct4 in complex formation in presence of 
Sox2. The presence of monomer of Oct6 and Sox2 on NOS element reflects the absence 
of synergism in the binding interaction between them. Moreover, monomer complexes of 
Oct4 are absent which further reflects the preferable formation of heterodimers for the 
inherent cooperative nature of binding with Sox2 (Figure 6.6, upper panel). 
In addition, investigating the general trend in homodimer formation on different 
palindromic motif elements, I found that MORE element shows a better capability in 
making a homodimer complex compared to PORE elements irrespective of different POU 
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factors. The band intensity for homodimers formed in the case of MORE elements was 
observed to be higher compared to that of PORE elements (Figure 6.5a). The same trend 
is also observed in the newly found different PORE and MORE elements (Figure 6.7). I 
further confirmed the trend in the quantitative Kd findings showing MORE elements to be 
better for homodimer formation compared to PORE elements (Figure 6.5b). 
Homodimer formation was tested on the newly found palindromic motifs in the  
motif search for Oct4 and Oct6 − In the motif search, we found out some interesting 
motifs close to existing PORE and MORE motifs’ sequences from  available Oct4-ChIP-
seq data (ES cell line) and Oct6-ChIP-seq data (in NS cell line) using online cis-finder 
software. Using FP-EMSA, I observed that on average Oct6 showed better efficiency in 
homodimer formation than that of Oct4 in most cases from those newly found motifs 
(Figure 6.7). However, two motifs, p-ch-11 and p-ch-1 showed negligible homodimer 
formation illustrating them as not active motifs helping in gene regulation. Out of the new 
8 motifs, motifs including p-ch-9, kdm2-M, and Lemd-M showed better homodimer 
complexation. Thereby, this qualitative result further illustrates that Oct6 has better 
binding efficiency than Oct4 on palindromic motifs. 
4.3.5. Discussion 
Oct4 predominantly forms a heterodimer with Sox2 on SO-CRE − While Tanaka et al. 
suggested synergism between Brn2 and Sox2 on the Nestin element and they do show a 
heterodimer complex in EMSAs and suggest Sox2-Brn2 protein-protein interaction in the 
absence of DNA, the EMSAs also indicated that both monomers are much more 
prevalent than the heterodimer. This may explain the lack of such a variant sox-oct motif 
appearing in the de novo motif discovery of Brn2 and Sox2 ChIP-seq 




Figure 6.6 | Looking into binding efficiency of Oct6 and Oct4 in presence of Sox2 (a) 
Highly improved non-conventional EMSA qualitatively showed that Oct6 has weaker 
efficiency of heterodimer formation with Sox2 compared to Oct4. First 5 lanes represent 
for Oct6 and next 5 lanes for Oct4. Oct6 showed relative high monomer formation with 
heterodimer complex when monomer complex is completely off in the case of Oct4 
showing its preferential synergistic binding with Sox2, which helped, in preferred 
heterodimer complex. (b) However, in absence of Sox2, the monomer complex formation 
ability of oct6 is comparable with that of Oct4 showing similar band intensity. This data 
illustrated that presence of Sox2 directly favors preferential binding of Oct4 with SO-
CRE; but Sox2 remains ineffective in the case of Oct6 as the binding synergism is 








data (Tanaka et al., 2004). This again supports the finding on Oct6 with Sox2 where Oct6 
does not preferentially form a heterodimer complex with Sox2 on the Nanog element. 
Additionally, it was noticed that Oct4 favours heterodimer formation in presence of Sox2 
due their synergistic effect in binding interaction. This observation is also well supported 
in literature (Rodda et al., 2005). Furthermore, the work by Kuroda et al. also supports 
favourable heterodimer formation between Sox2 and Oct4 on Nanog element (Kuroda et 
al., 2005). 
Dimer formation on MORE element is generally favourable than that on PORE 
element − The experimental data, both qualitative and quantitative, revealed that 
homodimer formation is more favourable on MORE than that on PORE element. It was 
qualitatively observed that the band intensity of the homodimer complex on the MORE 
element is greater than for the PORE element irrespective of POU factors (Figure 6.5 
and Figure 6.7). This suggests a favourable binding interaction. A similar trend was 
noticed 
101 | P a g e  
 
 
Figure 6.7 | Testing of homodimer formation on the newly found palindromic motifs. 
Qualitative experimental testing of homodimer formation for Oct6 and Oct4 with newly 
found 5 PORE and 3 MORE motifs in our motif search analysis and qualitatively tried to 
compare their binding interaction in terms of efficiency of homodimer formation with 
those elements. It was observed that in all cases Oct6 showed better homodimer 
formation than that of Oct4. As earlier we observed that MORE has better efficiency for 
forming homodimer than that of PORE element, we saw the similar trend (PORE element 
from lane 1 to lane 5 and MORE from lane 6 to lane 8). P= PORE, M= MORE. 
 
in the quantitative Kd determination where Kd for homodimer formation on MORE 
element is lower than on PORE, illustrating the higher binding affinity with the MORE 
compared to the PORE element. I further acquired knowledge from available 
crystallographic data for those homodimer complex formations on PORE and MORE 
elements with POU factors. Indeed, Botquin et al. investigated homodimer formation on 
PORE element by a crystallographic approach (Figure 6.9a) and they found out that the 
bipartite domain of POU factors binds across two stands of DNA creating two interfaces 
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where Serine 229 and Serine 107 provoke steric repulsion from phosphorylation through 
post translational modification of the protein (Botquin et al., 1998; Reményi et al., 2003).  
 
Figure 6.8 | Justification from crystallographic supporting the efficiency of MORE 
element. (a) Crystallographic data highly supports stable homodimer formation of POU 
proteins on MORE element because of the presence of electrostatic attraction in the 
interfaces. (b) One interface is shown in zoom option where one can clearly see the 
electrostatic attraction between (-ve) phosphorilated serine (385) and (+ve) lysine (296). 
(Modified from Kang et al., 2009).  
 
However, a similar situation will not be created in the case of the MORE element 
as packing of complex formation is completely different than that of the PORE element. 
A recent study illustrated the packing of the MORE complex in crystallographic data 
where they revealed that the bipartite domain of one POU factor binds with one strand of 
DNA and thereby creates a favourable interaction with Serine 285 and Lysine 296 after 
post translational modification (Figure 6.8). The negatively charged residue (Serine 285) 
will attract positively charged residue (Lysine 296) favouring strong interaction (Kang et 
al., 2009; Tomilin et al., 2000). 
 Oct6 does not prefer to make heterodimer complex with Sox2 while Oct4 does − 
At low concentration Oct4 favors to make monomer complexes in absence of Sox2. On 
the contrary, presence of Sox2 facilitates Oct4 binding to make a more stable heterodimer 
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Figure 6.9 | Justification from crystallographic for the findings from PORE and SO-CRE.  
(a) Crystallographic data is not supporting stable homodimer formation on PORE 
element because of the presence of electrostatic repulsion and steric hindrance in the 
interfaces and therefore the complexation only possible at higher concentration of Oct4. 
(b) Stable Sox2-Oct4 heterodimer formation on SO-CRE is assisted by the presence of 
electrostatic attraction in the interface between Oct4 and Sox2. (Modified from Botquin 
et al., 2003). 
 
complex on a combinatorial POU-Sox code. However at high concentration, Oct4 is 
capable of forming homodimer which could drive the expression of some genes 
responsible for differentiation of ES cell and ICM. In presence of normal Sox2 levels, 
Oct4 always prefers to form heterodimers on SO-CRE and facilitates the expression of its 
target genes maintaining the pluripotency of ICM and ES cell. Nevertheless, in absence 
or at very low concentration levels of Sox2, Oct4 with its high expression prefers to make 
homodimer as it is observed in primitive endoderm where formation of homodimer by 
Oct4 on PORE element regulates the Spp1 gene (also known as OPN) (Botquin et al., 
1998). Studies show that there is a temporal-spatial over-expression of Oct4 in primitive 
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endoderm which further supports the Spp1 gene expression (Guo et al., 2010; Palmieri et 
al., 1994).  Furthermore the available crystallographic study supports the present findings 
on SO-CRE. As shown in Figure 6.9b, it is clear that the synergism between Oct4 and 
Sox2 created by a favourable electrostatic interaction between arginine (75) and aspartic 
acid (29) overcomes the steric hindrance resulting in the stable heterodimer.  
Conversely, Oct6 shows a higher tendency to form the homodimer irrespective of 
presence or absence of Sox2. Although Oct6 can form a heterodimer with Sox2, 
heterodimer formation is not synergistically favourable while homodimer formation is 
synergistically favourable. That is why, although Sox2 is present in both ES and NS cells, 
most abundant Oct4 preferentially shows heterodimer formation with Oct4 in ES cell and 
highly expressed Oct6 preferentially shows homodimer formation in NS cell line which 
justify our notion on preferential dimerization due to having different binding strength in 
presence of Sox2 on different DNA binding sites. 
In summary, this study showed that preferential transcriptional complexation of 
POU factors in the presence of Sox2 reasons for the difference. Oct6 prefers to form 
homodimer on PORE/MORE rather making heterodimer with Sox2 on SO-CRE and this 
pattern of complexation supports the enrichment for PORE/MORE motifs in NS cells. 
Conversely, Oct4 prefers to form a heterodimer with Sox2 on SO-CRE supporting our 
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Chapter 5−Gen . Discussion & Conclusion 
5.1. General Discussion  
Transcriptional complexation between TFs and CREs in developmental genetic 
regulatory networks − The development of multicellular organisms consists of a complex 
series of genetic and epigenetic events that generate a multicellular adult body from a 
unicellular zygote. However, although embryonic development is a multistep process 
controlled by the successive upregulation and downregulation of many genes, a 
sophisticated regulatory network of transcription factors is directly involved in gene 
regulation facilitating healthy embryo development. It is known that a controlled complex 
network of binding interactions between these proteins and specific DNA sequence 
elements (i.e. CRE) located in the promoters and enhancers of developmental genes 
facilitate the recruitment of RNA polymerase by creating transcriptional activation 
complexes. The composition and architecture of these protein-DNA complexes that 
ultimately control gene expression in the temporal-spatial context of a developing 
organism is dependent on the primary structure of DNA elements. Thus, the recruitment 
of TFs on to CREs and the subsequent regulation of target genes are a key factor to 
understanding the complexities of mammalian development.  
Adding to the complexity, transcription factors often have context-dependent 
protein interaction partners that form multi-protein complexes on specific DNA 
sequences to activate or repress transcription. This combinatorial control enables 
multitudinous biological processes to be regulated with only a limited set of transcription 
factors encoded in the genome. A quantitative understanding of the interactions among 
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these transcription factors is, therefore, pivotal to gain insights into these complex 
biological phenomena. Such measurements formed the basis of my thesis. 
Transcriptional complexation and ICM cell fate decisions – The emergence of 
differing developmental genetic regulatory networks between sub-populations of cells 
within the mouse pre-implantation embryo is central to establishing different cell fates. 
transcription factor-DNA interactions are pivotal components of these networks. The 
earlier finding from the Robson lab that Sox2 was specifically expressed in inner cells of 
the morula preceding the establishment of the EPI and PE from these inner cells, argued 
that Sox2 was a driver of the emerging EPI/PE developmental genetic regulatory network 
(Guo et al., 2010). I subsequently validated these previously measured mRNA levels 
corresponded to a similar increase in Sox2 protein levels. This, and the identification of 
an inverse correlated expression   of Fgf4 and Fgfr2 within the ICM and downstream of 
Sox2 upregulation, was the foundation for establishing the hypothesis that I was testing in 
my thesis. Thus my focus has been on the kinetics of Sox2 binding to DNA. As Oct4 is a 
well known binding partner of Sox2, the transcriptional complexation involving Sox2, 
Oct4 and a number of SO-CREs has been a main focus. Note Oct4 levels, though 
relatively high, remain virtually unchanged during the morula to blastocyst transition 
(Palmieri, Peter et al. 1994; Dietrich and Hiiragi 2007) so this can not be the driver of the 
subsequent ICM heterogeneity. 
My in vitro measurements have revealed that the sox-oct and sox cis elements in 
Fgf4 and Fgfr2, respectively, would be the most responsive to the increasing 
concentrations of Sox2 found in the developing inner cells of the embryo. This would 
thus establish the heterogeneity (i.e. the inverse correlation of Fgf4/Fgfr2 in expression 
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level), through Sox2-driving repression of Fgfr2 and activation of Fgf4 combined with 
the two waves of inner cell formation, within the ICM. This newly established FGF 
signalling axis is known to be essential for the segregation of ICM into PE and EPI.  
The value of quantitative determinations − The vast majority of known protein-
DNA interactions are only known in qualitative terms, for instance the thousands of 
binding sites that are revealed from a typical single factor ChIP-seq experiment. While 
these datasets provide an extraordinary resource to begin to understand developmental 
regulatory networks, they tell us very little about the dynamics of assembly of 
transcriptional complexation. Information from structural biology, available for Sox2-
Oct4-DNA complexes, provides additional information. However, this still does not 
resolve all aspects of the complexation mechanism. For instance, Reményi et al 
successfully crystallized a complex containing Sox2, Oct1 and the SO-CRE of Fgf4 
(Reményi et al., 2003). From their crystal structure, it was very clear that Sox2 and Oct1 
(and, evidenced through homology modeling, Oct4) interact directly with each other 
while bound to the DNA element.  Thus there is protein-protein interaction between Sox2 
and Oct4 in the presents of DNA. However, it remained unclear whether these two TFs 
interacted in solution without DNA as there were conflicting reports (Ambrosetti et al., 
1997; Lam et al., 2012). In my thesis I have provided convincing evidence, using 
quantitative SW-FCCS, FRET, and my novel FP-EMSA techniques, that Oct4-Sox2 
protein-protein interaction is DNA dependent. In light of this and in the context of my 
main hypothesis, the key measurements to make at SO-CRE sites of interest are the 
binding affinities, at differing concentrations, of Sox2 to the Oct4-DNA complex, as 
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Sox2 is the factor that is dynamically changing in the transition from the morula to the 
ICM. 
Another advantage of my chosen fluorescent fusion protein strategy was the 
ability to definitively measure protein concentration in solution. My quantitative 
measurements on the assembly of Sox2-Oct4-DNA were able to determine the 
concentrations needed for complex formation. Specifically, I employed FCS to determine 
the Kd for Sox2-DNA and Oct4-DNA on a number of sox and oct cis elements revealing 
the variability ternary complex formation across different SO-CREs despite the relatively 
conserved sequence within these cis elements. Importantly, I measured a significant 
difference between the SO-CREs on Fgf4 and Nanog with Fgf4 requiring higher 
concentrations of Sox2 for complex formation. 
Importance of the single molecule sensitive FCS and FCCS techniques − FCS and 
FCCS are two pivotal techniques to understand the dynamics in the assembly of 
interacting binding partners. In the present study, FCS created the platform for the 
quantitative assay. The core capability of these techniques resides in the successful 
concentration measurement of full-length fusion proteins in crude nuclear cell lysates. 
Without knowing the concentration of the full-length fusion protein, I could never 
measure the Kd values of protein-DNA binding interactions. Furthermore, I did not find 
any alternative technique that could quantify a specific fusion protein amongst a mixture 
of proteins within a nuclear cell lysate. In addition, one can employ these techniques in 
live cells or embryos for studying the diffusion dynamics of a particular fusion protein at 
the single molecule level which can reveal the status of bound and unbound fractions of 
protein. FCCS (or SW-FCCS) is an extension of FCS and is often used where two 
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interacting molecules possess a similar molecular weight. It is helpful for exploring the 
protein-protein interactive network of transcription factors involved in pre-implantation 
development controlling cell fate choice. In the present study, I used it to investigate the 
protein-protein interaction between Sox2 and Oct4. This provided me clear knowledge 
regarding the status of the Sox2-Oct4 binding interaction.  
Impact of in vitro findings in terms of in vivo understanding − An often-asked 
question by critics is how relevant are in vitro findings to the context of in vivo 
understanding. Therefore, it is always recommended to verify the in vitro results in an in 
vivo system. In the present study, I sought indirect in vivo validation as it is currently 
technically challenging to check the binding interaction between Sox2 and Oct4 at a 
specific DNA element in an in vivo system. This is due to the presence of thousands of 
potential DNA binding sites in live ES cells or in live embryos which will not allow 
observing a specific binding event. Hence, the only way to achieve the target is to 
perform in vitro binding assays where we have better control over the specificity of DNA 
elements. Instead, I used an alternative approach to indirectly confirm the conclusion that 
I obtained from in vitro assay. This was the analysis of gene expression in Sox2 null 
embryos versus wild-type embryos by RT-PCR. I observed that the expression of Fgf4 
and Fgfr2 were most sensitive to the loss of Sox2 compared to Nanog, this paralleled the 
concentration requirements for complex formation I measured in vitro. While not directly 
measuring the complex formation in vivo it certainly proves the role Sox2 has in 
establishing the inverse correlation of Fgf4 and Fgfr2 within the early ICM. 
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One caveat is that chromatin accessibility is known to be a major influence on in 
vivo transcription factor binding (Biggin, 2011) and thus it should be considered when 
extrapolating in vitro binding data to the in vivo situation such as we have done here.  
From comprehensive ChIP-chip experiments done in the developing Drosophila embryo 
it has been shown the in vivo occupancy levels of DNA binding transcription factors 
closely correlates with chromatin accessibility (Li et al., 2011). In this context, the state 
of chromatin accessibility at the loci I have studied is important to consider. 
Although I do not specifically determine the level of chromatin accessibility I 
presume that at my Sox2 bound sites of interest chromatin is open and accessible and 
does not change from the 8-cell embryo through to the early blastocyst. The reasoning for 
this is as follows. Several studies have shown the highly specialized genomes of the 
oocyte and sperm are going through deprogramming during the pre-implantation 
development (Branco et al., 2008; Reik, 2007). I would emphasize that the morula stage 
possesses the most accessible chromatin which is well supported by global 
DNA methylation studies (Smith et al., 2012). Furthermore, impact of histone 
modifications at this embryo stage on chromatin status is yet to be measured. 
Additionally, the in vivo observation on Sox2 target genes of interest (Fgf4, Fgfr2, 
and Nanog) in the morula or earlier where they are expressed also supports the notion of 
the most accessible chromatin state in morula. This supports the opinion of freely 
available chromatin at these target sites. Thus, I would argue my in vitro binding data can 
anticipate the relative levels of in vivo DNA binding (Kaplan et al., 2011; Pique-Regi et 
al., 2011).  
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POU & Sox cis regulatory architecture in neural stem cells − Furthermore, I also 
resolved another important question regarding the nature of highly enriched cis regulatory 
element in between ES cell and NS cell. From the motif analysis of ChIP-seq data in ES 
cells for Oct4 and Sox2, I found that SO-CRE was the most enriched CRE in ES cell 
while PORE/MORE appeared to be the most enriched CRE in NS cells from Oct6 and 
Sox2 ChIP-seq data. Based on these findings, I hypothesized that Oct4 prefers association 
with Sox2 while Oct6 prefers self-association to facilitate the expression of those 
enhancers’ target genes. However, this needs experimental validation and I have provided 
that. This side project also gave me a wider scope of application of my developed 
quantitative assay.  
Therefore, the question will be why those cell lines differ in motif enrichment 
while Sox2 and similar POU factors express abundantly in both cell lines. Applying my 
quantitative assay (mainly FP-EMSA), I found that Oct6 shows a higher tendency to form 
homodimer irrespective of the presence or absence of Sox2 while Oct4 shows the reverse 
tendency by forming synergistically favourable heterodimer in the presence of Sox2. 
Consequently, different nature of partnering with Sox2, POU factors show the difference 
in complex formation on the cis regulatory element of their target gene. Hence, the 
difference in the nature of highly enriched motif is understood.  
Two important findings from my work that appear to be little appreciated in the 
current literature are 1) the significant differences in binding affinities between sequence 
variants within the same cis regulatory motif, and 2) the significant differences in real 
binding motifs between transcription factor paralogs. 
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The second finding refers to my work identifying that within ChIP-seq data from 
neural stem cells of Oct6, an Oct4 paralog.  So far, the most prominent motif within 
called peaks represent MORE and PORE elements, cis elements that bind POU factors 
making a homodimer (or paralog heterodimer) formation rather than the predominant SO-
CRE found in Oct4 (and Sox2) ChIP-seq data from ES cells. This is despite the fact that 
Sox2 is also expressed (along with a number of other Sox factors) in neural stem cells so 
the lack of a SO-CRE in the Oct6 ChIP-seq dataset cannot be explained through lack of a 
Sox partner. Therefore, this is solely due to the difference in binding affinity among 
transcription factor paralogs with a specific DNA binding site. Moreover, this is well 
supported by others as well as my current findings (Segal and Widom, 2009; Singh and 
Hannenhalli, 2010).  
5.2. Some limitations 
In all my analysis throughout this thesis I used the nuclear lysate from fusion 
protein construct transfected CHO cells. Thus all the binding assays were performed 
within the milieu of a nuclear lysate. With the fusion proteins I was able to track and 
measure the behaviour of transcription factors based on the fused fluorescent protein. 
Two issues arise from this, first is the question of whether the fused protein retains the 
full function of the endogenous protein and the second, whether other proteins/factors 
within the nuclear lysate interfere with my protein-DNA measurements. I have 
experimentally addressed functionality of the fused proteins, nuclear localization, SO-
CRE in vitro binding, and a SO-CRE based luciferase reporter assay all indicated 
functionality. In addition, similar fused Oct4 and Sox2 constructs have been successful in 
reprogramming embryonic fibroblasts to a pluripotent state (Lam et al., 2012). While I 
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cannot completely rule out the possibility of differences in DNA binding between the 
fused and endogenous proteins, the fact that both in vitro and in vivo functions are 
conserved argues against this. Furthermore, having a fluorescent molecule fused to the 
TF of interest is an essential component of my experimental design and it would be 
challenging without this. 
While it could be argued that studying TF-fusion protein function in the context of 
a nuclear lysate milieu is more representative of the true in vivo environment there would 
be advantages to using a purified protein instead. Note however, this remains a difficult 
and challenging task; getting purified full-length Oct4 has been particularly challenging 
(anecdotal evidence and personal communications). Therefore, purified protein reduces 
the cost of the experiments removing the need for dGdC (very expensive) to remove non-
specific protein-DNA interactions. Furthermore, once the assay will be simple, we can 
derive the accurate fitting model for generating Kd from bound fraction vs. concentration 
of protein plot. In addition, highly concentrated purified Sox2 and Oct4 protein actually 
can resolve any further issue on the strength of protein-protein interaction through my 
strategies which effectively could show that protein-protein interaction is DNA 
dependent.  
Sox2 concentration measurement during pre-implantation development – I used 
indirect immunofluroscence to measure the levels of Sox2 protein in the mouse pre-
implantation embryo. While I am confident in my measurements, which are essential in 
my model of the segregation of ICM into PE and EPI, these are relative measurements. 
Absolute measurements of Sox2 and Oct4 protein levels throughout pre-implantation 
development would be valuable data to add to the model. Once we quantify the absolute 
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level of protein present in each stage of early embryo, my present prediction regarding 
concentration levels in morula and ICM will be justified.  
5.3. Outlook 
Improvement of the developed quantitative assay – The novelty of the developed 
quantitative assay is significant because of its robustness and ability to derive quantitative 
data for binding interaction of full-length proteins. However, this is an alternative 
approach for quantitative determination on the assembly of Sox2-Oct4-DNA complex 
and thereby needs a lot of control experiments to distinguish the important findings. As 
mentioned in limitation, if we are able to purify the full-length proteins from crude cell 
lysate, it will be very simple to develop a quantitative assay on the purified wild type 
proteins and that will be economically cheaper compared to the present alternative 
quantitative assay. However, although someone might suggest developing an in vivo 
quantitative assay in live cell or in early mouse embryo, it is quite challenging to derive 
quantitative binding data based on specific DNA motifs, Sox2 and Oct4 in in vivo. This is 
because of the presence of thousands of similar effective binding site comparable to the 
specific one in live cell or in early embryo. 
Concentration measurement during mouse pre-implantation development − 
Measuring accurate concentrations of Sox2 and Oct4 will be pivotal to correlate in vitro 
binding data with that of the in vivo environment. In my thesis I determine the relative 
concentration of Sox2 protein levels, confirming that these levels parallel that measured 
at the mRNA level in the morula to ICM transition. However, the absolute concentration 
is not yet known; such measurements would be important to gain a truly systems level 
understanding of the pre-implantation regulatory network. This would be possible 
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combining some of the techniques I have used here (FCS) with appropriately engineered 
mice. Specifically, a transgenic mouse with a fluorescent protein fused to Sox2 and 
another to Oct4 by way of homologous recombination at the endogenous loci would need 
to be generated. I assume that the fusion does not disrupt the expression level and/or 
function of the targeted transcription factor; it is at least shown, fusion proteins work in 
reprogramming (Lam et al., 2012). With all these efforts, it would then be possible to 
measure Sox2 and Oct4 concentrations in vivo in the developing pre-implantation embryo 
using FCS.  
While challenging, this mouse engineering approach would virtually be the only 
way to track absolute concentrations of transcription factors with single cell resolution. 
There is an appropriate method to make such measurements in ES cells combining a 
quantitative western blot with transiently expressed fusion proteins and FCS as shown by 
Chung et al. (Chung et al., 2011). Western blotting of pre-implantation embryos is, 
however, unrealistic. A minimum of 50 embryos is required to achieve sufficient protein 
in a single lane of a Western blot. Even if technically possible, such an approach would 
loose the single cell resolution required to understand the dynamics of cellular decision 
making.   
Identifying additional essential cis regulatory elements – While there is no 
shortage of loci bound by Sox2 and Oct4 in pluripotent cells, discovered by ChIP-seq in 
ES cells, identifying which of these is truly functional in the developmental context of 
early embryonic development remains a challenge. In this regard, the most valuable 
information to elucidate functionally important cis elements is the generation and analysis 
of high quality, dynamic gene expression data. Such data, specifically the analysis of 48 
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genes in hundreds of individual cells harvested directly and at different developmental 
time points from the pre-implantation embryo, provided the basis for the hypothesis I 
tested in my thesis. The restriction of Nanog, Esrrb, Klf4, and Klf2, presumed to be 
immediately repressed upon FGF signalling within the ICM, along with Sox2, suggests 
these transcription factors and the cis regulatory elements they target would provide 
insight into the formation of the pluripotent cell. This, in fact, was an approach a 
postdoctoral fellow in the lab (Dr. Andrew Hutchins) targeted. He developed a 
bioinformatics tool to discover new composite cis regulatory motifs for different key 
transcription factors such as Sox2, Oct4, Esrrb, Nanog, Klf4 and Smad1. He found a 
number of interesting cis regulatory motifs; one in particular was an esrrb-sox cis element 
Nr0b1 that I subsequently validated with my FP-EMSA (Hutchins et al., 2012). I 
generated an Esrrb full-length fusion construct and measured Esrrb and Sox2 on this 
identified esrrb-sox motif of Nr0b1 (also called Dax1) and observed that Sox2 and Esrrb 
create a heterodimer complex on this. This particular Sox2-Esrrb heterodimer complex on 
Nr0b1 is highly conserved through eutherian mammals suggesting the Esrrb-Sox2 
complex may be significant in the pluripotent gene regulatory network in parallel to the 
well-studied Sox2-Oct4 heterodimer complex noting Nr0b1 is essential for pluripotent 
cells (Khalfallah et al., 2009). It is also reported that Esrrb and Sox2 co-localize on 
genome as identified by ChIP-seq of these transcription factors in ES cells (Chen et al., 
2008). Thereby, it will be interesting to determine their binding interaction in protein-
protein and protein-DNA complex assembly in a quantitative approach. This will provide 
a better interactive network involved in maintaining pluripotency and self-renewal of ES 
cells. 
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Looking beyond Sox2, Oct4 and Oct6 – In the present study I only considered 
Sox2, Oct4 and Oct6 as required for my hypothesis of two projects. However, it will be 
significant if I extend this study focusing on some other lineage specific transcription 
factors such as Nanog (EPI specific) and Esrrb (EPI specific) to better understand the 
interactive network in protein level with Sox2 and Oct4 using our present knowledge. 
Transcription factors like Nanog and Esrrb are additional key regulators required together 
with Sox2 and Oct4 for sustaining pluripotency in ES cells and EPI. It will be fascinating 
to look for any binding interaction present among these essential transcription factors. An 
understanding on their mutual binding interaction could be pivotal for driving the 
regulation of many target genes which have yet to be determined. There are some reports 
saying that Nanog shows a homodimer forming tendency through qualitative observation 
(Wang et al., 2008). However, this needs a quantitative validation.  
The system level understanding of my thesis work promises to critical insights 
into the differentiation of pluripotent ES cells and the segregation of different cell 
lineages during pre-implantation embryo development. For the first time, this study 
quantitatively showed that the critical concentration level of a key transcription factor 
(e.g Sox2) can be also the pivotal driving force for specific gene expression (e.g. Fgf4) 
responsible for the segregation of certain cell lineage (e.g. ICM). Alternatively, looking 
into the quantitative determination of the protein-DNA (monomer) and protein-protein-
DNA (heterodimers/homodimer) can even distinguish the preferred binding pathway for 
key transcription factors involved in the pluripotency and self renewal of ES cells. 
Basically, my another study based on differential binding of different POU factors (Oct4 
and Oct6) in presence of Sox2 on PORE/MORE and SO-CRE shed light on the presence 
118 | P a g e  
 
of different mechanism of interactive regulatory network  in ES cell and NS cell. 
Therefore, these insights will help us to better understand the mechanistic network of 
those transcription factors which are key to maintaining pluripotency and critical for 
controlled differentiation. Furthermore, acquiring basic knowledge of the controlled 
differentiation could be the potential step for regenerative medicine which is the long 


















119 | P a g e  
 
Bibliography  
Alexopoulou, A.N., Couchman, J.R., and Whiteford, J.R. (2008). The  CMV early 
enhancer/chicken β actin (CAG)  promoter can be used to drive transgene expression during the 
differentiation of murine embryonic stem cells into vascular progenitors. BMC cell biology 9, 2. 
 
Ambrosetti, D.C., Basilico, C., and Dailey, L. (1997). Synergistic activation of the fibroblast 
growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by 
a specific spatial arrangement of factor binding sites. Molecular and Cellular Biology 17, 6321. 
 
Andrews, N.C., and Faller, D.V. (1991). A rapid micropreparation technique for extraction of 
DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 19, 
2499. 
 
Aragon, S.R., and Pecora, R. (1976). Theory of dynamic light scattering from polydisperse 
systems. The Journal of Chemical Physics 64, 2395. 
 
Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., and Lonai, P. (1998). Targeted disruption 
of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation 
mammalian development. Proceedings of the National Academy of Sciences 95, 5082. 
 
Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and Lovell-Badge, R. (2003). 
Multipotent cell lineages in early mouse development depend on Sox2 function. Genes & 
Development 17, 126. 
 
Bacia, K., Majoul, I.V., and Schwille, P. (2002). Probing the endocytic pathway in live cells using 
dual-color fluorescence cross-correlation analysis. Biophysical Journal 83, 1184. 
 
Beddington, R.S.P., Robertson, E.J., and Hill, M. (1999). Axis development and early review 
asymmetry in mammals. Cell 96, 195. 
 
Berland, K.M., So, P.T., and Gratton, E. (1995). Two-photon fluorescence correlation 
spectroscopy: method and application to the intracellular environment. Biophysical Journal 68, 
694. 
 
Bermingham, J.R., Scherer, S.S., O'Connell, S., Arroyo, E., Kalla, K.A., Powell, F.L., and 
Rosenfeld, M.G. (1996). Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and 
is required for normal respiration. Genes & Development 10, 1751. 
 
Biggin, M.D. (2011). Animal transcription networks as highly connected, quantitative continua. 
Developmental Cell 21, 611. 
 
Boer, B., Kopp, J., Mallanna, S., Desler, M., Chakravarthy, H., Wilder, P.J., Bernadt, C., and 
Rizzino, A. (2007). Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic 
stem cells inhibits the expression of Sox2: Oct-3/4 target genes. Nucleic Acids Research 35, 
1773. 
 
120 | P a g e  
 
Botfield, M.C., Jancso, A., and Weiss, M.A. (1992). Biochemical characterization of the Oct-2 
POU domain with implications for bipartite DNA recognition. Biochemistry 31, 5841. 
 
Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, C., Gross, M.K., Vriend, G., and Schöler, 
H.R. (1998). New POU dimer configuration mediates antagonistic control of an osteopontin 
preimplantation enhancer by Oct4 and Sox2. Genes & Development 12, 2073. 
 
Bowles, J., Schepers, G., and Koopman, P. (2000). Phylogeny of the SOX family of 
developmental transcription factors based on sequence and structural indicators. Developmental 
Biology 227, 239. 
 
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., 
Kumar, R.M., Murray, H.L., and Jenner, R.G. (2005). Core transcriptional regulatory circuitry in 
human embryonic stem cells. Cell 122, 947. 
 
Branco, M.R., Oda, M., and Reik, W. (2008). Safeguarding parental identity: Dnmt1 maintains 
imprints during epigenetic reprogramming in early embryogenesis. Genes & Development 22, 
1567. 
 
Buschmann, V., Krämer, B., Koberling, F., Macdonald, R., and Rüttinger, S. (2009). Quantitative 
FCS: determination of the confocal volume by FCS and bead scanning with the microtime 200. 
PicoQuant. 
 
Carey, M. (1998). The enhanceosome and minireview transcriptional synergy. Cell 92, 5. 
 
Catena, R., Tiveron, C., Ronchi, A., Porta, S., Ferri, A., Tatangelo, L., Cavallaro, M., Favaro, R., 
Ottolenghi, S., and Reinbold, R. (2004). Conserved POU binding DNA sites in the Sox2 upstream 
enhancer regulate gene expression in embryonic and neural stem cells. Journal of Biological 
Chemistry 279, 41846. 
 
Chazaud, C., Yamanaka, Y., Pawson, T., and Rossant, J. (2006). Early lineage segregation 
between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK 
pathway. Developmental Cell 10, 615. 
 
Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V.B., Wong, E., Orlov, Y.L., Zhang, W., 
and Jiang, J. (2008). Integration of external signaling pathways with the core transcriptional 
network in embryonic stem cells. Cell 133, 1106. 
 
Chew, J.L., Loh, Y.H., Zhang, W., Chen, X., Tam, W.L., Yeap, L.S., Li, P., Ang, Y.S., Lim, B., 
and Robson, P. (2005). Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the 
Oct4/Sox2 complex in embryonic stem cells. Molecular and Cellular Biology 25, 6031. 
 
Chung, Y.D., Sinzinger, M.D., Bovee-Geurts, P., Krause, M., Dinkla, S., Joosten, I., Koopman, 
W.J., Adjobo-Hermans, M.J.W., and Brock, R. (2011). Analyzing the homeostasis of signaling 
proteins by a combination of western blot and fluorescence correlation spectroscopy. Biophysical 
Journal 101, 2807. 
 
121 | P a g e  
 
Ciemerych, M.A., Mesnard, D., and Zernicka-Goetz, M. (2000). Animal and vegetal poles of the 
mouse egg predict the polarity of the embryonic axis, yet are nonessential for development. 
Development 127, 3467. 
 
Dietrich, J.E., and Hiiragi, T. (2007). Stochastic patterning in the mouse pre-implantation 
embryo. Development 134, 4219. 
 
Ellis, P., Fagan, B.M., Magness, S.T., Hutton, S., Taranova, O., Hayashi, S., McMahon, A., Rao, 
M., and Pevny, L. (2004). SOX2, a persistent marker for multipotential neural stem cells derived 
from embryonic stem cells, the embryo or the adult. Developmental Neuroscience 26, 148. 
 
Elson, E.L., and Magde, D. (1974). Fluorescence correlation spectroscopy. I. Conceptual basis 
and theory. Biopolymers 13, 1. 
 
Episkopou, V. (2005). SOX2 functions in adult neural stem cells. Trends in Neurosciences 28, 
219. 
 
Feldman, B., Poueymirou, W., Papaioannou, V.E., DeChiara, T.M., and Goldfarb, M. (1995). 
Requirement of Fgf4 for postimplantation mouse development. Science 267, 246. 
 
Fleming, T.P. (1987). A quantitative analysis of cell allocation to trophectoderm and inner cell 
mass in the mouse blastocyst. Developmental Biology 119, 520. 
 
Fong, C.Y., Bongso, A., Ng, S.C., Kumar, J., Trounson, A., and Ratnam, S. (1998). Blastocyst 
transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and 
understanding implantation. Human Reproduction 13, 2926. 
 
Foo, Y.H., Korzh, V., and Wohland, T. (2012). Fluorescence correlation and cross-correlation 
spectroscopy using fluorescent proteins for measurements of biomolecular processes in living 
organisms. Fluorescent Proteins II, 213. 
 
Forsen, S., and Linse, S. (1995). Cooperativity: over the Hill. Trends in Biochemical Sciences 20, 
495. 
 
Fried, M., and Crothers, D.M. (1981). Equilibria and kinetics of lac repressor-operator 
interactions by polyacrylamide gel electrophoresis. Nucleic Acids Research 9, 6505. 
 
Fried, M.G. (1989). Measurement of protein-DNA interaction parameters by electrophoresis 
mobility shift assay. Electrophoresis 10, 366. 
 
Fried, M.G., and Crothers, D.M. (1984). Equilibrium studies of the cyclic AMP receptor protein-
DNA interaction. Journal of Molecular Biology 172, 241. 
 
Garner, M.M., and Revzin, A. (1981). A gel electrophoresis method for quantifying the binding 
of proteins to specific DNA regions: application to components of the Escherichia coli lactose 
operon regulatory system. Nucleic Acids Research 9, 3047. 
 
122 | P a g e  
 
Gerbe, F., Cox, B., Rossant, J., and Chazaud, C. (2008). Dynamic expression of Lrp2 pathway 
members reveals progressive epithelial differentiation of primitive endoderm in mouse blastocyst. 
Developmental Biology 313, 594. 
 
Gilbert, S.F. (2001). Ecological developmental biology: developmental biology meets the real 
world. Developmental Biology 233, 1. 
 
Gilbert, S.F., and Sarkar, S. (2000). Embracing complexity: organicism for the 21st century. 
Developmental Dynamics 219, 1. 
 
Greber, B., Wu, G., Bernemann, C., Joo, J.Y., Han, D.W., Ko, K., Tapia, N., Sabour, D., 
Sterneckert, J., and Tesar, P. (2010). Conserved and divergent roles of FGF signaling in mouse 
epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6, 215. 
 
Guo, G., Huss, M., Tong, G.Q., Wang, C., Li Sun, L., Clarke, N.D., and Robson, P. (2010). 
Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to 
blastocyst. Developmental Cell 18, 675. 
 
Hanna, J., Markoulaki, S., Mitalipova, M., Cheng, A.W., Cassady, J.P., Staerk, J., Carey, B.W., 
Lengner, C.J., Foreman, R., and Love, J. (2009). Metastable pluripotent states in NOD-mouse-
derived ESCs. Cell Stem Cell 4, 513. 
 
Hanna, J.H., Saha, K., and Jaenisch, R. (2010). Pluripotency and cellular reprogramming: facts, 
hypotheses, unresolved issues. Cell 143, 508. 
 
Hardy, K., and Spanos, S. (2002). Growth factor expression and function in the human and mouse 
preimplantation embryo. Journal of Endocrinology 172, 221. 
 
Harley, V.R., Lovell-Badge, R., and Goodfellow, P.N. (1994). Definition of a consensus DNA 
binding site for SRY. Nucleic Acids Research 22, 1500. 
 
Heinze, K.G., Koltermann, A., and Schwille, P. (2000). Simultaneous two-photon excitation of 
distinct labels for dual-color fluorescence crosscorrelation analysis. Proceedings of the National 
Academy of Sciences 97, 10377. 
 
Hellman, L.M., and Fried, M.G. (2007). Electrophoretic mobility shift assay (EMSA) for 
detecting protein-nucleic acid interactions. Nature Protocols 2, 1849. 
 
Hendrickson, W., and Schleif, R. (1985). A dimer of AraC protein contacts three adjacent major 
groove regions of the araI DNA site. Proceedings of the National Academy of Sciences 82, 3129. 
 
Herr, W., and Cleary, M.A. (1995). The POU domain: versatility in transcriptional regulation by a 
flexible two-in-one DNA-binding domain. Genes & Development 9, 1679. 
 
Hess, S.T., Huang, S.H., Heikal, A.A., and Webb, W.W. (2002). Biological and chemical 
applications of fluorescence correlation spectroscopy. Biochemistry 41, 697. 
 
Hiiragi, T., Louvet-Vallée, S., Solter, D., and Maro, B. (2006). Embryology: Does prepatterning 
occur in the mouse egg? Nature 442, E3-E4. 
123 | P a g e  
 
 
Howley, C., and Ho, R.K. (2000). mRNA localization patterns in zebrafish oocytes. Mechanisms 
of Development 92, 305. 
 
Hwang, L.C., Gösch, M., Lasser, T., and Wohland, T. (2006). Simultaneous multicolor 
fluorescence cross-correlation spectroscopy to detect higher order molecular interactions using 
single wavelength laser excitation. Biophysical Journal 91, 715. 
 
Hwang, L.C., and Wohland, T. (2004). Dual - colour fluorescence cross-correlation spectroscopy 
using single laser wavelength excitation. ChemPhysChem 5, 549. 
 
Hwang, L.C., and Wohland, T. (2005). Single wavelength excitation fluorescence cross-
correlation spectroscopy with spectrally similar fluorophores: resolution for binding studies. The 
Journal of Chemical Physics 122, 114708. 
 
Ilia, M., Beasley, C., Meijer, D., Kerwin, R., Cotter, D., Everall, I., and Price, J. (2002). 
Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. American Journal 
of Psychiatry 159, 1174. 
 
Jacobson, E.M., Li, P., Leon-del-Rio, A., Rosenfeld, M.G., and Aggarwal, A.K. (1997). Structure 
of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes 
& Development 11, 198. 
 
Jauch, R., Choo, S.H., Ng, C.K.L., and Kolatkar, P.R. (2010). Crystal structure of the dimeric 
Oct6 (POU3f1) POU domain bound to palindromic MORE DNA. Proteins: Structure, Function, 
and Bioinformatics 79, 674. 
 
Johnson, M.H., Chisholm, J.C., Fleming, T.P., and Houliston, E. (1986). A role for cytoplasmic 
determinants in the development of the mouse early embryo? Journal of Embryology and 
Experimental Morphology 97, 97. 
 
Johnson, M.H., and McConnell, J.M.L. (2004). Lineage allocation and cell polarity during mouse 
embryogenesis (Elsevier). 
 
Kamachi, Y., Uchikawa, M., and Kondoh, H. (2000). Pairing SOX off: with partners in the 
regulation of embryonic development. Trends in Genetics 16, 182. 
 
Kang, J., Gemberling, M., Nakamura, M., Whitby, F.G., Handa, H., Fairbrother, W.G., and 
Tantin, D. (2009). A general mechanism for transcription regulation by Oct1 and Oct4 in 
response to genotoxic and oxidative stress. Genes & Development 23, 208. 
 
Kaplan, T., Li, X.Y., Sabo, P.J., Thomas, S., Stamatoyannopoulos, J.A., Biggin, M.D., and Eisen, 
M.B. (2011). Quantitative models of the mechanisms that control genome-wide patterns of 
transcription factor binding during early Drosophila development. PLoS Genetics 7, e1001290. 
 
Khalfallah, O., Rouleau, M., Barbry, P., Bardoni, B., and Lalli, E. (2009). Dax-1 knockdown in 
mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem 
Cells 27, 1529. 
 
124 | P a g e  
 
Kim, J.B., Zaehres, H., Wu, G., Gentile, L., Ko, K., Sebastiano, V., AraÃºzo-Bravo, M.J., Ruau, 
D., Han, D.W., and Zenke, M. (2008). Pluripotent stem cells induced from adult neural stem cells 
by reprogramming with two factors. Nature 454, 646. 
 
Kondoh, H., and Kamachi, Y. (2010). SOX-partner code for cell specification: Regulatory target 
selection and underlying molecular mechanisms. The International Journal of Biochemistry & 
Cell Biology 42, 391. 
 
Kopp, J.L., Ormsbee, B.D., Desler, M., and Rizzino, A. (2008). Small increases in the level of 
Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26, 903. 
 
Koutsourakis, M., Langeveld, A., Patient, R., Beddington, R., and Grosveld, F. (1999). The 
transcription factor GATA6 is essential for early extraembryonic development. Development 126, 
723. 
 
Kurimoto, K., Yabuta, Y., Ohinata, Y., Ono, Y., Uno, K.D., Yamada, R.G., Ueda, H.R., and 
Saitou, M. (2006). An improved single-cell cDNA amplification method for efficient high-density 
oligonucleotide microarray analysis. Nucleic Acids Research 34, 42. 
 
Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S., Suemori, H., Nakatsuji, N., and Tada, 
T. (2005). Octamer and Sox elements are required for transcriptional cis regulation of Nanog 
gene expression. Molecular and Cellular Biology 25, 2475. 
 
Laniel, M.A., and Béliveau, A., S. L.Guérin (2001). Electrophoretic mobility shift assays for the 
analysis of DNA-protein interactions. Methods in Molecular Biology-Clifton then Totowa- 148, 
13. 
Levine, M., and Tjian, R. (2003). Transcription regulation and animal diversity. Nature 424, 147. 
 
Li, X.Y., Thomas, S., Sabo, P.J., Eisen, M.B., Stamatoyannopoulos, J.A., and Biggin, M.D. 
(2011). The role of chromatin accessibility in directing the widespread, overlapping patterns of 
Drosophila transcription factor binding. Genome Biology 12, R34. 
 
Liu, P., Sudhaharan, T., Koh, R.M.L., Hwang, L.C., Ahmed, S., Maruyama, I.N., and Wohland, 
T. (2007). Investigation of the dimerization of proteins from the epidermal growth factor receptor 
family by single wavelength fluorescence cross-correlation spectroscopy. Biophysical Journal 93, 
684. 
 
Loh, Y.H., Wu, Q., Chew, J.L., Vega, V.B., Zhang, W., Chen, X., Bourque, G., George, J., 
Leong, B., and Liu, J. (2006). The Oct4 and Nanog transcription network regulates pluripotency 
in mouse embryonic stem cells. Nature Genetics 38, 431. 
 
Longabaugh, W.J. (2012). BioTapestry: A tool to visualize the dynamic properties of gene 
regulatory networks. Methods in Molecular Biology (Clifton, NJ) 786, 359. 
 
Magde, D., Elson, E., and Webb, W.W. (1972). Thermodynamic fluctuations in a reacting 
system-measurement by fluorescence correlation spectroscopy. Physical Review Letters 29, 705. 
 
Magde, D., Elson, E.L., and Webb, W.W. (1974). Fluorescence correlation spectroscopy. II. An 
experimental realization. Biopolymers 13, 29. 
125 | P a g e  
 
 
Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K., Okochi, H., 
Okuda, A., Matoba, R., and Sharov, A.A. (2007). Pluripotency governed by Sox2 via regulation 
of Oct3/4 expression in mouse embryonic stem cells. Nature Cell Biology 9, 625. 
 
Morris, S.A., Teo, R.T.Y., Li, H., Robson, P., Glover, D.M., and Zernicka-Goetz, M. (2010). 
Origin and formation of the first two distinct cell types of the inner cell mass in the mouse 
embryo. Proceedings of the National Academy of Sciences 107, 6364. 
 
Morrisey, E.E., Ip, H.S., Lu, M.M., and Parmacek, M.S. (1996). GATA-6: a zinc finger 
transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. 
Developmental Biology 177, 309. 
 
Morrisey, E.E., Tang, Z., Sigrist, K., Lu, M.M., Jiang, F., Ip, H.S., and Parmacek, M.S. (1998). 
GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse 
embryo. Genes & Development 12, 3579. 
 
Nichols, J., Silva, J., Roode, M., and Smith, A. (2009). Suppression of Erk signalling promotes 
ground state pluripotency in the mouse embryo. Development 136, 3215. 
 
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, 
H., and Smith, A. (1998). Formation of pluripotent stem cells in the mammalian embryo depends 
on the POU transcription factor Oct4. Cell 95, 379. 
 
Nishimoto, M., Fukushima, A., Okuda, A., and Muramatsu, M. (1999). The gene for the 
embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts 
with a complex composed of Oct-3/4 and Sox-2. Molecular and Cellular Biology 19, 5453. 
 
Niswander, L., and Martin, G.R. (1992). Fgf4 expression during gastrulation, myogenesis, limb 
and tooth development in the mouse. Development 114, 755. 
 
Niwa, H., Miyazaki, J., and Smith, A.G. (2000). Quantitative expression of Oct-3/4 defines 
differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics 24, 372. 
 
Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R., and Rossant, J. 
(2005). Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123, 
917. 
 
Nüsslein-Volhard, C. (1991). Determination of the embryonic axes of Drosophila. Development 
113, 1. 
 
Orr-Urtreger, A., Givol, D., Yayon, A., Yarden, Y., and Lonai, P. (1991). Developmental 
expression of two murine fibroblast growth factor receptors, flg and bek. Development 113, 1419. 
 
Palmieri, S.L., Peter, W., Hess, H., and Scholer, H.R. (1994). Oct-4 transcription factor is 
differentially expressed in the mouse embryo during establishment of the first two 
extraembryonic cell lineages involved in implantation. Developmental Biology 166, 259. 
 
126 | P a g e  
 
Pan, X., Foo, W., Lim, W., Fok, M.H.Y., Liu, P., Yu, H., Maruyama, I., and Wohland, T. (2007). 
Multifunctional fluorescence correlation microscope for intracellular and microfluidic 
measurements. Review of Scientific Instruments 78, 053711. 
 
Pedersen, R.A. (1986). Potency, lineage, and allocation in preimplantation mouse embryos, Vol 3 
(Cambridge University Press, Cambridge). 
 
Pelton, T.A., Bettess, M.D., Lake, J., Rathjen, J., and Rathjen, P.D. (1998). Developmental 
complexity of early mammalian pluripotent cell populations in vivo and in vitro. Reproduction, 
Fertility and Development 10, 535. 
 
Pesce, M., and Schöler, H.R. (2001). Oct-4: gatekeeper in the beginnings of mammalian 
development. Stem Cells 19, 271. 
 
Pique-Regi, R., Degner, J.F., Pai, A.A., Gaffney, D.J., Gilad, Y., and Pritchard, J.K. (2011). 
Accurate inference of transcription factor binding from DNA sequence and chromatin 
accessibility data. Genome Research 21, 447. 
 
Plusa, B., Piliszek, A., Frankenberg, S., Artus, J., and Hadjantonakis, A.K. (2008). Distinct 
sequential cell behaviours direct primitive endoderm formation in the mouse blastocyst. 
Development 135, 3081. 
 
Reik, W. (2007). Stability and flexibility of epigenetic gene regulation in mammalian 
development. Nature 447, 425. 
 
Reményi, A., Lins, K., Nissen, L.J., Reinbold, R., Schöler, H.R., and Wilmanns, M. (2003). 
Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 
and Sox2 on two enhancers. Genes & Development 17, 2048. 
 
Revzin, A. (1989). Gel electrophoresis assays for DNA-protein interactions. BioTechniques 7, 
346. 
 
Rigler, R., Földes-Papp, Z., Meyer-Almes, F.J., Sammet, C., Völcker, M., and Schnetz, A. 
(1998). Fluorescence cross-correlation: a new concept for polymerase chain reaction Journal of 
Biotechnology 63, 97. 
 
Rodda, D.J., Chew, J.L., Lim, L.H., Loh, Y.H., Wang, B., Ng, H.H., and Robson, P. (2005). 
Transcriptional regulation of nanog by OCT4 and SOX2. Journal of Biological Chemistry 280, 
24731. 
 
Roode, M., Blair, K., Snell, P., Blair, K.E., Marchant, S., Smith, A., and Nichols, J. (2012). 
Human hypoblast formation is not dependent on FGF signalling. Developmental Biology 361, 
358. 
Rosner, M.H., Vigano, M.A., Ozato, K., Timmons, P.M., Poirie, F., Rigby, P.W.J., and Staudt, 
L.M. (1990). A POU-domain transcription factor in early stem cells and germ cells of the 
mammalian embryo. Nature 345, 686. 
 
Rossant, J. (1976). Postimplantation development of blastomeres isolated from 4-and 8-cell 
mouse eggs. Journal of Embryology and Experimental Morphology 36, 283. 
127 | P a g e  
 
 
Rossant, J., Chazaud, C., and Yamanaka, Y. (2003). Lineage allocation and asymmetries in the 
early mouse embryo. Philosophical Transactions of the Royal Society of London Series B: 
Biological Sciences 358, 1341. 
 
Rossant, J., and Tam, P.P. (2002). Mouse development: patterning, morphogenesis and 
organogenesis. Recherche 67, 02. 
 
Rossant, J., and Tam, P.P.L. (2009). Blastocyst lineage formation, early embryonic asymmetries 
and axis patterning in the mouse. Development 136, 701. 
 
Rudnick, J., and Bruinsma, R. (1999). DNA-protein cooperative binding through variable-range 
elastic coupling. Biophysical Journal 76, 1725. 
 
Ruvkun, G., and Finney, M. (1991). Regulation of transcription and cell identity by POU domain 
proteins. Cell 64, 475. 
 
Scheidereit, C., Heguy, A., and Roeder, R.G. (1987). Identification and purification of a human 
lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an 
immunoglobulin promoter in vitro. Cell 51, 783. 
 
Schöler, H.R., Hatzopoulos, A.K., Balling, R., Suzuki, N., and Gruss, P. (1989). A family of 
octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific 
expression of an Oct factor. The EMBO Journal 8, 2543. 
 
Schöler, H.R., Ruppert, S., Suzuki, N., Chowdhury, K., and Gruss, P. (1990). New type of POU 
domain in germ line-specific protein Oct4. Nature 344, 435. 
 
Schwille, P., and Haustein, E. (2002). Fluorescence correlation spectroscopy: An introduction to 
its concepts and applications. Biophysics Textbook Online (BTOL). 
 
Schwille, P., Meyer-Almes, F.J., and Rigler, R. (1997). Dual-color fluorescence cross-correlation 
spectroscopy for multicomponent diffusional analysis in solution. Biophysical Journal 72, 1878. 
 
Segal, E., and Widom, J. (2009). From DNA sequence to transcriptional behaviour: a quantitative 
approach. Nature Reviews Genetics 10, 443. 
 
Shaner, N.C., Lin, M.Z., McKeown, M.R., Steinbach, P.A., Hazelwood, K.L., Davidson, M.W., 
and Tsien, R.Y. (2008). Improving the photostability of bright monomeric orange and red 
fluorescent proteins. Nature Methods 5, 545. 
 
Sharov, A.A., and Ko, M.S.H. (2009). Exhaustive search for over-represented DNA sequence 
motifs with CisFinder. DNA Research 16, 261. 
 
Shi, X., Foo, Y.H., Sudhaharan, T., Chong, S.W., Korzh, V., Ahmed, S., and Wohland, T. (2009). 
Determination of dissociation constants in living zebrafish embryos with single wavelength 
fluorescence cross-correlation spectroscopy. Biophysical Journal 97, 678. 
 
128 | P a g e  
 
Singh, L.N., and Hannenhalli, S. (2010). Correlated changes between regulatory cis elements and 
condition-specific expression in paralogous gene families. Nucleic Acids Research 38, 738. 
 
Smith, Z.D., Chan, M.M., Mikkelsen, T.S., Gu, H., Gnirke, A., Regev, A., and Meissner, A. 
(2012). A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 
484, 339. 
 
Suzuki, N., Rohdewohld, H., Neuman, T., Gruss, P., and Schöler, H.R. (1990). Oct-6: a POU 
transcription factor expressed in embryonal stem cells and in the developing brain. The EMBO 
Journal 9, 3723. 
 
Tanaka, S., Kamachi, Y., Tanouchi, A., Hamada, H., Jing, N., and Kondoh, H. (2004). Interplay 
of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Molecular 
and cellular biology 24, 8834. 
 
Tarkowski, A.K. (1959). Experiments on the development of isolated blastomeres of mouse eggs. 
Nature 184, 1286. 
 
Thompson, N.L. (1991). Fluorescence correlation spectroscopy. In topics in fluorescence 
spectroscopy. Techniques. J. R. Lakowicz, editor. Plenum Press, New York 1, 337. 
 
Thompson, N.L., Lieto, A.M., and Allen, N.W. (2002). Recent advances in fluorescence 
correlation spectroscopy. Current Opinion in Structural Biology 12, 634. 
 
Tokuzawa, Y., Kaiho, E., Maruyama, M., Takahashi, K., Mitsui, K., Maeda, M., Niwa, H., and 
Yamanaka, S. (2003). Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem 
cell self-renewal and mouse development. Molecular and Cellular Biology 23, 2699. 
 
Tomilin, A., Reményi, A., Lins, K., Bak, H., Leidel, S., Vriend, G., Wilmanns, M., and Schöler, 
H.R. (2000). Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific 
POU dimer configuration. Cell 103, 853. 
 
Tsunoda, Y., and McLaren, A. (1983). Effect of various procedures on the viability of mouse 
embryos containing half the normal number of blastomeres. Journal of Reproduction and Fertility 
69, 315. 
 
Verrijzer, C.P., Alkema, M.J., van Weperen, W.W., Van Leeuwen, H.C., Strating, M.J., and Van 
der Vliet, P.C. (1992). The DNA binding specificity of the bipartite POU domain and its 
subdomains. The EMBO Journal 11, 4993. 
 
Wang, J., Levasseur, D.N., and Orkin, S.H. (2008). Requirement of Nanog dimerization for stem 
cell self-renewal and pluripotency. Proceedings of the National Academy of Sciences 105, 6326. 
 
Wang, Z.X., Kueh, J.L.L., Teh, C.H.L., Rossbach, M., Lim, L., Li, P., Wong, K.Y., Lufkin, T., 
Robson, P., and Stanton, L.W. (2007). Zfp206 is a transcription factor that controls pluripotency 
of embryonic stem cells. Stem Cells 25, 2173. 
 
Wegner, M., Drolet, D.W., and Rosenfeld, M.G. (1993). POU-domain proteins: structure and 
function of developmental regulators. Current Opinion in Cell Biology 5, 488. 
129 | P a g e  
 
 
Widengren, J., Mets, Ã., and Rigler, R. (1999). Photodynamic properties of green fluorescent 
proteins investigated by fluorescence correlation spectroscopy. Chemical Physics 250, 171. 
 
Wilson, M., and Koopman, P. (2002). Matching SOX: partner proteins and co-factors of the SOX 
family of transcriptional regulators. Current Opinion in Genetics & Development 12, 441. 
 
Wohland, T., Friedrich, K., Hovius, R., and Vogel, H. (1999). Study of ligand-receptor 
interactions by fluorescence correlation spectroscopy with different fluorophores: evidence that 
the homopentameric 5-hydroxytryptamine type 3As receptor binds only one ligand. Biochemistry 
38, 8671. 
 
Wood, H.B., and Episkopou, V. (1999). Comparative expression of the mouse Sox1, Sox2 and 
Sox3 genes from pre-gastrulation to early somite stages. Mechanisms of Development 86, 197. 
 
Yamanaka, Y., Lanner, F., and Rossant, J. (2010). FGF signal-dependent segregation of primitive 
endoderm and epiblast in the mouse blastocyst. Development 137, 715. 
 
Yamanaka, Y., Lanner, F., and Rossant, J. (2011). FGF signal-dependent segregation of primitive 
endoderm and epiblast in the mouse blastocyst. Development 137, 715. 
 
Yamanaka, Y., Ralston, A., Stephenson, R.O., and Rossant, J. (2006). Cell and molecular 
regulation of the mouse blastocyst. Developmental Dynamics 235, 2301. 
 
Yuan, H., Corbi, N., Basilico, C., and Dailey, L. (1995). Developmental-specific activity of the 
FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes & Development 9, 
2635. 
 
Zacharias, D.A., Violin, J.D., Newton, A.C., and Tsien, R.Y. (2002a). Partitioning of lipid-
modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913. 
 
Zacharias, D.A., Violin, J.D., Newton, A.C., and Tsien, R.Y. (2002b). Partitioning of lipid-
modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913-916. 
 
Zappone, M.V., Galli, R., Catena, R., Meani, N., De Biasi, S., Mattei, E., Tiveron, C., Vescovi, 
A.L., Lovell-Badge, R., and Ottolenghi, S. (2000). Sox2 regulatory sequences direct expression of 
a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, 
revealing regionalization of gene expression in CNS stem cells. Development 127, 2367. 
 
Zernicka-Goetz, M. (1998). Fertile offspring derived from mammalian eggs lacking either animal 
or vegetal poles. Development 125, 4803. 
 
Zernicka-Goetz, M. (2005). Cleavage pattern and emerging asymmetry of the mouse embryo. 
Nature Reviews Molecular Cell Biology 6, 919. 
 
Zwart, R., Broos, L., Grosveld, G., and Meijer, D. (1996). The restricted expression pattern of the 
POU factor Oct-6 during early development of the mouse nervous system. Mechanisms of 
Development 54, 185. 
130 | P a g e  
 
Appendix 
Appendix A − (construct design): 
Appendix A1 – Primer sequences for fusion PCR 







N terminal fusion 
1F eGFP AATTGAGCTCTATGGCCACAACCATGGTGAGCAAGGGCGAGGAGC 45   
1R eGFP GAAGCCAGGTGTCCAGCCATGCCGCTGCCGCCCTTGTACAGCTCGTCCATGCC 53   
 2F Oct4 GGCATGGACGAGCTGTACAAGGGCGGCAGCGGCATGGCTGGACACCTGGCTTC 
53 
  
 2R Oct4 AGTCGCGGCCGCTTCAGTTTGAATGCATGGGAG 
33 
  
 1F seq EG-Oct CAAGGACGACGGCAACTACAAG 22   
 1R seq EG-Oct GTCTGGCTGAACACCTTTC 19   
      
pCAG Oct4-eGFP 1F Oct4 AATTGAGCTCCCGTCCCTAGGTGAGCCG 28   
C terminal fusion 1R Oct4 CCTCGCCCTTGCTCACCATGCCGCTGCCGCCGTTTGAATGCATGGGAGAGC 51   
 2F eGFP GCTCTCCCATGCATTCAAACGGCGGCAGCGGCATGGTGAGCAAGGGCGAGG 51   
 2R eGFP AGTCGCGGCCGCTTTACTTGTACAGCTCGTCC 32   
 1F seq Oct-EG Not required    
 1R seq Oct-EG Not required    
      
pCAG mCherry-
Sox2 1F mCherry AATTGAGCTCTATGGCCACAACCATGGTGAGC 
32 
  
N terminal fusion 1R mCherry GCTTCAGCTCCGTCTCCATCATGCCGCTGCCGCCCTTGTACAGCTCGTCCATGC 54   
 2F Sox2 GCATGGACGAGCTGTACAAGGGCGGCAGCGGCATGATGGAGACGGAGCTGAAGC 54   
 2R Sox2 AGTCGCGGCCGCTTCACATGTGCGACAGGGGCAG 34   
 1F seq mC-SO GTAATGCAGAAGAAGACC 
18 
  
 1R seq mC-SO CTCCTTCATGTGCAGAGC  19   
      
pCAG Sox2-
mCherry 1F Sox2 AATTGAGCTCCCAGCGCCCGCATGTATAACATG 
33 
  
C terminal fusion 1R Sox2 CCTCCTCGCCCTTGCTCACCATGCCGCTGCCGCCCATGTGCGACAGGGGCAGTG 54   
 2F mCherry CACTGCCCCTGTCGCACATGGGCGGCAGCGGCATGGTGAGCAAGGGCGAGGAGG 54   
 2R mCherry AGTCGCGGCCGCTTTACTTGTACAGCTCGTCCATGC 36   
 1F seq SO-mC GAAGGATAAGTACACGCTTCC 
21 
  
 1R seq SO-mC CCGTCCTCGAAGTTCATCAC 20   







1F eGFP AATTGAGCTCTATGGCCACAACCATGGTGAGCAAGGGCGAGGAGC 
   





AGGAATGCTCGTCAAGAAGA    
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pCAG mCherry-
eGFP 1F mCherry AATTGAGCTCTATGGCCACAACCATGGTGAGC    




2F pctrl2  
eGFP 
CCTCGCCCTTGCTCACCATGCCGCTGCCGCCCTTGTACAGCTCGTCCATGC 51   








   
pCAG-eGFP 1F eGFP same as above    
 2R eGFP same as above    
 pCAGseqF same as below    
 pCAGseqR2 same as below    
      
pCAG-mCherry 1F mCherry same as above    
 2R mCherry same as above    
 pCAGseqF same as below    
 pCAGseqR2 same as below    
      
pCAG eGFP-Oct6 
N terminal fusion 
eG-Oct6 1F:  AATTGAGCTCCACAACCATGGTGAGCAAGGGCGAGGAGC    
eG-Oct6 1R: TACTGCGCGGTGGTGGCCATGCCGCTGCCGCCCTTGTACAGCTCGTCCATGC    
 eG-oct6 2F: GCATGGACGAGCTGTACAAGGGCGGCAGCGGCATGGCCACCACCGCGCAGTA    
 eG-oct6 2R: AGTCGCGGCCGCCGTCTAACTGCGCGCCGGAGGCACCG    
      
Appendix A2 – Reaction mixture of initial PCR  
( Mix 1)Reagent Amount Final Concentration 
sterile ddH2O 11 µl  
dNTP mix (10 mM each dNTP) 0.5 µl 200  µM of each dNTP 
upstream and downstream  
primer mix (15 µM each) 
0.5 µl 300 nM of each primer 
template DNA (15 ng/µl) 0.5 µl 7.5 ng 
Final volume 12.5 µl 
 
( Mix 2) Reagent Amount Final Concentration 
sterile ddH2O 9.625 µl  
Expand High Fidelity buffer,  




1x (1.5 ml MgCl2) 
Expand High Fidelity enzyme mix 0.375 µl 1.3 U/reaction 
Final volume 12.5 µl  
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Appendix A3 – Reaction mixture of fusion PCR  
Mix 1 
  Reagent Amount Final Concentration 
sterile ddH2O 8.5 µl  
dNTP mix (10 mM each dNTP) 0.5 µl 200  µM of each dNTP 
upstream and downstream primer mix (15 µM 
each) 
0.5 µl 300 nM of each primer 
PCR product of 5’ gene 1.5 µl 
 
PCR product of 3’ gene 1.5 µl 
 Final volume 12.5 µl  
Mix 2 
  
Reagent Amount Final Concentration 
sterile ddH2O 9.625 µl  
Expand High Fidelity buffer, 10x with 15 ml 
MgCl2 
2.5 µl 1x (1.5 ml MgCl2) 
Expand High Fidelity enzyme mix 0.375 µl 1.3 U/reaction 
Final volume 12.5 µl 
 
 
Appendix A4 − thermal cycling parameter for initial and fusion PCR 
Step Temperature Time Cycle 
initial denaturation 95oC 2 m 1x 
denaturation 95oC 15 s 
10x annealing 55oC* 30 s 
elongation 72oC 45 s 
denaturation 95oC 15 s 
20x 
annealing 55oC 30 s 
elongation 72oC 
45 s + 5s for 
each successive 
cyle 
final elongation 72oC 7 m 1x 




133 | P a g e  
 
Appendix A5 − Fusion plasmid design 
Here are those plasmid maps which were used in the present study, shown below; 
 
Figure A.1 | Plasmid maps of Oct4, Sox2, Oct6, and positive control are shown here. (a) 
Expression plasmid and the fusion template of eGFP-Oct4, (b) Expression plasmid and 
the fusion template of mCherry-Sox2, (c) Expression plasmid and the fusion template of 




SW-FCCS – FINDING COMPLEX PERCENTAGE 





F1(t) F2(t)    Equation (14)
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where 1 and 2 refers to the two detection channels. Each of the detection channels 
receives the signals from different fluorescent labels.  
With the assumption that the binding stoichiometry is 1:1, 
The ACF and CCF’s amplitude can be expressed as a function of count rate per particle 
per second (cps) and the concentrations of the particles are (Shi et al., 2009): 
2 2 2
2
( ) ( ) ( )
(0)
[ ( ) /( )]
η η η η
η η η η β
+ + +
=
+ + + +
g g g g
g g r r g g r r gr
g g g g g g
A eff g g r r g g r r gr A eff
C C q q C
G
N V C C q q C N V
     Equation (15)        
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      Equation (17)         
where 
Gg(0) refers to the amplitude of the ACF in the green channel (eGFP); 
Gr(0) refers to the amplitude of the ACF in the red channel (mCherry); 
Gx(0) refers to the amplitude of the CCF; 
gβ  and rβ  refers to the uncorrelated background count rate in the green and red channels 
respectively;  
AN  is Avogadro’s constant;  
g
gη   and grη  are the cps of green and red labeled particles in the green channel 
respectively;  
r
gη  and rrη  are the cps of green and red labeled particles in the red channel respectively. 
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gq  and rq  are correction factors to account for changes in fluorescence yields upon 
binding.  
Cg, Cr, and Cgr are the concentrations of the unbound green, unbound red and the complex 




Cg + Cgr[ ]
x 100%
   Equation (18) 
Calibration of the system was done by using rhodamine 6G with a diffusion coefficient of 
426 μm2/s (Zacharias et al., 2002b) and excitation using 514nm laser. The effective 
observation was calculated from Equation (5). The concentrations of the unbound and 
complex particles can be calculated using Equations (8) to (10) with found amplitude of 
the cross-correlation functions and cps.  
Appendix C 
DNA motifs that we used in our experiments:  
Nanog-Cy5-F       5'-Cy5-TCCACCATGGACATTGTAATGCAAAAGAAGCTGTAAG-3‘       
Utf1-Cy5-F           5’-Cy5-GGATGAGCCGTCATTGTTATGCTAGTGAAGTGCCGGC-3’ 
Fgf4-Cy5-F             5'-Cy5-TAGAAAACTCTTTGTTTGGATGCTAATGGGATACTTA-3‘ 
Oct4-Cy5-F           5’-Cy5-CTATCATGCACCTTTGTTATGCATCTGCCGTCTGCCC-3‘ 
Sox2-Cy5-F           5'-Cy5-CTCGGGCAGCCATTGTGATGCATATAGGATTATTCA-3‘ 
All those oligos were annealed with their respective reverse complements for making 








Figure A.2 | Obtaining bound fraction plot from FCS and EMSA for Kd determination. 
EMSA and FCS were two chosen methods used to obtain a bound fraction plot in order to 
derive the Kd value. The band intensities from the EMSA scan allowed the computation 
of bound fraction. In FCS, the shift in the autocorrelation curve allowed the computation 














Figure A.3 | The location of different SO-CREs with respect to their different target genes 
are shown in a pictorial way. Thick line represents the exon of the genes and thin line 
represents the intron of a gene. Red protein stands for the fusion mCherryu-Sox2 and 
green ball stands for fusion protein eGFP-Oct4. 
 
 
138 | P a g e  
 
Appendix F. 





Figure A.4 | Transfection efficiency of mCherry-eGFP plasmid driven by pCAG 
vector is shown in ES cells. 
